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ABSTRACT 
In both mammals and parasites, S-adenosyl-L-homocysteine hydrolase 
(SAHH) plays a crucial role in regulating S-adenosylmethionine dependent 
transmethylations by catalyzing the reversible conversion of adenosyl-L-
homocysteine (AdoHcy) to adenosine and homocysteine. Inhibitors of parasite 
SAHHs (e.g., those of Leishmania, Plasmodium, Trypanosoma) are potential anti-
parasitic agents which may present selective inhibition if their inhibitory activity is 
weaker for Homo sapiens SAHH (Hs-SAHH). This study was aimed at addressing the 
differences in structure and kinetic properties between Hs-SAHH and Tc-SAHH, the 
SAHH of Trypanosoma cruzi, the organism which causes Chagas disease in humans.  
The available X-ray structures of Hs-SAHH and Tc-SAHH show no 
significant difference between the active sites of the two enzymes, providing no 
definite suggestions for designing selective anti-parasitic inhibitors. Therefore, we 
have designed a series of biochemical, biophysical and computational studies 
focusing on enzyme interactions with the nicotinamide cofactors. These studies 
showed that the equilibrium and kinetic properties of the association and dissociation 
of the cofactor NAD+ from the enzymes of Hs-SAHH and Tc-SAHH are qualitatively 
similar but quantitatively distinct. Briefly, association of NAD+ to both enzymes is a 
complex process, composed of two parts: a fast-binding phase (dead time) and a 
slow-binding phase. The fast-binding phase comes from one class of the 
homotetrameric apo-enzyme active sites, which binds cofactor weakly and generates 
full activity very rapidly (in less than a minute). The slow-binding phase comes from 
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the other class of active sites which binds cofactor more strongly but generates 
activity only slowly (over 30 min). These two classes of active sites appear to be 
numerically equal. The kinetics of slow binding of NAD+ to two enzymes show 
concentration dependence, and the cofactor binds to Hs-SAHH almost 10 times faster 
than to Tc-SAHH. The final binding affinity of cofactor NAD+ to Tc-SAHH persists 
at micromolar levels while Hs-SAHH decreases the binding affinity from micromolar 
to nanomolar over a period of time and its equilibrium affinity stays at nanomolar 
levels. In contrast to the complex kinetics of association, both enzymes undergo 
dissociation of NAD+ from all four sites in a single first-order reaction. The 
dissociation of NAD+ from two enzymes shows complex temperature dependence and 
NAD+ leaves from Tc-SAHH much faster than from Hs-SAHH. Compared to the 
traditional selective inhibitor target site (the substrate-binding domain of SAHH), the 
identified differential features between Hs-SAHH and Tc-SAHH suggest the use of a 
novel target site, the cofactor (NAD+/NADH)-binding domain. 
In a detailed analysis, two structural elements, the helix 18 at the C-terminal 
and the β-sheet A of the Rossmann motif in the cofactor-binding domain, were 
identified as possible sources of the distinct properties of the two enzymes. The site-
directed mutagenesis approach was employed to create two kinds of mutants: the 
“humanized” Tc-SAHH (helix 18 or β-sheet A of Tc-SAHH replaced by that of 
human enzyme) and the “parasitized” Hs-SAHH (helix 18 or β-sheet A of Hs-SAHH 
replaced by that of parasite enzyme). As expected, the results for the two mutants 
were intermediate between the two wild types: the “humanized” Tc-SAHH exhibits 
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similar kinetics and thermodynamics to wild type Hs-SAHH while the “parasitized” 
Hs-SAHH has properties close to wild type parasite enzymes.  
Moreover, in an alanine scanning computational study, two conserved 
residues at the C-terminus, a Lys and a Tyr, are found to be involved in the 
differential kinetic properties of the two enzymes. All these data support the view that 
the cofactor-binding domain is a good target for designing selective inhibitors against 
parasite enzymes. 
In addition, this work found a selective inhibitor which bound to the 
traditional target site – the substrate binding site, and studied its inactivation 
mechanism and kinetic features. Ribavirin, an analogue of adenosine, exhibits 
preferential time-dependent inactivation on Tc-SAHH over Hs-SAHH and provides a 
structural lead to design more selective inhibitors.  
Overall, studies on differential cofactor association and dissociation properties 
between Hs-SAHH and Tc-SAHH will help us understand better on these two 
enzymes and lead to design potential selective inhibitors targeting at cofactor-binding 
sites for treatment of Chagas disease.  
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Chapter 1 
 
Introduction to Hs-SAHH and Tc-SAHH 
 
1.1. The role of SAHH in methyl transfer 
 
S-adenosyl-L-homocysteine (AdoHcy) hydrolase (SAHH; EC 3.3.1.1.) is the 
only known enzyme responsible for the reversible conversion of AdoHcy to 
adenosine (Ado) and homocysteine (Hcy) (Scheme 1.1.), which occurs downstream 
of the S-adenosylmethionine (AdoMet)-dependent transmethylation metabolic 
pathway [1, 2]. AdoMet-dependent methyl transfers are involved in a wide variety of 
important biological functions and the corresponding methyl acceptors in this 
pathway include macromolecules such as proteins, nucleic acids, polysaccharides and 
also include small molecules such as histamines and phospholipids [3]. Since 
AdoHcy is a powerful product inhibitor which functions as a switch to regulate the 
AdoMet-dependent methyl transfers, SAHH plays a crucial role in the AdoMet-
dependent transmethylation pathway through controlling the intracellular levels of 
AdoHcy [1]. The catabolic reaction of AdoHcy favors the hydrolytic direction under 
physiological conditions [1]. Thus, inhibition of SAHH in mammalian cells will 
result in increased cellular level of AdoHcy and further blocking of the methyl cycle.  
 
 
 2
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 1.1. The role of SAHH in methyl transfer and its metabolic pathways. 
Abbreviations: ADA, adenosine deaminase; AK, adenosine kinase. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Methyl acceptor
(mRNA, DNA, 
protein, lipids)
S-Adenosyl-
methionine
+
Methylated acceptor
+
S-Adenosyl-
homocysteine homocysteine + adenosine
inosine
ADA
SAHH
S-Adenosyl-methionine-dependent
methyltransferases
ATP
AK
Transsulfuration
pathway
urine
 
 3
Since it has a unique role in methyl transfer, SAHH has been considered as an 
antiviral target in chemotherapy for decades, since the 5’-terminal residue of viral 
mRNA is an AdoMet-dependent transmethylase substrate [4, 5]. Moreover, 
overactive malfunction of SAHH will result in abnormally high blood levels of Hcy, 
which increases the risk of cardiovascular disease [6-8] and possible amyloid diseases 
[9], and so SAHH has been considered as a target for treatment of above diseases as 
well. Recently, a new pharmacological interest has developed in SAHH as an anti-
parasitic agent [10].  
 
1.2. The importance of selective inhibitors against Tc-SAHH and 
therapeutics in Chagas disease 
 
Besides mammalian organisms, parasites such as Trypanosoma cruzi [11], 
Plasmodium falciparum [12] and Leishmania donovani [10, 13] also encode their 
own SAHHs (Tc-SAHH, Pf-SAHH and Ld-SAHH, respectively) as well as AdoMet-
dependent methyltransferases [14]. Similar to mammalian organisms, parasites use 
their AdoMet-dependent methyltransferase to methylate the 5’-cap of their mRNAs, 
which are important for their growth [14]. Thus, inactivation of parasitic SAHH will 
result in the blocking of methyl transfer and further suppress the growth of parasites. 
Earlier studies [10, 11] have shown that there are differences of the kinetic and 
thermodynamic parameters between human and parasite enzymes. Parasite enzymes 
have weaker binding affinities for NAD+ and/or lower catalytic activities than those 
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of the human enzyme [10, 11]. These differences provide the possibility of designing 
selective inhibitors against parasite SAHHs without inactivation of human SAHH 
(Hs-SAHH).  
 
In this study we are specifically interested in Trypanosoma cruzi. There 
currently are 8-11 million people infected with Chagas disease (also known as 
American trypanosomiasis) by the protozoan parasite Trypanosoma cruzi (Center for 
Disease and Control, Chagas Disease Fact Sheet, June 2007). This disease is 
transmitted by triatomine insects when they feed on the blood of human hosts [15]. 
Chagas disease mainly resides in rural areas of Mexico, Central America and South 
America and seriously threatens the public health there [15]. Because of increased 
population movement, it has been reported that there are rare cases in southern parts 
of the USA (Center for Disease and Control, Chagas Disease Fact Sheet, June 2007). 
It is therefore useful to continue biochemical, biophysical and computational studies 
on the distinguishing features between Hs-SAHH and Tc-SAHH because these 
studies could lead to development of compounds with clinical potential as anti-
parasitic agents and eventually to improved treatments of Chagas disease.  
 
1.3. Structural similarities between Hs-SAHH and Tc-SAHH 
 
So far there are eleven available X-ray structures of SAHH from different 
sources (Protein Data Bank files: 1a7a, 1ky4, 1ky5, 1li4, 1d4f, 1ky4, 1xwf, 1k0u, 
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2h5i, 1xbe, 1v8b) including wild types of human placenta, rat liver, Plasmodium 
falciparum and Trypanosoma cruzi (unpublished data from our group) as well as 
various mutated forms, providing highly useful information for SAHH investigations. 
The alignment of SAHH amino acid sequences from different sources shows the 
primary structure is highly conserved [1].  
 
1.3.1. The structure of Hs-SAHH 
  
Hs-SAHH is a homotetramer (Figure 1.1.) composed of four ~ 47.5 kDa 
monomers [1, 16]. Each monomer has 432 residues and can be divided into three 
parts: one substrate-binding domain, one cofactor-binding domain (complexed to a 
molecule of NAD+/NADH) and a small extended C-terminal “tail” [1, 16]. Both 
structure and normal mode analysis identify a hinge region [residues 182-196 (hinge 
region 1) and 352-356 (hinge region 2)] which connects the substrate-binding domain 
(SBD, residues 5-180 and 357-374) with the cofactor-binding domain (CBD, residues 
191-356) [1, 17, 18]. This hinge regulates a ~ 19 ° reorientation of the SBD relative to 
the CBD in the direction of the open-to-closed transition and enables a 
conformational change in SAHH, which plays an important role in substrate capture 
and in the subsequent series of catalytic reactions [16, 17].  
 
Between the SBD and the CBD there is a deep cleft which works as a channel 
for substrates entering the active site and also for products being released into  
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Figure 1.1. The tetramer structure of SAHH containing cofactor NAD+ (Brown) (pdb 
code: 1KY4). Four cofactor-binding domains (green) form the central core and four 
substrate-binding domains (red) are located outside.  
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solution [1]. In terms of quaternary structure, the tetramer is composed of two dimers, 
formed by monomers A and B, and monomers C and D, respectively. The two dimers 
bind each other tightly and build a “dimer of dimers” [1]. The short tail (residue 380-
432) of monomer A extends to monomer B and helps to cover monomer B’s cofactor-
binding site, and vice versa [1]. This tail exchange also occurs between the C and D 
monomers [1]. Moreover, the four cofactor-binding domains from four monomers 
bind each other tightly to form a central core with the four substrate-binding domains 
facing outside [1].   
 
Comparing the available X-ray structures, there are two different 
conformations of SAHH: the open form and the closed form. Since rat SAHH shares 
97 % sequence identity with the human enzyme,  the entire protein structure of rat 
SAHH is assumed to be very similar to that of the human enzyme [19]. The open 
conformation comes from the structure of that rat enzyme (PDB code: 1KY4) [20] 
while the closed conformation is from the human source structure [PDB code: 1A7A 
[1] or 1LI4 [16]]. It is worth emphasizing that the X-ray structure (PDB:1A7A) of 
SAHH which contains the inhibitor DHCeA shows a twisted-closed conformation: a 
14 º reorientation of two halves of the  homotetramer to tightly seal the active core 
[1]. Comparison of the open and closed conformations, Figure 1.2. shows a 19° 
rotation of the substrate binding domain toward the cofactor binding domain, which 
transits the open to the closed conformation. The open-to-closed conformational 
transition is related to the catalytic reactions involving the substrate and cofactor  
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  Open      Closed 
 
Figure 1.2. Open conformation (pdb: 1KY4, rat source) and closed conformation 
(pdb: 1LI4, human source) of SAHH monomer from crystallization (created by 
Molecular Operation Environment). The top domain is the cofactor-binding domain; 
the bottom domain is the substrate-binding domain; the right loop is the C-terminal 
tail. SAHH in open conformation only contains cofactor NAD+ (ball-and-stick) and 
SAHH in closed conformation contains cofactor NADH (ball-and-stick) and oxidized 
inhibitor-NepA (ball-and-stick). Comparison of open conformation and closed 
conformation, the substrate-binding domain rotates ~ 19 ° toward to the cofactor 
binding domain to form an active site for catalysis. 
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NAD(H) in the active site. The open conformation of SAHH enables substrate 
binding and the closed conformation provides a closer contact between substrate and 
cofactor in active site needed for catalysis. The enzyme converts back to the open 
conformation upon product release [21].   
 
Besides the X-ray structures, there is other evidence for SAHH domain 
motions. Computationally, normal mode analysis of low-frequency collective motions 
of SAHH reveals the different mechanical properties of the open and closed forms of 
SAHH. The hinge-bending motion in the direction of the open-to-closed 
conformational transition is unique to the open form of SAHH and occurs 
independently of other protein vibrations [17]. In the closed form, normal mode 
calculations show the amplitude of the hinge-bending motion in each subunit of 
SAHH is  smaller than that in the open form, and the hinge bending motions of 
individual subunits are strongly coupled to each other and other low frequency 
vibrations, including subunit reorientations [17]. This mechanical coupling, a 
characteristic of the closed form, may transmit the information of any structural 
changes related to the catalytic reactions in one of the four active sites to other active 
sites. Normal mode analysis also identified that the 20-ps hinge-bending vibrations of 
subunits only reach  an amplitude motion of ~ 1° which is much smaller than the 
amplitude of 19° in the global structural transition, so the 19° SBD vs. CBD  
reorientation cannot be described as a simple elastic deformation [17].  
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Experimentally, time-resolved fluorescence anisotropy measurements were 
carried out on native SAHH and three catalytically active mutants, M351P, H353A 
and P354A, all labeled with the fluorescent probe PMal at residues C113 and C421 [18]. 
Data analysis was focused on the time constants for reorientation motions and the 
data for wild type SAHH with/without ligand provides important information on the 
effect of ligand binding and oxidation on hinge-bending motions. Wild type SAHH 
without substrate exhibits three rotational correlation times: 0.5 ns reflecting local 
chromophore reorientations and protein vibrations; 14 ns involving domain 
reorientation; and 82 ns manifesting the overall protein tumbling in solution [18]. 
Wild type SAHH bound with 3’-deoxyAdo/NAD+ or 3’-keto-Ado/NADH 
(Ado/NAD+) shows similar three-component anisotropy decay, but for wild type 
SAHH bound with 3’-keto-NepA/NADH, the 10-20 ns domain reorientation is not 
detected [18]. These results indicate that there is an equilibrium between open and 
closed structures of SAHH. This equilibrium is shifted toward to a more mobile open 
form in the presence of the substrate-free enzyme (E-NAD+), as well as in the 
presence of the intermediates which are formed early in the catalytic cycle after 
substrate binding or formed late prior to product release (E-NAD+/ligand). This 
equilibrium is shifted toward the more rigid closed form in the presence of SAHH 
with substrates/analogues of the central catalytic intermediate (E-NADH/ligand) [18]. 
In addition, the fluorescence anisotropy studying of three mutations with/without 
ligand was used to investigate the roles of these residues in the hinge region 2 
(residues 352-356) in hinge bending motions. Mutants M351P and P354A show a 
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similar pattern of behavior to wild type SAHH, which indicates that residues M351 
and P354 have no significant effects on domain motion [18]. For the H353A mutant, 
the 10-20 ns domain motion wasn’t detected with/without ligand, and the longest 
component was shortened to 55-71 ns for all four ligation states of mutant H353A. 
This indicates mutant H353A changes its domain motion dynamics independent of 
presence of ligand or oxidation state of cofactor [18]. Since the H353A mutant 
remains catalytically active, this mutant may slow down its hinge bending motions to 
a long time scale similar as that of overall protein tumbling or longer, or exhibit 
modified shape and size of the protein [18]. If the hinge bending motions slow down 
to the time scale of the enzyme’s turnover (the order of a second), this would be out 
of the detectable range for the fluorescence anisotropy study (0.1 - 200 ns) [18]. 
Overall, hinge region 2 doesn’t make a direct contribution to catalytic activity. In 
contrast, hinge region 1 contains residues N181, K186, N190, N191 which are in the 
active site, which are involved in binding the substrate and thus are directly able to 
affect the activity [18].  
 
To get a direct and clear picture of the domain motions of SAHH, a 15 ns 
dynamics simulation of the open form of SAHH with explicit solvent was performed 
using Amber7 software. Very similar to the X-ray structure, the trajectories show that 
at the tetramer level the four cofactor binding domains form a central core which 
remains  relatively rigid, and that the four substrate binding domains, located at the 
protein exterior, exhibit flexible reorientations of large amplitude. Interestingly, the 
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fluctuations of domains between open and closed conformations within each subunit 
constitute only ~ 20 % of the trajectory domain motions. At the tetramer level, the 
remaining ~ 80 % of the domain motions are perpendicular to the direction of the 
open-to-closed structural transition, and may be described as a “breathing-type” 
motion with substrate-binding domains moving to and from the tetrameric core of 
SAHH. Furthermore, the domain reorientations in solution can be represented as a 
combination of a faster process with 20-50 ps rotational correlation times and 3-4° 
amplitude, and a slower process with 8-23 ns correlation times and 14-22° amplitude. 
The time scale of the faster process is very close to that of the hinge-bending 
vibrations which were found in the normal mode analysis while the slow process well 
matches the fluorescence anisotropy decay measurements, which detected the 10-20 
ns domain motion with ca. amplitude of 26° in SAHH without substrate. Therefore, 
the slow process is assigned to the rotational diffusion of the domains within a core 
with 10-20° half-angle. Overall, the results of the simulation agree with the previous 
data and help us to better understand SAHH domain motions in solution [22].   
 
The X-ray structures are especially important tools in structural and functional 
studies of SAHHs. Below is a summary of the X-ray structures of six wild types of 
SAHH (data available from the Protein Data Bank).  
 
(1.) 1KY4 [20] [refined from 1B3R [19]]: structure of the rat enzyme with 
cofactor NAD+ with no substrate. 
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(2.) 1A7A [1]: structure of the human enzyme with cofactor NADH reduced 
by the substrate analogue DHceA, which is oxidized to the 3’-keto form 
and bound to the active site. This structure is a twisted-closed form with a 
~14° rotation of the AB dimer relative to the CD dimer. 
(3.) 1K0U [23]: structure of the rat enzyme with bound D-eritadenine, an 
acyclic-sugar analog of Ado, with the cofactor in the NAD+ state. 
(4.) 1LI4 [16]: structure of the human enzyme with bound oxidized 3’-keto-
NepA, an analogue of the intermediate 4’,5’–didehydro-5’-deoxy-3’-
ketoAdo, and with the cofactor in the NADH state. 
(5.) 1XBE (unpublished data, Dr.s Q.-S. Li and Huang W.): structure of the 
Trypanosoma cruzi enzyme bound to oxidized 3’-keto-NepA, an analogue 
of the intermediate 4’, 5’–didehydro-5’-deoxy-3’-ketoAdo, and with the 
cofactor in the NADH state. 
(6.) 1V8B [24]: structure of the Plasmodium falciparum enzyme complexed to 
the substrate Ado and the cofactor NAD+.  
 
The nature of the residues involved in substrate and cofactor binding are 
crucial for understanding the catalytic mechanism of SAHH and to help design 
inhibitors. These residues could be identified from the above available high-
resolution crystal structures; the importance of some of them has already been 
verified by mutagenesis. Figure 1.3. (a and b) shows the position of the residues 
(E156, N181, K186, D190, N191, N80, D134 and F302) involved in binding the  
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    B 
 
 
 
 
 
 
Figure 1.3. (a) The residues involved in substrate binding. (Adopted from Elrod, et 
al. 2002 [25]); (b) The residues involved in Hcy binding (N80, D134, F302) are 
shown in yellow. (Created by Molecular Operation Environment) 
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substrate AdoHcy and the position of other residues located in active site. Table 1.1 in 
the Appendix lists all known mutations of SAHH from human and rat sources 
including residues involved in catalysis (Redox), hinge bending, cofactor binding and 
substrate binding (adenine/ribose/ Hcy).  
 
1.3.1.1.  The Rossmann motif and α- helix 18 of SAHH 
 
There are two important sub-structures of SAHH, the Rossmann motif fold 
and a helix at the C-terminal tail, which are involved in cofactor binding. An 
introduction to these two sub-structures is given briefly below. Detailed studies of the 
roles of these two structures in cofactor association with and dissociation from SAHH 
are described in Chapters 3 and 4. 
 
The Rossmann motif (Fig. 1.4.) can be found in most classical nicotinamide 
adenine dinucleotide (NAD+) binding proteins [26]. Its βαβαβ unit associated with an 
additional β strand forms a “core”, the minimum secondary necessary structure to 
bind the cofactor in this motif [27]. In addition, the first 30-35 amino acids of the 
“core” are a fingerprint region for the identification of dinucleotide binding. There are 
several conserved characteristics within this fingerprint sequence: 1) a six residue 
glycine-rich sequence (GXGXXG) involved in phosphate binding; 2) six conserved 
positions only containing hydrophobic amino acids; 3) a conserved negatively 
charged residue and 4) a conserved positively charged residue [26]. Specifically, the  
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Figure 1.4. Rossmann motif in the cofactor-binding domain of Hs-SAHH (pdb: 1LI4) 
contains two βαβαβ units (one is brown, one is pink). (Created by Molecular 
Operation Environment) 
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six conserved hydrophobic residues are located on the first β-sheet, the first α-helix 
and the second β-sheet, which form a hydrophobic core and are crucial to pack the β-
sheets against the α-helix in crucial secondary structure interactions [27]. Moreover, a 
second repeated βαβαβ unit, related to the first one by a two-fold rotation, can 
usually be found in NAD(P)+ binding proteins [27].  
 
There are two classical Rossmann motifs seen in each subunit of SAHH (Fig. 
1.4.): one in the substrate-binding domain and the other in the cofactor-binding 
domain. The Rossmann motif in the NAD+ binding domain has a second repeated 
βαβαβ unit. Alignment of the fingerprint sequences (first 30-35 amino acids) of the 
Rossmann motif in the NAD+-binding domain of human and parasitic SAHHs reveals 
that the two small conserved hydrophobic residues on the first β-sheet of the 
Rossmann motif are conserved in Hs-SAHH and Pf-SAHH, but replaced by two 
hydrophilic residues in Tc-SAHH and Ld-SAHH. The replacement of the 
hydrophobic residues by two hydrophilic residues may weaken the hydrophobic 
interactions and increase the flexibility of the hydrophobic core formed by the six 
hydrophobic residues and other residues, which further influences NAD+ binding and 
dissociation.  
 
The C-terminal tail of SAHH is a flexible structure. The tail includes a short 
helix - 18 (Fig. 1.5.), located 8 amino acid residues ahead of the last Lys among Hs-  
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Figure 1.5. Top: The structure and position of helix 18 from the X-ray structure of 
Hs-SAHH (pdb: 1A7A). The helix 18 located on the C-terminal tail is close to the 
cofactor NAD(H) (blue) of the neighboring subunit. Bottom: Lys426 (yellow) and 
Tyr430 (purple) are on the end of the tail, which is involved in direct interaction with 
the cofactor NAD(H) (blue). (Created by Molecular Operation Environment) 
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SAHH and parasitic SAHHs (Tc-SAHH, Ld-SAHH and Pf-SAHH). The residues 
Lys426 and Tyr430 in the C-terminal loop of Hs-SAHH are observed close to NAD+ in 
X-ray structures, and may form hydrogen bonds with NAD+. A stable helix 18 may 
help to locate residues Lys426 and Tyr430 at suitable positions in the NAD+ binding 
pocket. Therefore, the relative stability of helix 18 is important for determining the 
differences in cofactor-binding affinity between human and parasitic enzymes.  
 
1.3.1.2.  Subunit interactions 
 
Inter-subunit binding may be involved in understanding such mechanistic 
features as active-site “sealing” (see above on the dimer-dimer rotation) and also 
cooperative phenomena that may be important in enzyme function (see Chapter 2 for 
cooperativity in the kinetics of cofactor association). It has been reported that K426 of 
Hs-SAHH, which is located on the C-terminal tail, is a residue involved in subunit 
binding. The mutant K426A of Hs-SAHH lost almost 100 % catalytic activity in both 
the synthetic and hydrolytic direction. This mutant retains only 48 % of its tetrameric 
structure. Its cofactor binding affinity also decreased dramatically (NAD+ content of 
purified coenzyme is only 9 % while NADH content of purified coenzyme is 28 %) 
[28]. 
 
Moreover, there are several residues in the hinge region 2 whose mutations 
also perturb the quaternary structure, such as H353F, F356A, T363A, T363P (Dr. M. 
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Wang-dissertation). In addition, previous data of Dr. X. Yang (unpublished) shows 
that the binding of NAD+ to Hs-SAHH exhibits some positive cooperativity and may 
be fit to a two-site model. However, there is no suggestion from the crystallographic 
structures to explain the dimer-dimer cooperativity, since SAHH is homotetramer and 
the dimers AB and CD do not exhibit any structural differences [1].  
 
 1.3.1.3. Isoforms of SAHH 
 
A random investigation of red blood cell samples from a hospital laboratory 
was performed and several polymorphic isoforms named SAHH-1 to 4 were 
identified by horizontal starch gel electrophoresis [29]. SAHH-1 (SAHH; EC 3.3.1.1.) 
in this study is the wild type form encoded by Homo sapiens [1].  Functional analysis 
shows that isoforms SAHH-2 and SAHH-3 exhibit more than 94 % catalytic activity 
of the wild type SAHH-1 and their kinetic parameters are very similar to that of the 
wild type enzyme [30]. Tracing the genetic background, a single nucleotide 
polymorphism (SNP) results in one amino acid change in isoform SAHH-2 
(nucleotide C112_T; amino acid R38W) and isoform SAHH-3 (nucleotide G377_A; 
amino acid G123R) [30]. However, isoform SAHH-4 exhibits no change at the gene 
level. Possible explanations for the difference between properties of SAHH-1 and 
SAHH-4 might be some unknown posttranslational modifications [30].  Moreover, 
individuals with isoform SAHH do not report having any clinical symptoms such as 
SAHH deficiency or high levels of plasma AdoHcy [29].    
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1.3.2. The structure of Tc-SAHH 
 
The SAHH of Trypanosoma cruzi (437 aa and ~ 48 kDa per subunit) was 
cloned and purified by former scientists in our laboratory [11]. The sequence of Tc-
SHAH shares 74 % identity with Hs-SAHH [11]. The X-ray structure of Tc-SAHH 
treated with the inhibitor Neplanocin A has been recently determined (unpublished 
data, Drs. Q.-S. Li and W. Huang). Comparison of the X-ray structures of Hs-SAHH 
and Tc-SAHH shows that there is no significant difference between them at the 
structural levels of the tetramer, subunit, CBD, SBD and C-terminal tail. The residues 
directly interacting with the substrate and the residues directly interacting with NAD+ 
are all conserved. However it was reported that parasitic enzymes such as Tc-SAHH 
[11], Ld-SAHH [10] and Pf-SAHH bound cofactor NAD+ less tightly than Hs-SAHH 
(unpublished data, S. Cai), which suggests that there are some structural factors 
causing the differences in properties between Hs-SAHH and parasite enzymes.  
 
1.4. The catalytic mechanism of SAHH 
 
SAHH is a hydrolase for which the catalytic mechanism was the topic of 
intense earlier studies. Briefly, the catalytic reaction of SAHH for human and parasite 
is the reversible hydrolysis and synthesis of AdoHcy to/from Ado and Hcy.     
 
AdoHcy + H2O Ado + Hcy
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This equilibrium favors the hydrolytic direction in vivo because of rapid 
removal of products - Ado catalyzed by Ado deaminase and Hcy by the 
transsulfuration pathway. In contrast, this equilibrium favors the synthetic direction in 
the biochemical assays in vitro [1].  
 
The total catalytic process can be divided into two independent parts: a 
reduction/oxidization portion and an elimination/addition part, which is shown as a 
cycle in Scheme 1.2. [16, 31, 32]. The redox part utilizes a tightly bound 
NAD+/NADH as a cofactor for hydrogen transfer. In the hydrolysis direction, the 3’-
OH group of substrate AdoHcy transfers hydrogen to NAD+, which forms 3’-keto-
AdoHcy and NADH. The 3’-keto-AdoHcy makes its 4’-CH bond susceptible to 
attack and activates elimination of Hcy from the 4’-CH bond, followed by Michael 
addition of water to form 3’-keto-Ado. Tightly bound NADH returns hydrogen to 3’-
keto-Ado and this catalytic process is completed with Ado released from the SAHH 
containing the cofactor NAD+. 
 
This catalytic cycle involves in two enzyme conformational changes (Protein 
Data Bank code 1A7A) [1, 21]: an open-closed interconversion of each monomer, 
which regulates substrate binding and product release, and a ~14° rotation of one 
dimer relative to the second dimer, which leads to a reduction in the volume of 
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Scheme 1.2. Catalytic cycle of SAHH in both hydrolytic and synthetic directions with 
redox partial reactions and elimination/addition partial reaction. Shown B represents 
the enzyme accepting and returning the proton at the 4’ position. SAHH with NAD+ 
stay in an open conformation while SAHH with NADH stay in a closed conformation 
for a series of catalytic reactions.  
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the tetramer and may serve to “seal” the closed form. The “sealed” active sites help to 
prevent contact of intermediates with the environment during a series of transition 
states [21, 33].  
 
The kinetics of individual steps in the SAHH catalytic cycle have been 
measured and a model suggested that integrates the kinetics, the structural and 
dynamic results, and the findings from site-directed mutagenesis [16]. The model 
emphasizes the roles of avoidance of abortive reactions and stabilization of transition 
states in achieving efficient level of catalysis [16, 34-36]. There are three 3’-keto 
intermediates in the catalytic cycle and none of them can survive exposure to the 
aqueous buffer environment [16].  
 
Any release and/or exposure of intermediates will result in abortive products 
and an uncompleted catalytic cycle. Instead, a tight closure of the active site builds a 
barrier of 110 kJ/mol for abortive release of intermediates, which is ~ 50 kJ/mol 
higher than diffusional limits and decreases the rate of abortive release by 108-109 
fold when the concentrations of AdoHcy, Ado and Hcy are at 1 µM [16]. In addition, 
the central intermediate 4’, 5’-didehydro-5’-deoxy-3’-keto-adenosine also needs to be 
protected from the nearby cofactor NADH to avoid premature reduction of the 3’-
keto group of the intermediate [16]. This 3’-keto structure of the central intermediate 
is crucial for activation of the next step of Michael addition of water/Hcy to the 4’,5’-
double bond. To achieve the necessary protection, residue His 301 shifts its position 
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so that its side chain buttresses the cofactor NADH at a greater separation from the 
intermediate. The result is an apparent increase in distance between C-4’ (cofactor 
NADH) and C-3’ (substrate) of about 0.4 Å [16]. The barrier for the abortive 
reduction of the central intermediate is 86-89 kJ/mol, which is 22-24 kJ/mol higher 
than the barrier for productive reduction (65-67 kJ/mol). This difference in barrier 
heights results in a rate of productive reduction that is faster by 103-104 fold than the 
rate of abortive reduction [16]. The catalysis of most steps in the reaction depends on 
acid-base catalysis for transition-state stabilization, so that the potentially needed 
exchange of protons with the medium would seem to be difficult in the closed 
conformation. However, SAHH depends on a chain of water molecules to deliver 
protons between the active site and the buffer environment to maintain the suitable 
protonation states of functional residues during the catalytic cycle [16]. 
 
Many attempts have been made to design mechanism-based inhibitors 
targeting the substrate binding site and utilizing its catalytic potentialities, and some 
progress has been achieved [1, 2, 37]. The partial “oxidative” reaction 
(reduction/oxidation) and partial “hydrolytic” (elimination/addition) reaction provide 
two design targets [37]. Type I inactivators, which are oxidized to the 3’-keto form 
with SAHH catalysis and conversion of NAD+ to NADH, target the oxidative partial 
reaction [38]. Neplanocin A (NepA) with Ki of 8.4 nM is an example of type I 
inactivators and its catalytic reaction stops after oxidation at the 3’ position produces 
a material that is structurally an analogue of the central intermediate 4’, 5’-didehydro-
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5’-deoxy-3’-keto-adenosine [1, 39]. On the other hand, type II inactivators are not 
only oxidized in the 3’-position by SAHH but also form covalent bonds with enzyme 
in reactions analogous to the elimination/addition partial reaction [38]. For example, 
(E)-5’, 6’-didehydro-6’-deoxy-6’fluorohomoadenosine (EDDFHA) is a type II 
inactivator by generating electrophiles at the active site and forming a covalent bond 
to irreversibly inactivate the enzyme [40]. Figure 1.6. shows the structures of the    
above two types of inhibitors and their inactivation mechanisms.     
 
The question of approaches to drug design will be treated further in Chapter 6 
of this study.  
 
1.5. Scope of this dissertation 
 
Major studies of the structure, function and catalytic mechanism of SAHH 
have been performed over the past decades.  This has built the foundation for the new 
research and forms the basis of this work which involves the comparison of the 
properties between human and parasitic SAHHs. This is aimed at developing 
effective antiparasitic medicines against serious human diseases. Tc-SAHH, which 
was cloned, purified and crystallographically analyzed in our laboratory, is the object 
of my study which is to identify distinguishing features between Hs-SAHH and 
parasitic enzymes by use of biochemical, biophysical and computational approaches. 
The results are intended to lead to the design of selective inhibitors against Tc-SAHH 
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Figure 1.6. Type I inhibitor (NepA) and Type II inhibitor (EDDFHA) structure and 
its inactivation mechanism  (adopted from Elrod, et al. 2002 [25]). 
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 as anti-parasitic agents at the traditional substrate binding site or new targeting sites 
(e.g. cofactor binding site). Furthermore, this work includes kinetics, and mechanistic 
studies of a selective compound, which deepens our understanding of selective 
inhibition against Tc-SAHH.   
 
Summary of the Contents in this Dissertation: 
In this chapter, the structures and functions (biological role and catalytic 
mechanism) of Hs-SAHH and Tc-SAHH are reviewed. In Chapter 2, the basic 
features of association and dissociation of cofactor NAD(H) to Hs-SAHH and Tc-
SAHH are described. Chapters 3 and 4 include studies on the role of the stability of 
helix 18 and the role of two conserved hydrophobic residues on the first β-sheet of 
the Rossmann motif of the cofactor-binding domain in the differential cofactor-
binding features of Hs-SAHH and Tc-SAHH, respectively. In Chapter 5, 
computational alanine scanning is performed to predict the residues important for the 
differential cofactor-binding features of Hs-SAHH and Tc-SAHH and experimental 
mutagenesis is carried out to test two predicted residues (a Lys and a Tyr on the C-
terminal tail). In Chapter 6, the kinetics and inactivation mechanism of ribavirin, a 
selective inhibitor which is structurally similar to adenosine, were studied for a 
traditional targeting site in the substrate binding domain. Conclusions and limitations 
are described in Chapter 7.  
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Appendix: Table 1.1. Mutations of SAHH from human, rat and trypanosomal 
resources. 
SAHH of Human or 
Rat Sources 
Function/ 
Location of 
Mutation 
Tc-SAHH Function/ 
Location of 
Mutation 
H54N-rat catalysis   
H55A redox   
C79A redox   
N80S Hcy   
D130N-rat catalysis   
D134N Hcy   
E155Q-rat catalysis   
E155D-rat catalysis   
E156A active   
N181A active   
K185N-rat catalysis   
K186A active   
D189N-rat catalysis   
N190S-rat catalysis   
D190A catalysis   
N191A active   
D244E-rat cofactor binding   
H300N-rat    
H301A redox   
F302G Hcy   
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SAHH of Human or 
Rat Sources 
Function/ 
Location of 
Mutation 
Tc-SAHH Function/ 
Location of 
Mutation 
D303S Hcy   
M351P Hinge   
H352N-rat    
H353A Hinge   
H353F Hinge   
P354A Hinge   
F356A Hinge   
T363A Hinge   
M367A Hinge   
K426A Tail (Monomer) K431A Tail 
K426E Monomer   
K426R Quaternary   
Y430F Tail   
Y430A Tail Y435A Tail 
R431A Tail   
Hs-18Pf-SAHH: 
E411D_K412N_ 
A414C_Y416F 
Helix 18 Tc-18Hs-SAHH: 
A416E_R417K_ 
D420Q _I422L 
Helix 18 
Hs-18Tc-SAHH: 
E411A_K412R_Q415D 
Helix 18   
Hs-βATc-SAHH: 
V215T_V217C 
 
β sheet-A Tc-βAHs-SAHH: 
T214V_C216V 
β sheet-A 
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Chapter 2 
 
Basic Features of the Association and Dissociation 
Processes in Comparative Kinetics of Cofactor Association 
and Dissociation for Hs-SAHH and Tc-SAHH.  
 
2.1. Introduction 
 
The enzymes from T. cruzi and L. donovani were reported to bound NAD+ 
less tightly than the human enzyme, and the enzyme from P. falciparum was 
observed to bound NAD+ less tightly than the human enzyme (unpublished data). 
Therefore, the cofactor-binding site and its properties have become a focus of interest 
for finding those distinguishing features among these enzymes that might permit 
differential inhibition. In the present work, we have systematically analyzed the 
comparative kinetics of cofactor association and dissociation and their temperature 
dependences for Hs-SAHH and Tc-SAHH.  
 
2.2. Methods 
 
2.2.1. Expression and purification of Hs-SAHH and Tc-SAHH.   
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The expression of the two enzymes was basically the same as previously 
described [1, 2]. Briefly, in separate experiments the gene encoding each enzyme was 
inserted into the vector pPROK-1 (Clonetech, CA) and the recombinant plasmids 
were transferred into E. coli strain JM109. The transformed E. coli cells grew in 1 L 
of 2×YT medium containing ampicillin (100 mg/L) at 37 oC.  When the absorbance at 
600 nm reached 0.4 ~ 0.8, 1 mM isopropyl-1-thio-β-D-galactopyranoside was added 
to induce protein expression during incubation at 37 oC for 8 h for Hs-SAHH and at 
25 oC for 12 h for Tc-SAHH.  
 
The procedures for purification of the two enzymes were the same except that 
50 µM NAD+ was added to the buffer before purification of Tc-SAHH. The harvested 
E. coli cells containing the enzyme were stored at -80 oC. Preparation of a cell-free 
extract was carried out as previously described [1, 2].  The enzyme was purified from 
cell-free extract by means of four columns in an FPLC system (Amersham 
Biosciences). The buffer during all purification processes was 50 mM TrisHCl, pH 
7.4, containing 1 mM EDTA. A typical procedure is as follows. The cell-free extract 
was loaded onto a Q-sepharose Fast Flow column (26/10) and the enzyme was eluted 
with 50 to 150 mM NaCl in buffer.  The enzyme sample was then passed through a 
Hiload Phenyl-sepharose column (26/10), a Hiload superdex 200 (16/60) column, and 
placed on a MonoQ (10/10) column from which the purified enzyme was eluted with 
50 to 300 mM NaCl in buffer.  
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2.2.2. Enzyme activity assay and determination of kinetic properties.   
 
SAHH activity was assayed in the synthetic direction by measuring the rate of 
formation of AdoHcy from Ado and Hcy by use of HPLC as previously described [3, 
4].  The enzyme activity in the hydrolytic direction was determined by coupling the 
conversion of AdoHcy to Ado and Hcy to the deamidation of Ado with catalysis by 
Ado deaminase [4]. 
 
2.2.3. Determination of apo-enzyme concentrations by titration with 
NAD+.  
 
Apo-enzyme was prepared as previously described [5]. All enzyme and apo-
enzyme concentrations used in this paper are given as formal concentrations of 
monomeric subunit.  Because NAD+ binds to both Hs-SAHH and Tc-SAHH very 
tightly at 22 oC (Kd below 50 nM at 22 oC for both enzymes), the concentration of 
apo-enzyme can be determined by NAD+ titration.  To a volume of 10 µl containing 
initially 40 µM of apo-enzyme were added successive 10-µl portions of NAD+ stock 
solution to produce concentrations from 1.5 to 180 µM. The solutions were then 
incubated at 22 oC till no further increase was observed in enzyme activity (usually 
from 20 to 90 min). Enzyme activity was measured in the hydrolytic direction. 
Concentrations of NAD+ were increased to approximately 9 times the saturation value 
and the enzyme concentration (monomers) was taken as equal to the concentration of 
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enzyme-bound NAD+ under saturation conditions. At values of [NAD+] below the 
equivalence point, the activity is equal to γ[NAD+], where γ is the activity per 
occupied active site and is equal to the slope of the plot of activity vs. [NAD+]. Above 
the equivalence point, the slope becomes zero and the intercept becomes γ[E]tot = γ 
[NAD+]bound where [E]tot is the total enzyme concentration expressed as monomers. 
The ratio intercept/slope thus yields [E]tot = [NAD+]bound. The values of [E]tot 
corresponded closely to the values calculated from the protein concentration. 
 
2.2.4. Determination of rate constants for association of NAD+ and 
NADH with apo-enzyme (apparent first-order rate constant kapp 
and apparent second-order rate constant kon).   
 
Typically, to a 50 µl solution (50 mM phosphate buffer, pH 7.4, 1 mM 
EDTA) containing 2 µM apo-enzyme were added successive portions of 50 µl of 
stock solution to produce concentrations of NAD+ from 1 to 300 µM.  Samples were 
taken for activity assay at measured times during incubation at the desired 
temperature. The measured activities A were either converted to the amount of 
enzyme: NAD+ complex or used directly in eq. 1. 
             A = Af  - (Af – Ao)[exp(-kappt)]   (1) 
Here, A is the activity measured at time t, Ao is the activity at the apparent time zero 
(reflecting reaction during the dead-time of the experiment), Af is the activity at the 
end of the experiment, and kapp is a first-order rate constant for association that 
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generally will be a function of [NAD+]. At [NAD+] = 5 µM, Ao is quite small and kapp 
is approximately proportional to [NAD+]; an apparent second-order rate constant for 
the association reaction kon was therefore calculated from data at this concentration as 
kon = kapp/[NAD+] and was used in the calculation of the equilibrium dissociation 
constant (see below). 
 
 In the measurement of kapp for NADH, the bound NADH was monitored by a 
fluorescence method as previously described [3]. 
 
2.2.5. Determination of the rate constants for dissociation of NAD+ from 
Hs-SAHH and Tc-SAHH (koff).   
 
A 200 µL solution containing 4 µM SAHH, 80 U/ml alcohol dehydrogenase, 
30 mM 2-propanol, 2 mM NADH and 1 mM EDTA in a 50 mM phosphate buffer at 
pH 7.4 was incubated at a desired temperature. Samples were taken at measured times 
for determination of enzyme activity. The concentration of NADH, binding of which 
to the enzyme rendered the dissociation of NAD+ irreversible, was in large excess 
over the enzyme concentration and did not significantly change during the 
experiments. As a control for thermal inactivation of the enzyme, the activity of 
SAHH was also determined under the same conditions as above except that no 
NADH or alcohol dehydrogenase was present. The time dependence of relative 
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enzyme activity (A/Ao) in both the dissociation experiment and the thermal 
inactivation control fitted to eq (2), which is equivalent to eq (1) with Af = 0. 
A/Ao = exp(-kobs t)                  (2) 
 
In the control experiment for loss of activity by thermal inactivation, kobs = 
kina, the first-order rate constant for thermal inactivation of the enzyme. When thermal 
inactivation and NAD+ dissociation were occurring simultaneously, kobs = ktot = kina + 
koff, where koff is the apparent first-order rate constant for dissociation of NAD+. The 
rate constant koff for NAD+ dissociation was then obtained from koff  =  ktot – kina.  
 
2.2.6. Thermal stability determinations by circular dichroism (CD) 
spectroscopy.   
 
CD spectra were measured with a Jasco J-720 spectropolarimeter equipped 
with a Peltier temperature controller.  Enzyme samples (0.1 mg/mL in 50 mM 
phosphate buffer, pH 7.4 and 1 mM EDTA) were contained in 0.1 cm path length 
cells.  A resolution of 0.2 nm and a scanning speed of 20 nm/min with a 2 s response 
time were employed.  Spectra presented are an average of three consecutive spectra.  
For the thermal stability experiment, the signal at 222 nm was measured at 0.1 °C 
intervals with use of a 60 °C/hour temperature ramp rate.    
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2.2.7. Thermal stability measurements by differential scanning 
calorimetry (DSC).   
 
Apo-enzyme samples (2 mg/mL) were degassed under mild vacuum for 15 
minutes before obtaining thermograms with a Microcal DSC instrument 
(Northampton, MA).  A 0.9 ml solution of buffer containing 50 mM phosphate and 1 
mM EDTA, pH 7.4, was placed in the reference cell and the apo-enzyme sample in 
the same buffer was placed in the sample cell.  Thermograms from 25 to 80 °C were 
collected at a scan rate of 60 °C/hr.  Similar scans obtained with buffer in both the 
reference and sample cells were subtracted from the apo-enzyme thermograms. 
 
2.2.8. Determination of the equilibrium dissociation constants (Kd) for 
NAD+ and NADH.   
 
The equilibrium dissociation constants for NAD+ were calculated from the 
ratio of the dissociation and association rate constants, KdNAD+ = koff/kon, which were 
measured as described above. 
 
The equilibrium dissociation constants for NADH were calculated from the 
loss of enzyme activity as NADH replaces NAD+ in the enzyme active sites. In the 
absence of added NADH, the activity of the enzyme will be proportional to the 
fraction of enzyme associated with NAD+ as in eq (3) 
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A([NADH] = 0) = αEtot[[NAD+]/(KdNAD+ + [NAD+])]   (3)
  
where α is a known function of the enzyme kinetics (for the hydrolytic direction of 
SAHH action, α is proportional to kcat[AdoHcy]/(KM + [AdoHcy]) and [Etot] is the 
total concentration of enzyme in all forms (E and E:NAD+). In the presence of 
NADH, the activity A is proportional to a total enzyme concentration given by eq 
(4a), 
 [Etot] = [E] + [E:NAD+] + [E:NADH]  =   
[E:NAD+](KdNAD+ /[NAD+] + 1 + KdNAD+ [NADH]/KdNADH[NAD+])            (4a) 
so that the activity is given by eq (4b). 
A =  α[Etot] / (KdNAD+ /[NAD+] + 1 + KdNAD+ [NADH]/KdNADH[NAD+])           (4b) 
Combining eqs 3 and 4b then gives eq (5): 
A([NADH] = 0)/A = 1 + ([NADH]/ KdNADH)( KdNAD+/( KdNAD+ + [NAD+])  (5) 
Because KdNAD+ is known, non-linear least-squares fitting (Origin, Microcal) of A as 
a function of [NADH] to eq (5) then yields KdNADH. 
  
2.2.9. Inhibition of Hs-SAHH and Tc-SAHH by the NAD(H) analogs, S-
NAD+ and S-NADH.  
 
Thionicotinamide adenine dinucleotide (S-NAD+) was obtained from Sigma 
(T7375). The reduced form of thionicotinamide adenine dinucleotide (S-NADH) was 
prepared from the oxidized form by use of alcohol dehydrogenase (Sigma, A-3263).  
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Reduction of the oxidized form of S-NAD+ was followed by HPLC using the 
procedure described under enzyme activity assay. Loss of activity of Hs-SAHH and 
Tc-SAHH was monitored as above, and equilibrium dissociation constants of the 
thione-analogs S-NAD+ and S-NADH were calculated by the same method used for 
NADH. To determine koff for S-NAD+ and S-NADH, 20 µL volumes of solutions of 
Hs-SAHH or Tc-SAHH reconstituted with S-NAD+ and S-NADH (and thus 
catalytically inactive) were incubated in the presence of 5 mM NAD+ at 37 °C. 
Samples were taken at desired times and the activity was measured. The fractional 
gain in activity with time was taken as equal to the fractional release of S-NAD+ or S-
NADH. 
 
2.3. Results 
  
2.3.1. Kinetics of the dissociation of NAD+ from Hs-SAHH and Tc-SAHH.  
 
Fig. 2.1. shows the loss of fractional activity as a function of time as NAD+ 
dissociates from Hs-SAHH and Tc-SAHH. The data are described by a simple single-
exponential function (eq 2) and after correction for thermal inactivation (negligible 
under these circumstances) yield the dissociation constant koff.  
 
2.3.2. Temperature dependence of the kinetics of the dissociation of 
NAD+ from Tc-SAHH and Hs-SAHH.  
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Figure 2.1. The time course of the loss in enzyme activity at 37 °C as NAD+ 
dissociates from Hs-SAHH (shallow curve, kobs = koff = 5.1 ± 0.1 x 10-5 s-1) and Tc-
SAHH (steep curve, kobs = koff = 4.7 ± 0.1 x 10-3 s-1). The solid lines are exponential 
functions (eq (2) above).  
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Fig. 2.2. presents Eyring plots of the first-order rate constants koff for 
dissociation of the cofactor NAD+ from Hs-SAHH (31 °C to 45.5 °C) and from Tc-
SAHH (21 °C to 37 °C). The Eyring plots are non-linear for both enzymes, consisting 
of a linear low-temperature regime and a linear high-temperature regime. Two 
expressions [(eqs (6a) and (6b)] were considered for fitting of the data, corresponding 
to mechanistic models treated in the Discussion Section.  
koff / (kT/h)  =  exp (∆S‡ℓ / R – ∆H‡ℓ / RT) + exp (∆S‡h / R– ∆H‡h / RT) (6a) 
 
koff / (kT/h)  =  [exp(∆S‡ℓ / R – ∆H‡ℓ / RT)](1/{1 + [exp(∆Soℓh / R) – ∆Hoℓh / RT]}) + 
[exp (∆S‡h / R) – ∆H‡h /RT)]([exp(∆Soℓh / R) – ∆Hoℓh / RT]/{1 + [exp(∆Soℓh / R – 
∆Hoℓh / RT)]})       (6b) 
The expression of eq (6a), where the subscript ℓ denotes the quasi-thermodynamic 
parameters of activation for the low-temperature regime and the subscript h denotes 
those for the high-temperature regime, corresponds to parallel dissociation reactions 
with different activation parameters. Attempts to fit this expression to the data 
produced very large errors in the adjustable parameters and plots that failed to 
intersect some of the points. This expression produces curvature that is too gentle to 
correspond to all the data. 
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The expression of eq (6b) allows for a more abrupt shift from the low-
temperature to the high-temperature regime in a transition with equilibrium 
thermodynamic parameters ∆Soℓh and ∆Hoℓh. This approach requires determination of  
 
 
 
 
 
Figure 2.2. The temperature dependence of the rate constant for dissociation of 
NAD+ from Hs-SAHH (lower curve) and from Tc-SAHH (upper curve). The lines are 
intersecting Eyring plots with the parameters given in Table 2.1. 
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six adjustable parameters. Since the data sets contain only seven (Tc-SAHH) and 
eight (Hs-SAHH) experimental points, the full-scale fitting exercise is futile. 
Therefore the two temperature regimes were independently fitted to an Eyring 
expression [eqs (6c) and (6d)] for each set of data. 
koff / (kT/h)  =  exp (∆S‡ℓ / R– ∆H‡ℓ / RT)   (6c) 
koff / (kT/h)  =  exp (∆S‡h / R – ∆H‡h / RT)   (6d) 
 The values of the quasi-thermodynamic parameters of activation are given in 
Table 2.1.The conversion temperature To for passage from the low-temperature 
regime to the high-temperature regime is given by eq (7) and values are given in 
Table 2.1. 
 To = (∆H‡h – ∆H‡ℓ )/ (∆S‡h  – ∆S‡ℓ )   (7) 
 
2.3.3. Kinetics of the association of NAD+ with Tc-SAHH and Hs-SAHH.  
 
In contrast to the simple first-order reaction of cofactor dissociation, the 
association of NAD+ with rat-liver SAHH has been reported [5] to exhibit biphasic 
kinetics, with half of the full complement of the cofactor binding during the dead-
time of the experiment and the other half binding over about an hour (concentrations 
of apo-enzyme 15.9 µM and NAD+ 185-555 µM). Fig. 2.3. shows the association 
kinetics for Tc-SAHH and Hs-SAHH for 1 µM apo-enzyme (as monomers) reacting 
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with 1-100 µM NAD+ (further experiments, not shown, extended the range of [NAD+] 
to 300 µM). Both enzymes exhibit first-order kinetics of cofactor association at all    
Table 2.1.  Quasi-thermodynamic parameters of activation and conversion 
temperatures a, b for NAD+ dissociation from Hs-SAHH (30 °C to 37 °C) and Tc-
SAHH (20 °C to 37 °C), pH 7.4. 
 
Enzyme 
 
 
∆S‡ℓ 
(J/mol-K) 
 
∆H‡ℓ 
(kJ/mol) 
 
∆S‡h 
(J/mol-K) 
 
∆H‡h 
(kJ/mol) 
 
To, K 
 
Hs-SAHH 
 
24 ± 1 
 
 
116 ± 4 
 
600 ± 25 
 
297 ± 9 
 
314 ± 21 
(41 °C) 
 
Tc-SAHH 
 
170 ± 15 
 
154 ± 8 
 
610 ± 30 
 
287 ± 8 
 
 
302 ± 34 
(29 °C) 
a Values in the table above obtained from fits to eqs (6) and (7) of the data shown in 
Fig. 2.2.  
b Temperature of intersection of the high-temperature and low-temperature limbs of 
the temperature dependence and thus the temperature of conversion between the two 
regimes. 
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Figure 2.3. The time course of the rise in enzyme activity as NAD+ associates with 
the apo-forms of Hs-SAHH and Tc-SAHH at 23 °C and pH 7.4. In each case, 
representative curves are shown for low, medium, and high concentrations of NAD+ 
(identified on the graphs by values of [NAD+] in µM). The lines are plots of eq (8), 
with parameters Ao (the initial activity, reflecting the fast-binding component), Af 
(the final activity, reflecting the sum of fast-binding and slow-binding components), 
and kapp (the rate constant for the slow-binding component) the values of which will 
be presented in figures below. Note that all three parameters rise as [NAD+] rises. 
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cofactor concentrations, with the rise in enzyme activity A upon cofactor binding 
following eq (8), equivalent to eq. (1) above, with Ao the activity at the apparent time 
zero, Af the activity at very long times, and kapp, the first-order rate constant, all being 
functions of [NAD+]. 
A = Af - [(Af - Ao) exp (- kapp t)]     (8) 
 
Particularly at cofactor concentrations greater than about 7 µM, considerable 
binding occurs during the mixing period or dead-time of the experiment (fast binding) 
and is measured by Ao.  The remainder of the sites is occupied more slowly with a 
rate constant kapp (slow binding) to produce a total final activity Af which is the sum 
of activities generated by the fast-binding component and the slow-binding 
component.  
  
A model to be presented in the Discussion Section suggests that the 
magnitudes of the fast-binding component of activity Ao, the sum of fast-binding and 
slow-binding components of activity Af, and the rate constant kapp for the slow-
binding component of activity should depend on [NAD+] according to eqs (9a), (9b), 
and (9c), respectively. 
 Ao = (At/2)[[NAD+]n /(Kon + [NAD+]n)]   (9a) 
 Af = At[[NAD+]/(Kf + [NAD+])]    (9b) 
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 kapp =  ka[[NAD+]/(Ka + [NAD+])]    (9c) 
Here At is the total enzyme activity at saturating [NAD+] after completion of slow 
binding, ka is the limiting rate constant for slow binding at high [NAD+], n is a Hill 
coefficient needed to give an approximate account of apparent cooperativity, and Ko, 
Kf, and Ka are equilibrium dissociation constants of NAD+ from three different forms 
of the active site (more detail is given in the Discussion Section). The data in Fig. 2.4. 
were fit to eq (9c) resulting in the values of ka and Ka shown in the figure. 
  
The dependence of the rate constant kapp on cofactor concentration for the 
slow-binding reaction thus exhibits saturation above about 30 µM for both enzymes 
(Fig. 2.4.), consistent with the previous report for the rat-liver enzyme [6] that the 
slow-binding rate constant is independent of cofactor concentration in the 
concentration range studied by those authors (185-555 µM). Furthermore, the 
affinities for NAD+ of the various forms of the enzymes envisioned in the model 
described in the Discussion Section are sufficiently low that even when the 
concentrations of enzyme (monomers) and cofactor are equal at 1 µM, only about 20-
25% of monomers are occupied by cofactor at the end of the experiment, so that 
roughly first-order kinetics are observed in this case, and more rigorously as the 
concentration of cofactor rises (Fig. 2.3). 
 
2.3.4. Partition between fast and slow binding of NAD+ to Hs-SAHH and 
Tc-SAHH as a function of [NAD+].  
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Figure 2.4. The dependence on the concentration of NAD+ of the rate constants for 
the slow-binding phase of the association of NAD+ with the apo-forms of Hs-SAHH 
and Tc-SAHH at 23 °C and pH 7.4. Some obvious signs of cooperativity for Hs-
SAHH have been neglected and the data in both cases have been fitted to the simple 
hyperbolic saturation function of eq (9c). The parameters are shown in the figures 
with the standard deviations of fit in parentheses. 
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Fig. 2.5. shows the fractional activity produced in the fast-binding phase (as 
measured by Ao, the activity at the apparent zero of time), in the slow-binding phase 
(as measured by [Af ― Ao]), and the total fractional activity produced in both phases 
(Af), all as a function of the cofactor concentration. The total fractional activity 
saturates at close to unity in the range of 10-20 µM cofactor for both enzymes. The 
slow-binding reaction dominates at low cofactor concentrations, increasingly so until 
it accounts for about 80-85% of the total activity at about 10 µM cofactor for both 
enzymes. Thereafter the fast-binding reaction increases in relative importance until 
the two processes each account for half the total activity above about 50 µM cofactor 
for Hs-SAHH and above about 300 µM cofactor for Tc-SAHH. 
 
 For Hs-SAHH, the fast-binding component shows extraordinary cooperativity 
as evidenced by the sigmoid appearance of the fast-binding curve in Fig. 2.4. To 
account approximately for this characteristic, the Hill equation [eq (9a)] was 
employed to fit the data in Fig. 2.4. Slow binding was described by eqs [(9b) - (9a)]. 
For total binding, the simple hyperbolic form of eq (9b) was adequate and was 
therefore employed. Although the sigmoid character of the fast-binding curve for Tc-
SAHH is less pronounced, the same three equations (eqs (9a), (9b), and (9c)) were 
also used for these data. 
 
 For Hs-SAHH, the fast-binding data yield Ko = 35 ± 1 µM, n = 2.7 ± 0.2, At = 
1.27 ± 0.04. The total-binding data with n effectively fixed at 1.0 yield Kf = 1.4 ± 0.1  
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Figure 2.5. The dependence on [NAD+] of the fractions of enzyme activity generated 
in the fast-binding phase (Ao in eq (8)), the slow-binding phase (Af - Ao in eq (8)), 
and the total activity (Af in eq (8)). The data were obtained in the kinetic experiments 
summarized in Fig. 2.3., with those at left (A) for Hs-SAHH and those at right (B) for 
Tc-SAHH. For each enzyme, the data for fast binding, total binding, and slow binding 
were independently fitted to eq (9a), eq (9b), and [eq (9b)-eq (9a)], respectively, to 
obtain the parameters given in the text. Eq. (9a) was used for fast binding in place of 
a hyperbolic function because of the distinctly sigmoid appearance of the data for Hs-
SAHH; eq (9a) was then also used for consistency in treating the data for Tc-SAHH, 
where the sigmoid character is less pronounced. 
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µM, At = 1.01 ± 0.02. The slow-binding data yield Ko = 30 ± 4 µM, Kf = 1.3 ± 0.3 
µM, n = 3.8 ± 1.4, At = 0.97 ± 0.06.  For Tc-SAHH, the fast-binding data yield Ko = 
45 ± 4 µM, n = 1.5 ± 0.1, At = 0.94 ± 0.04. The total-binding data with n fixed at 1.0 
yield Kf = 1.5 ± 0.2 µM, At = 1.01 ± 0.02. The slow-binding data yield Ko = 31 ± 9 
µM, Kf = 2.0 ± 0.4 µM, n = 1.7 ± 0.4, At = 1.13 ± 0.09. Mean values of the 
parameters are shown in Table 2.5. of the Discussion Section. 
  
2.3.5 Temperature dependence of the slow-binding kinetics of the 
association of NAD+ with Hs-SAHH and Tc-SAHH.  
 
The effect of temperature on the slow-binding rate constant for association of 
NAD+ with Hs-SAHH and Tc-SAHH is shown by the Eyring plots in Fig. 2.6. The 
rate was measured at 5 µM NAD+, where the reaction is approximately first-order in 
the cofactor for both enzymes (see Fig. 2.4.), and the first order rate constants kapp 
were divided by 5 µM to produce the second-order rate constants ko plotted. 
  
On the basis of a model, developed in more detail in the Discussion Section, 
in which a partial, reversible, and perhaps quite local unfolding at higher temperatures 
deprives both enzymes of the capacity for cofactor binding, the apparent second-order 
rate constant ko for cofactor binding will be given by kon(1/[1 + Kun]) where kon is the 
second-order rate constant for cofactor binding to the native form of the enzyme and 
the factor in parentheses is the fraction of enzyme in the native form, Kun being the  
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Figure  2.6. The temperature dependence of the rate constant for the slow-binding 
phase of the association of NAD+ with the apo-forms of Hs-SAHH (upper curve) and 
Tc-SAHH (lower curve). The lines are plots of eq 10 with the parameters shown in 
Table 2.2. The rate constants were obtained in kinetic experiments of the kind 
summarized in Figure 2.3. 
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equilibrium constant for the unfolding. The temperature dependence of the apparent 
association constant ko will then be described by eq (10), where we take the standard-
state concentration of NAD+, [NAD+]ss = 1 M: 
ℓn (ko/T) = ∆S‡on / R – ∆H‡on / RT – ℓn [1 + exp(∆Soun / R – ∆Houn / RT)] 
                                - ℓn [NAD+]ss + ℓn (k/h)                                            (10) 
Here the subscript “on” denotes the quasi-thermodynamic parameters of activation for 
cofactor binding and the subscript “un” denotes the thermodynamic parameters of the 
reversible unfolding process. The values of these quantities are given in Table 2.2. 
The table also gives the ratio ∆Houn/∆Soun, a rough measure of the “melting 
temperature” for the structural transition under observation. 
 
2.3.6. Equilibrium dissociation constants of NAD+ from Hs-SAHH and 
Tc-SAHH in the temperature range 30 – 37 ºC.  
 
From the kon and koff values at temperatures between 30 ºC and 37 ºC (Fig. 
2.2. and Fig. 2.6.), equilibrium dissociation constants KdNAD+ for NAD+ were 
calculated for Hs-SAHH and Tc-SAHH (Table 2.3.).  The values are of the order of 
nanomolar for Hs-SAHH and micromolar for Tc-SAHH with the value of the ratio 
(KdNAD+)Tc / (KdNAD+)Hs being about 600 at 37 ºC. Table 2.3. also shows the values of 
enthalpies and entropies of dissociation of NAD+ from the two enzymes. 
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Table 2.2.  Thermodynamic and quasi-thermodynamic parameters for NAD+ 
association with Hs-SAHH and Tc-SAHH at temperatures in the interval 11-45 °C. 
 
 
Enzyme 
 
 
∆S‡on 
(J/K-mol) 
 
∆H‡on 
(kJ/mol) 
 
∆Soun 
(J/K-mol) 
 
∆Houn 
(kJ/mol) 
 
∆Houn/∆Soun 
(K) 
 
Hs-SAHH 
 
-56 ± 9 
 
38 ± 3 
 
+788 ± 5 
 
243 ± 2 
 
308 ± 3 
(35 °C) 
 
Tc-SAHH 
 
 
+225± 13 
 
118 ± 4 
 
+631 ± 8 
 
182 ± 2 
 
288 ± 5 
(15 °C) 
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Table 2.3. Equilibrium dissociation constants for NAD+ from its complexes with Hs-
SAHH and Tc-SAHH at temperatures from 30 to 37 ˚C 
 
 
Hs-SAHH, 
KdNAD+, nM 
(Temperature, 
°C) 
 
9.6 ± 0.4 
(30 ˚C) 
 
13 ± 1 
(32 ˚C) 
 
17 ± 1 
(34 ˚C) 
 
31 ± 3 
(37 ˚C) 
 
∆Ho = 130 ± 9 
kJ/mol 
∆So = 274 ± 9 
J/mol-K 
 
Tc-SAHH, 
KdNAD+, µM 
(Temperature, 
°C) 
 
0.63 ± 
0.04 
(30 ˚C) 
 
2.1 ± 0.2 
(32 ˚C) 
 
5.7 ± 0.6 
(34 ˚C) 
 
19 ± 2 
(37 ˚C) 
 
∆Ho = 378 ± 
24 kJ/mol 
∆So = 1131 ± 
83 J/mol-K. 
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2.3.7. Kinetics and thermodynamics at 37 ºC of the association with and 
dissociation from Tc-SAHH and Hs-SAHH of NADH.  
 
The equilibrium constants KdNADH for dissociation of NADH from its 
complexes with Hs-SAHH and Tc-SAHH were measured by competition between 
NAD+ (with dissociation constants given in Table 2.3.) and NADH, as described 
above. The values are 5.0 ± 0.1 nM for Hs-SAHH and 69 ± 6 nM for Tc-SAHH. 
   
At concentrations of NADH below 7 µM, the association rate with Hs-SAHH 
is first-order in NADH so that the rate constant kon could be measured as 1940 ± 90 
M-1s-1 for Hs-SAHH and 930 ± 90 M-1s-1 for Tc-SAHH.   
  
The dissociation of NADH from Hs-SAHH is too slow to allow measurement 
of the rate constant for dissociation koff but koff can be computed from KdNADHkon as 
9.7 ± 2.0 x 10-6 s-1. A similar calculation for Tc-SAHH yields 64 ± 10 x 10-5 s-1, while 
a direct measurement, which is possible here, yields 69 ± 6 x 10-5 s-1. 
 
2.3.8. Thermal stability of the apo-forms of Hs-SAHH and Tc-SAHH.  
 
Melting temperatures were determined both by DSC and CD for the thermal 
unfolding of the two proteins. The values for apo-Hs-SAHH are 44.9 ± 0.3 °C (DSC) 
and 44.2 ± 0.4 °C (CD) and for apo-Tc-SAHH are 53.0 ± 0.4 °C (DSC) and 52.8 ± 
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0.4 °C (CD). At temperatures below these values, apo-Hs-SAHH loses its capacity to 
bind NAD+ (and thus become an active catalyst) more rapidly than does apo-Tc-
SAHH (at 22 °C, Hs-SAHH loses this capacity completely within 30 hr, while Tc-
SAHH still retains half of its capacity at 90 hr). 
 
2.3.9. Evaluation of the NAD+ and NADH analogs S-NAD+ and S-NADH 
as selective inhibitors for Hs-SAHH and Tc-SAHH.  
 
S-NAD+ and S-NADH, the side-chain thione analogs of the natural cofactors, 
were tested for their ability to inhibit AdoHcy hydrolase activity.  Hs-SAHH and Tc-
SAHH, reconstituted with S-NAD+, show about 1% of the activity of the NAD+ form 
and the S-NADH forms of both enzymes show no measurable activity. The 
association and dissociation rate constants and equilibrium dissociation constants for 
S-NAD+ and S-NADH with Hs-SAHH and Tc-SAHH at 37 ºC are summarized in 
Table 2.4. As a test of the relative efficacy of these substances as inhibitors of Hs-
SAHH and Tc-SAHH, the enzymes (both in their active NAD+ forms) were exposed 
to 50 µM S-NAD+ or 20 µM S-NADH in the presence of 50 µM NAD+ to simulate 
roughly the estimated [6] 70 µM levels of NAD+ in vivo (Fig. 2.5.). Hs-SAHH was 
affected very little (2% inhibition with each inhibitor) in the first 5 min, during which 
Tc-SAHH lost 45% of its activity with S-NAD+ or 52% with S-NADH. Apparent 
equilibrium was reached for Tc-SAHH at 10-20 min of exposure with all activity lost  
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Table 2.4. Rate and equilibrium constants for the association and dissociation of S-
NAD+ and S-NADH with Hs-SAHH and Tc-SAHH at 37 ˚C 
 
Enzyme 
 
Ligand 
 
kona (M-1s-1) 
 
106koff (s-1) 
 
Kd (nM) 
 
Hs-SAHH 
S-NAD+ 4153 ± 303 162 ± 11 39 ± 1 
S-NADH 4000 ± 712 148 ± 26 37 ± 1 
 
Tc-SAHH 
S-NAD+ 356 ± 29 5450 ± 300 15,300 ± 9,000 
S-NADH 467 ± 59 304 ± 26 651 ± 60 
        aCalculated as koff / Kd 
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in the presence of S-NADH and about half lost in the presence of S-NAD+. The 
apparent equilibrium for Hs-SAHH is reached only after 12 h of incubation. 
 
2.4. Discussion 
 
2.4.1. Kinetics of the dissociation of NAD+ from Hs-SAHH and Tc-SAHH.  
 
The data presented in Fig. 2.1. and Table 2.1. show that the dissociation of 
four equivalents of NAD+ from the four active sites of homotetrameric SAHH 
proceeds by a simple first-order reaction, making no distinction in rate of dissociation 
among the four active sites. The loss of cofactor thus exhibits no apparent 
cooperativity. The rate constants for dissociation are substantially larger for Tc-
SAHH than for Hs-SAHH: for example, at 37 °C, dissociation from Tc-SAHH is 
approximately 90-fold faster (caption of Fig. 2.1.). 
 
2.4.2. Temperature dependence of the kinetics of the dissociation of 
NAD+ from Tc-SAHH and Hs-SAHH.  
 
Figure 2.2. shows that the rate constants of NAD+ dissociation in the cases of 
both Hs-SAHH and Tc-SAHH generate non-linear Eyring plots. The upward 
curvature or “bowl shape” of these two plots can arise from a number of sources. The 
possible explanations are not always practically or even theoretically distinguishable 
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but a reasonable hypothesis would be that a structural change in the enzyme as the 
temperature is changed affects the activation parameters for the dissociation reaction. 
Attempts to describe the temperature dependence simply by two parallel routes of 
dissociation with different activation parameters were unsuccessful. The data are too 
sparse to evaluate in detail the hypothesis of a thermally induced structural transition, 
but some comments on the activation parameters in the high-temperature and low-
temperature regimes can be made. 
   
As Table 2.1. shows, the value of ∆H‡ along the low-temperature limb of the 
Eyring plots is 116 kJ/mol for Hs-SAHH and 154 kJ/mol for Tc-SAHH, so that if 
entropic contributions were equal the cofactor would dissociate from Hs-SAHH 4 x 
106-fold faster than from Tc-SAHH at 300 K. In fact the values of ∆S‡ along the low-
temperature limb of the Eyring plots are +24 J/mol-K for Hs-SAHH and +170 J/mol-
K for Tc-SAHH, a difference that, taken alone, would confer a rate advantage of 4 x 
107-fold on dissociation from Tc-SAHH over Hs-SAHH. The entropic contribution 
thus more than overcomes the enthalpic contribution so that dissociation of NAD+ 
from Tc-SAHH is faster than from Hs-SAHH by roughly 10-fold in the low-
temperature regime. 
 
 Along the high-temperature limb of the Eyring plots, the values of ∆H‡ and 
∆S‡ for the two enzymes are within experimental error of each other (but note the 
long extrapolation of a few points to obtain the values). Phenomenologically, 
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dissociation occurs from Tc-SAHH more rapidly than from Hs-SAHH by factors in 
the range of 10-100-fold, and indeed the mean values of both ∆H‡ and ∆S‡ favor a 
more rapid dissociation from Tc-SAHH by factors in this range. One feature of the 
data is that the conversion temperature between the thermal regimes, which is given 
by eq (7) above, is considerably higher for Hs-SAHH (about 41 °C) than for Tc-
SAHH (about 29 °C). The result is that at 37 °C, Tc-SAHH has entered the high-
temperature regime and the rate constant has been increasing rapidly with 
temperature while Hs-SAHH remains in the low-temperature regime, where the rate 
constant is not increased as much by the rising temperature. At 37 °C then, 
dissociation from Tc-SAHH is about 90-fold faster than from Hs-SAHH. 
 
 The large increase in the values of the entropies of activation for dissociation 
of NAD+ from both enzymes as the temperature rises through the range of 30-40 °C 
may suggest that the faster dissociation rates at higher temperatures derive in part 
from an increased mobility in the apo-enzyme of the unoccupied binding site for 
NAD+. The fact that the conversion temperature is lower for Tc-SAHH would then 
suggest that the ease with which the increased mobility can be thermally induced is 
greater for Tc-SAHH. 
 
2.4.3. Observed kinetics of the association of NAD+ with Tc-SAHH and 
Hs-SAHH.  
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The association process, in contrast to the dissociation process, appears 
kinetically complicated, as shown above in Figs. 2.3., 2.4., and 2.5. The association 
processes for Hs-SAHH and Tc-SAHH show qualitatively similar but quantitatively 
different characteristics, as measured by the appearance of enzyme activity when 
NAD+ becomes bound in the active sites.  
 
 For each enzyme, there is a fraction of occupation Ao of the total binding that 
occurs during the dead-time of the experiment, and depends in a saturating manner on 
[NAD+]. A first-order time-dependent fraction of binding with rate constant kapp then 
follows and kapp also depends in a saturating manner on [NAD+]. The total fraction of 
binding Af at the end of the slow-binding phase depends in a saturating manner on 
[NAD+] and corresponds to full occupancy of all active sites at high cofactor 
concentrations. All three kinetic parameters of binding, Ao, Af, and kapp, thus exhibit 
saturation behavior with cofactor concentration but the half-saturation concentrations 
of cofactor are different in each case (Figs. 2.4. and 2.5.).  
 
 Fig. 2.5. also shows that the fraction of activity generated by the slow-binding 
phenomenon (Af – Ao) exhibits a particularly complex dependence on [NAD+]. At 
low [NAD+], the slow-binding fraction rises sharply until it accounts for more than 
80% of the total binding. Thereafter, it falls as the fast-binding fraction increases until 
at high [NAD+] (>60 µM for Hs-SAHH and >200 µM for Tc-SAHH), both the slow-
binding and fast-binding phenomena account for roughly half of the enzyme activity. 
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2.4.4. A Model for the kinetics of association of NAD+ with Hs-SAHH and 
Tc-SAHH.  
 
A model that accommodates these observations is depicted in Fig. 2.7. Its 
basic assumption is that apo-SAHH from both species, before exposure to cofactor, 
contains two equally populated classes of active sites. Upon introduction of cofactor, 
all sites can and do bind NAD+ rapidly, but in one class of sites (dissociation constant 
Ko) binding of NAD+ generates a fully functional active site, while in the other class 
of sites (dissociation constant Ka) binding of NAD+ generates no enzyme activity. 
Thus the initial activity Ao (see Figs. 3, 4, 5 and eqs (9) above) is given by the total 
population of potentially functional sites (At/2) multiplied by the fraction of these 
sites occupied at a given [NAD+] = N, i.e., Nn/(Kon + Nn). The Hill-equation 
formalism allows for the sigmoid character of the N-dependence of Ao visible in Fig. 
2.5. In Fig. 2.7., the initial situation is portrayed by the left-hand box and the 
expression for Ao is given below the box. 
  
Binding at the non-functional sites, although tighter than to the potentially 
functional sites, generates no activity. Binding of the cofactor in such a site does, 
however, initiate a time-dependent process (rate constant ka) in which the non-
functional sites, occupied to a fractional extent (N/{Ka + N) of their total, are 
transformed - along with their partner sites whether or not the latter are occupied - 
into pairs of active sites both of which are potentially fully catalytically active when  
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Figure 2.7. Speculative model for association and time-dependent activation of apo-
SAHH by binding of NAD+. The tetrameric apo-enzyme molecule is assumed to 
contain two classes of binding sites in equal amounts, the molecule thus being 
represented by a square-circle figure. The box at left represents the situation during 
the fast-binding phase. Upon introduction of the cofactor, represented by the letter N, 
both classes of sites are assumed to become wholly or partially occupied as shown in 
the box at left. The circle-sites are assigned a cofactor dissociation constant Ko, and 
are assumed fully capable of catalysis when occupied. The square-sites are assigned a 
cofactor dissociation constant Ka and they are assumed incapable of catalysis whether 
or not they are occupied by N or not. Equilibration of binding occurs within the dead-
time of the experiment and constitutes the fast phase of generation of catalytic 
Ao = (At/2)Nn/(Kon + Nn) 
kapp = kaN/(Ka + N) 
Af = (At)N/(Kf + N) 
 
Fast-binding phase 
N 
N 
N 
N 
N 
N 
N N 
N 
N 
N 
Slow-binding phase 
N 
N 
N 
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activity, which arises solely from the occupied circle-sites. The initial activity is then 
equal to Ao as shown below the box at left. The box at right represents the situation 
following the slow-binding phase. During the slow phase, those species that contain 
N bound into a square-site undergo a reorganization in which the occupied square-site 
and the adjacent circle site, whether occupied or not, are converted to oval-sites as 
shown at right. Oval-sites have the same catalytic activity as circle-sites, but their 
substrate affinity is greater so that, as shown, more sites are rapidly occupied, as they 
become oval-sites. The reorganization is driven by the fraction of occupied square-
sites, thus occurring with rate constant kaN/(Ka + N). Because the reorganization is 
irreversible, the entirety of the enzyme will be converted during the slow phase. The 
resulting enzyme equilibrates rapidly with free N, with all sites now having a 
dissociation constant Kf. The final activity is then given by the expression shown 
below the box at right. The three equations in the figure are eqs 9a-9c of the text.  
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occupied by cofactor. This slow-binding phase leads to a functionally homotetrameric 
enzyme with equilibrium constant Kf for dissociation of NAD+ from any of the active 
sites. This form of the enzyme is in rapid, reversible cofactor-binding equilibrium at 
all active sites. 
  
The situation at the end of the slow-binding phase is represented in Fig. 2.7. 
by the box on the right-hand side. Since binding at all sites is now rapid and 
reversible and because (a) Kf < Ka < Ko so that all sites at the end of the slow phase 
have greater cofactor affinity than any site before the slow phase, and (b) the slow 
phase leads to the generation of two potentially functional sites of high affinity where 
only the non-functional partner was occupied initially, the overshoot phenomenon 
results at low cofactor levels. At low NAD+ levels, the occupancy of the initially 
functional sites is low (especially as a consequence of the cooperativity in their 
occupation), and the occupancy of non-functional sites is relatively high. The highly 
occupied non-functional sites then transform along with their partner sites into fully 
functional sites of still higher affinity. These factors combine to generate the 
overshoot characteristic. 
  
The expression over the arrow describes the N-dependence of kapp (Fig. 2.4.) 
and the expression below the right-hand box describes the N-dependence of Af (Fig. 
2.5.). 
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 The values of the parameters of the model, as can be understood from Fig. 2.7. 
and eqs (9), are given in Table 2.5. The values were obtained by fitting of the data of 
Figs. 3, 4, and 5 to eqs (9) as described in the Results section.  
 
 To put into quantitative terms the description given above, fast binding of 
NAD+ within the dead-time of the experiment occurs to potentially functional sites 
from which the dissociation constant Ko is 33 µM (Hs-SAHH) to 38 µM (Tc-SAHH). 
At the same time, sites with no catalytic capacity but greater affinity (Ka = 19 µM for 
Hs-SAHH, about 4 µM for Tc-SAHH) are rapidly occupied. A time-dependent 
conversion then ensues of these sites (and their partner sites whether occupied or not) 
to fully active sites (ka about 10-fold larger for Hs-SAHH and corresponding to 
characteristic times of about 20 s for Hs-SAHH and 3 m for Tc-SAHH). At the end of 
the time-dependent phase, all active sites have the same activity and dissociation 
constant (1.4-1.5 µM for both enzymes). 
 
 The qualitative character of the cofactor-association process is the same for 
both enzymes, and some quantitative features are similar. For example, the non-
functional sites of the apo-enzyme bind cofactor about twice as tightly as the 
functional active sites for Hs-SAHH and 10-fold as tightly for Tc-SAHH. This feature 
contributes to the overshoot of the slow-binding reaction (Fig. 2.5.), because more of 
the non-functional than the functional sites are initially occupied. More important, 
however, is the fact that each occupied non-functional site leads to two functional  
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Table 2.5. Values of rate and equilibrium constants in the kinetics of the fast and 
slow binding phases of the association reaction of NAD+ with Hs-SAHH and Tc-
SAHH at 23 °C and pH 7.4, according to the model of Figure 2.7. 
 
 
Enzyme 
 
Ko, µM 
binding to fully 
functional sites 
of apo-SAHH 
Ka, µM 
binding to 
non- 
functional 
sites of 
apo-SAHH 
Kf, µM 
binding to fully 
functional sites 
of holo-SAHH 
ka, s-1 
transformation of 
apo-sites to 
functional holo-sites 
ka/Ka, M-1s-1 
binding and 
transformation of 
apo-sites to holo-
sites 
 
Hs-SAHH 
 
33 ± 4 
n = 
3.3 ± 1.4 
 
19 ± 8 
 
1.4 ± 0.3 
 
5.5 ± 0.8 x 10-2 
 
2.9 ± 1.2 x 103 
 
Tc-SAHH 
 
38 ± 9 
n = 
1.6 ± 0.4 
 
3.8 ± 
0.6 
 
1.8 ± 0.4 
 
6.0 ± 0.2 x 10-3 
 
1.6 ± 0.3 x 103 
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sites of high affinity in the final enzyme, and thus the slow phase comes to account 
for 80-85% of the final activity at [NAD+] below the saturation values for the 
functional active sites.  
 
 These qualitative features apply to both enzymes but quantitative distinctions 
exist. The achievement of final full activity occurs about 10 times faster for Hs-
SAHH, as already noted. Furthermore, the rates of cofactor dissociation are quite 
different for the two enzymes, as will be discussed below, and both of these 
distinctions may be of some importance. 
 
 It should be noted as well that the values of Kf, the apparent dissociation 
constants of NAD+ corresponding to a period about 30 to 60 min after mixing of apo-
enzymes with cofactor, are of the order of 1-2 µM (23 °C) for both Hs-SAHH and Tc-
SAHH (Table 2.5.). When the dissociation constants of NAD+ are instead calculated 
as the ratio of dissociation and association rate constants, the dissociation rate 
constants obtained from fully reconstituted enzyme that has not only completed both 
phases of binding but thereafter undergone further maturation for some hours or 
more, KdNAD+ for Tc-SAHH remains about the same (0.6 µM at 30 °C: Table 2.3.). In 
contrast, the KdNAD+ for Hs-SAHH is around 10 nM at 30 °C, roughly 100-fold 
smaller than Kf. These results seem to indicate that the loose binding observed for Tc-
SAHH after 30 to 60 min persists and represents the final thermodynamic equilibrium 
binding, while with Hs-SAHH, a further change in the strength of binding occurs over 
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some hours, resulting in a further 100-fold increase in the strength of cofactor 
association with Hs-SAHH.  
 
2.4.5. Temperature dependence of the slow-binding kinetics of the 
association of NAD+ with Hs-SAHH and Tc-SAHH.  
 
The data of Fig. 2.6. were obtained at 5 µM NAD+ so that for Hs-SAHH (Ka = 
19 µM at 23 °C: Table 2.5.) the apparent second-order rate constant ko is roughly 
equal to ka /Ka, a constant similar to kcat/KM in enzyme catalysis. For Tc-SAHH (Ka = 
4 µM at 23 °C: Table 2.5.), the situation is not so simple; the phenomenological 
observation that ko in the neighborhood of 5 µM NAD+ remains proportional to 
[NAD+] for Tc-SAHH leads us to treat it as roughly equal to ka /Ka. Fig. 2.6. shows 
that at low temperatures the observed ko is about the same for the two enzymes. 
Extrapolating to 23 °C gives a value near 1500 M-1s-1, not so different from ka/Ka 
(2900 M-1s-1 for Hs-SAHH, 1600 M-1s-1 for Tc-SAHH: Table 2.5.) 
 
 As already noted, the “dome-shaped” temperature dependences in Fig. 2.6. 
can arise from a model in which rising temperature on the one hand increases the 
value of the rate constant ka/Ka while at the same time increasing the fraction of 
protein that has undergone an at least partial, reversible unfolding to a form that can 
no longer bind the cofactor (equilibrium constant Kun so that, as above, ko = kon(1/[1 + 
Kun]) with kon being approximately equal to ka/Ka.  
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 As can be seen both from Fig. 2.6. and Table 2.2., the quasi-thermodynamic 
parameters of activation for kon are different for Hs-SAHH and Tc-SAHH The values 
of ∆H‡ (kJ/mol) are approximately 38 and 118, respectively, and the values of ∆S‡ 
(J/mol-K) being about -56 and +225, respectively. The low-temperature limbs of the 
temperature dependences for the two enzymes do nearly superimpose, but only 
because the enzyme with the more favorable enthalpy of activation (Hs-SAHH) also 
has the less favorable entropy of activation. The combination of a small enthalpic 
barrier with a negative entropy of activation for Hs-SAHH would be consistent with a 
transition state for Hs-SAHH that comes after the development of a considerable part 
of the binding interactions between cofactor and protein (low enthalpy from liberation 
of binding energy, negative entropy from rigidification of segments of protein and 
cofactor structures). The combination of a larger enthalpic barrier with a positive 
entropy of activation for Tc-SAHH would be consistent with a transition state for Tc-
SAHH that comes at a point where desolvation of the cofactor has advanced to some 
degree (thus high enthalpy from loss of solvation energy, positive entropy from 
liberation of water molecules) but few protein-cofactor interactions have developed, 
and thus the liberation of binding energy and rigidification of structure cannot cancel 
the contributions just described. 
 
 The thermodynamic values for the equilibrium constant of the postulated 
unfolding phenomenon are not extremely different for Hs-SAHH and Tc-SAHH 
[∆Houn (kJ/mol) about 243 and 182, respectively, and ∆Soun (J/mol-K) near +788 and 
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+631, respectively: Table 2.2.]. The ratios ∆Houn/∆Soun of these values lead to 
“melting” temperatures for the corresponding unfolding process of 35 °C  (Hs-
SAHH) and 15 °C (Tc-SAHH), not far from the temperatures at which the two Eyring 
plots exhibit maxima (34 °C for Hs-SAHH, 17 °C for Tc-SAHH: Fig. 2.6.). It should 
be noted that this “melting” does not correspond to global unfolding of the enzymes, 
which occurs around 44-45 °C (Hs-SAHH) and 52-53 °C (Tc-SAHH). This suggests 
a more local phenomenon is adversely affecting the capacity of the enzyme to bind 
the cofactor. 
 
 The maxima are not expected to occur at the global “melting” temperatures 
but rather at the temperature for which the local unfolding process begins to dominate 
the rate process in determining the value of ko, i.e., the temperature Tmax for which 
d[ℓn(ko/T)]/d(1/T) = 0. From this requirement, it emerges that at Tmax, the fraction of 
locally unfolded protein [Kunmax/(1 + Kunmax)] = ∆H‡on/∆Houn. This fraction is 0.19 for 
Hs-SAHH and 0.61 for Tc-SAHH, yielding values of Kmax of 0.23 (Hs-SAHH) and 
1.6 (Tc-SAHH), whence Tmax ( =  [∆Houn/(∆Soun - Rℓn[Kmax])]) is found as 34 °C (Hs-
SAHH) and 16 °C (Tc-SAHH) in good agreement with the observations of 34 °C for 
Hs-SAHH and 17 °C for Tc-SAHH.  
 
2.4.6. Equilibrium dissociation constants of NAD+ from Hs-SAHH and 
Tc-SAHH in the temperature range 30 – 37 ºC.  
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In this limited temperature range where the on-rate constants and off-rate 
constants for both enzymes exhibit linear Eyring plots, effective equilibrium 
dissociation constants can be calculated for NAD+ (Table 2.3.). They are substantially 
larger for Tc-SAHH than for Hs-SAHH, the ratio ranging from 66 at the low end to 
613 at the high end of the temperature range. The lower relative affinity of Tc-SAHH 
for the oxidized cofactor derives from the cancellation of enthalpic and entropic 
factors. There is a much greater enthalpy cost of dissociation from Tc-SAHH (greater 
by 248  ± 25 kJ/mol) but this is combined with a larger entropic advantage for 
dissociation of NAD+ from Tc-SAHH (greater by 263 ± 25 J/mol-K). The increased 
affinity of several hundred fold shown by Hs-SAHH thus arises from this cancellation 
of two very large and opposite contributions.  
 
 For both enzymes, the enthalpy of dissociation of NAD+ is positive and the 
entropy of dissociation of NAD+ is positive. This result is expected for the enthalpy 
because the attractive interactions of the cofactor with its binding site must be 
ruptured upon dissociation. The observed result is also expected for the entropy 
because two particles are generated from one (a minor contribution) and because 
rupture of the binding interactions allows increased freedom of motion within both 
cofactor and enzyme molecules. One interpretation of the much larger values of both 
the enthalpy and entropy terms for Tc-SAHH than for Hs-SAHH would be that a 
substantially greater mobility of the unoccupied cofactor-binding site in apo-
TcSAHH would require a larger entropy loss to fix in place the enzyme structural 
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elements that bind to the cofactor  (thus a larger entropy gain on dissociation) but that 
the same mobility would permit the development of a more favorable set of binding 
interactions, producing a larger release of energy upon binding and a larger energy 
cost of dissociation. This subject will be addressed in later papers in this series. 
 
2.4.7. Kinetics and thermodynamics at 37 ºC of the association with and 
dissociation from Tc-SAHH and Hs-SAHH of NADH.  
 
The association rate constant for NADH is about twice as large for Hs-SAHH  
(1940 M-1s-1) as for Tc-SAHH (930 M-1s-1), while the dissociation rate constant is 
smaller by about six-fold, resulting in a lower NADH-affinity for Tc-SAHH relative 
to Hs-SAHH by about 14-fold. This difference is somewhat smaller than was true for 
NAD+ (600-fold tighter with Hs-SAHH), which results from the fact that the affinity 
of Hs-SAHH for cofactor is roughly the same whether the cofactor is oxidized or 
reduced (in the range of nanomolar in both cases), while the affinity of Tc-SAHH for 
cofactor is much greater for the reduced form (a bit over nanomolar) than for the 
oxidized form (roughly micromolar). 
  
2.4.8. Thermal stability of the apo-forms of Hs-SAHH and Tc-SAHH.  
 
As has already been mentioned, the global unfolding of apo-Hs-SAHH occurs 
at a temperature approximately 10 °C lower than for apo-Tc-SAHH. Combined with 
 81
the observations above that the two enzymes have differing affinities for both 
oxidized and reduced cofactors, and that in the case of the oxidized cofactor, these 
difference arise from large and opposing differences in enthalpies and entropies of 
association and dissociation, the difference in overall thermal stability favoring Tc-
SAHH may signal differences in the dynamics of the cofactor binding sites. Since we 
can detect no structural differences in this region of the enzymes (unpublished data, 
which refer to the enzyme with NADH and oxidized substrate-analog as ligands) the 
dynamical differences may allow the nucleation of the global unfolding process in the 
cofactor-binding region, at a lower temperature for Hs-SAHH than for Tc-SAHH. 
This could reflect a greater thermal mobility for the cofactor site in Hs-SAHH, 
allowing it to adapt to the cofactor as it binds, leading to stronger affinity. This would 
conflict, however, with the larger entropy of dissociation shown by Tc-SAHH, so the 
matter is almost certainly more complicated than this view. 
 
2.4.9. Evaluation of the NAD+ and NADH analogs S-NAD+ and S-NADH 
as selective inhibitors for Hs-SAHH and Tc-SAHH.  
 
The comparative inhibitory effect of S-NAD+ and S-NADH on Hs-SAHH and 
Tc-SAHH (Fig. 2.8., Table 2.4.) does not depend only on their relative affinity for the 
two enzymes, which is nearly 400-fold greater for Hs-SAHH in the case of S-NAD+ 
and nearly 20 times greater for Hs-SAHH in the case of S-NADH. Instead the major 
factor is the exposure of an empty cofactor binding site to the environment, which  
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Figure 2.8. Loss of activity of Hs-SAHH (top curve, for 50 µM S-NAD+ and for 20 
µM S-NADH) and of Tc-SAHH (middle curve, 50 µM S-NAD+, and lower curve, 20 
µM S-NADH) in solutions containing 4 µM enzyme and 50 µM NAD+ at 37 ºC, pH 
7.4. Errors were calculated from two independent measurements. 
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occurs by dissociation of NAD+ with a rate constant at 37 °C for Hs-SAHH of 5.8 x 
10-5 s-1 and for Tc-SAHH of 4.7 x 10-3 s-1, a factor (as noted above) of about 90-fold 
faster for Tc-SAHH. The exposed site is then competitively trapped by the inhibitor 
and the cofactor. The dissociation is probably the rate-limiting step and the half-life 
of dissociation (about 2.5 min from Fig. 2.2.) should match the half-life of inhibitor 
binding as is found, the latter being (Fig. 2.8.) about 2.5 min for binding of both S-
NAD+ and S-NADH. As Fig. 2.8. shows, the difference between the two inhibitors is 
that S-NADH is capable of displacing NAD+ and generating complete loss of activity. 
This is consistent with the substantially greater affinity of Tc-SAHH for S-NADH 
than for S-NAD+ (nearly 25-fold from Table 2.4.). 
 
 These data thus suggest that the faster off-rate of cofactor from Tc-SAHH 
could be exploited to design inhibitors that bind rapidly to the cofactor site of Tc-
SAHH but only far more slowly to Hs-SAHH. Such inhibitors could be highly 
selective for the parasitic enzyme on the basis of the kinetic properties of the parasitic 
and human enzymes even if, as seen here, the human enzyme has a much larger 
equilibrium affinity for the inhibitor (greater by 400-fold in this case). 
  
2.5. Conclusions.  
  
The equilibrium and kinetic properties of association and dissociation of 
cofactor by Hs-SAHH and Tc-SAHH are qualitatively similar. Both enzymes bind 
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NAD+ in a complex scheme that behaves as if the apo-enzyme has two numerically 
equal classes of sites that bind cofactor and generate catalytic activity either very 
rapidly (less than a minute) or quite slowly (over 30 min). Both enzymes undergo 
dissociation of NAD+ from all four sites in a single first-order reaction. Both enzymes 
exhibit the “dimer of dimers” structure (1, 11) in which the homotetramer is made up 
of two pairs of monomers, and within each pair of monomers, a C-terminal segment 
from each partner penetrates into the other partner subunit and forms part of the 
cofactor binding site. These two communicating active sites may thus correspond to 
the two classes of active sites required in the kinetic model for binding cofactor that is 
discussed above. 
  
 The quantitative properties for cofactor association and dissociation of Hs-
SAHH and Tc-SAHH are very different. The equilibrium affinity of Hs-SAHH for 
NAD+ and NADH are both in the nanomolar range, while the equilibrium affinity of 
Tc-SAHH for NAD+ is in the micromolar range and its affinity for NADH is in the 
nanomolar range, not far from the NADH affinity of Hs-SAHH. The slow binding of 
NAD+ by both enzymes exhibits saturation kinetics with respect to the cofactor 
concentration but binding to Hs-SAHH has a maximum rate constant around 0.06 s-1, 
while the rate constant for binding to Tc-SAHH levels out at 0.006 s-1.  
 
 The dissociation rate constants for NAD+ show a complex temperature 
dependence with both enzymes, but the cofactor always dissociates more rapidly from 
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Tc-SAHH than from Hs-SAHH, the ratio being around 80-fold at 37 °C. This feature 
presents an opening for selective inhibition of Tc-SAHH over Hs-SAHH, 
demonstrated with the thioamide analogs of NAD+ and NADH, which inactivated Tc-
SAHH to the extent of 60% (NAD+ analog) or 100% (NADH analog) within 30 min, 
while inhibition of Hs-SAHH approached 30% only after 12 h. The following 
chapters in this series will present information that illuminates the structural features 
of Hs-SAHH and Tc-SAHH that are responsible for these differences. 
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Chapter 3 
 
The Role of the Differential Stability of Helix α-18 in 
Comparative Kinetics of Cofactor Association and 
Dissociation for Hs-SAHH and Tc-SAHH. 
 
3.1. Introduction 
 
The X-ray crystallographic structures of Hs-SAHH [1], Pf-SAHH [2] and Tc-
SAHH [3] indicate a unique binding site for the cofactor, composed in part by 
elements of a penetrating C-terminal extension from an adjacent subunit. The C-
terminal extension is crucial in maintaining the activity and quaternary structure of 
SAHH [4, 5]. 
 
Although direct interactions between the cofactor and polypeptide that would 
normally be considered key interactions, including the interactions with the C-
terminal extension of the adjacent monomer, are generally conserved in the human 
and parasitic enzymes, significant differences in the kinetics and thermodynamics of 
NAD+ binding among the human and parasitic enzymes have been observed [6-8].  
Our previous work indicated that there may be some local elements near the cofactor 
binding site which play an important role in NAD+ binding [8]. Helix 18 (Fig. 3.1.), 
for example, terminates in a loop containing residues that interact with NAD+. In this  
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Figure 3.1. Above: the dimeric assocation of two monomeric subunits (red and 
green) within the tetrameric structure of Hs-SAHH (PDB 1A7A), showing the C-
terminal extensions containing helix 18 which penetrate into the adjacent subunit. 
Helix 18 is relatively near the cofactor (blue) and relatively distant from the substrate 
(yellow substrate-analog structure). Below: Detail of the helix-18 region in Hs-SAHH 
and Tc-SAHH (PDB 1XBE), showing the C-terminal loop that proceeds from helix 
18 and interacts with the cofactor. 
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paper, we present information that supports the hypothesis that helix 18 is an 
important element for human-parasitic distinctions in cofactor binding to SAHHs. 
 
3.2. Methods 
 
3.2.1. Site-directed mutagenesis.   
 
All mutants were created by site-directed mutagenesis PCR. Each 
amplification reaction contained the following in a volume of 50 µL: 25 pmol of each 
primer, 20 nmol of each deoxynucleoside triphosphate, 20 ng of template DNA, 6 µL 
of 10x Pfu DNA ploymerase buffer and 3U Pfu DNA polymerase (Stratagene).  
Sequences of primers used for site-directed mutagenesis were: 
5’-GCTAACTGATAACCAATGCCAGTACCTGGG-3’ and  
5’-CCCAGGTACTGGCATTGGTTATCAGTTAGC-3’ for Hs-SAHH,  
5’GACGAAGCTCACCGAGAAGCAGGCGCAGTACCTCGGCTGCCCCGT-3’&  
5’-ACGGGGCAGCCGAGGTACTGCGCCTGCTTCTCGGTGAGCTTCGTC-3’for 
Tc-SAHH.   
 
After 4 min of heat start step at 92 ˚C, 25 cycles of the following program 
were initiated: 20 second at 92 ˚C, 30 second at 55 ˚C and 20 min at 68 ˚C. PCR 
products were purified with PCR purification kit (Qiagen).  After treated with Dpn I 
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(Biolab), the PCR products were transformed into BL21(DE3) E. coli (Stratagene). 
The sequences of mutant genes were confirmed by DNA sequencing. 
 
3.2.2. Expression and purification of Hs-SAHH, Tc-SAHH and their 
mutants.   
 
The expression of Hs-SAHH, Tc-SAHH and their mutants was basically the 
same as previously described [6, 7].  The transformed E. coli cells grew in 1 L of 
2×YT medium containing ampicillin (100 mg/L) at 37 oC.  At OD600 = 0.4 ~ 0.8, 1 
mM isopropyl-1-thio-β-D-galactopyranoside was added to induce the protein 
expression at 37 oC for 8 h for Hs-SAHH and its mutant, and at 25 oC for 12 h for Tc-
SAHH and its mutant. The procedures for purification of these enzymes were the 
same except that 50 µM NAD+ was added to the buffer in the case of purification of 
Tc-SAHH and its mutant.  
 
3.2.3. Temperature-dependent fluorescence spectroscopy of Tc-SAHH 
and Tc-18Hs-SAHH in the presence of 8-anilino-1-naphthalene 
sulfonic acid.   
 
Fluorescence emission spectra of holo-Tc-SAHH and its mutant holo-Tc-
18Hs-SAHH (5.15 µM) in a solution containing a molar ratio of 12:1 ([dye]: 
[monomer]) of 8-anilino-1-naphthalene-sulfonic acid over protein were obtained 
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using a QuantaMaster™ spectrofluorometer (PTI, Monmouth Junction, NJ). The 
excitation wavelength was 372 nm and the emission was monitored at 480 nm over a 
range of temperature from 15 to 77.5 °C at 2.5 °C intervals.   
 
3.3. Results 
 
3.3.1. The stability of helix 18 in SAHHs, estimated from helix 
propensities, is greater for Hs-SAHH than for Tc-SAHH, Ld-SAHH, 
and Pf-SAHH. 
 
The helix propensity of each helix 18 is the sum of the helix propensities of all 
residues in the helix (Fig. 3.1., Table 3.1.). A good measure of the helix propensity of 
a residue is the relative frequency with which the residue is present in helices, as 
calculated by Kallberg, et al, from a non-redundant set of protein sequences with 
known three-dimensional structures (1324 proteins, total of 269,058 amino acid 
residues) by PHD (profile network from HeiDelberg) [8, 9]. Helix-propensity values 
are typically used to predict secondary structure. Here, however, we presume that a 
helix with a higher total helix-propensity value may be more stable and therefore 
show less mobility and flexibility. As shown in Table 3.1., the helix propensities of 
helix 18 in Hs-SAHH and Pf-SAHH are the highest and the lowest, respectively. 
 
3.3.2. Generation of SAHH mutants with altered structures of helix 18.   
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Table 3.1. The sequences and total helix propensity values for helix 18 of Hs-SAHH, 
Tc-SAHH, Ld-SAHH, and Pf-SAHHs. Individual sequence ranges for the helix are 
shown beneath the species identifier at left and the residue helix propensities are 
shown as subscripts. 
SAHH Sequences
 (propensity value) Total helix 
propensity 
Hs- (411-417) 
Tc- (416-422) 
Ld- (416-422) 
Pf- (459-465) 
E(1.37)K(1.14)Q(1.34)A(1.46)Q(1.34)Y(0.95)L(1.36) 
A(1.46)R(1.24)Q(1.34)A(1.46)D(0.83)Y(0.95)I(1.07) 
P(0.40)K(1.14)Q(1.34)A(1.46) E(1.37)Y(0.95)I(1.07) 
D(0.83)N(0.72)Q(1.34)C(0.75)Q(1.34)F(0.97)L(1.36) 
8.96 
8.35 
7.73 
7.31 
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With guidance from the total helix propensities in Table 3.1., three mutant 
enzymes were created and compared to Hs-SAHH and Tc-SAHH.  The mutants are 
(1) a Hs-SAHH mutant with its original helix 18 replaced with the one from Tc-
SAHH and denoted Hs-18Tc-SAHH (E411A/K412R/Q415D), (2) a Tc-SAHH 
mutant with its original helix 18 replaced with the one from Hs-SAHH and denoted 
Tc-18Hs-SAHH (A416E/R417K/D420Q/I422L), and (3) a Hs-SAHH mutant with its 
original helix 18 replaced with the one from Pf-SAHH and denoted Hs-18Pf-SAHH 
(E411D/K412N/A414C/Y416F). The set of helix-18 mutants thus includes the 
“trypanosomized” human enzyme, the “humanized” trypanosomal enzyme, and a 
“plasmodiumized” human enzyme. This last mutant, Hs-18Pf-SAHH, represents the 
human enzyme modified to have the helix 18 of lowest total helical propensity 
present in any of the parasitic enzymes. 
 
The mutant enzymes as well as the two wild type enzymes Hs-SAHH and Tc-
SAHH were expressed, purified and characterized under very similar conditions. In 
all cases, it was determined by CD that the secondary structure was not detectably 
changed, and by size-exclusion chromatography that the tetrameric quaternary 
structure was intact. All enzymes were fully reconstituted with oxidized cofactor. 
 
3.3.3. Catalytic kinetic constants of helix-18 mutant enzymes differ little 
from those of the wild-type enzymes.    
 
 94
Results of kinetic studies of Hs-SAHH, Tc-SAHH, and their helix-18 mutants 
are shown in Table 3.2. All enzymes exhibit nearly the same values for both the 
synthesis and hydrolysis of AdoHcy, minor exceptions being (1) the Km for AdoHcy 
of Hs-SAHH is twice of Tc-SAHH; (2) Km values for Hcy and AdoHcy of Tc-18Hs-
SAHH are about half and four times, respectively, those of Tc-SAHH. The indication 
is thus that these mutations, relatively remote from the center of catalysis, have no 
major effects on catalysis. 
 
3.3.4. The kinetics of the dissociation of NAD+ from Hs-18Pf-SAHH and 
Tc-18Hs-SAHH show the same biphasic temperature 
dependences observed with Hs-SAHH and Tc-SAHH.   
 
Eyring plots of the first-order rate constants koff for dissociation of the 
cofactor NAD+ from Hs-18Pf-SAHH (31 °C to 45.5 °C) and from Tc-18Hs-SAHH 
(21 °C to 45.5 °C) are similar to the ones for the two wild type enzymes (Fig. 3.2.): 
the dependences are non-linear for both enzymes, consisting of a linear low-
temperature regime and a linear high-temperature regime. Data for the two 
temperature regimes were independently fitted by the Eyring equations eqs (2a) and 
(2b) as before [8]. 
koff / (kT/h)  =  {exp [ (∆S‡ℓ / R) – (∆H‡ℓ / RT)]}    (2a) 
koff / (kT/h)  =  {exp [ (∆S‡h / R) – (∆H‡h / RT)]}    (2b) 
 
 95
Table 3.2.  Kinetic parametersa for Hs-SAHH, Hs-18Tc-SAHH, Tc-SAHH, Tc-18Hs-
SAHH and Hs-18Pf-SAHH measured in 50 mM phosphate buffer, pH 7.4, 1 mM 
EDTA at 37°C.   
kinetic 
parameter 
Hs-
SAHH 
Hs-18Tc-
SAHH 
Hs-18Pf-
SAHH 
Tc-18Hs-
SAHH 
Tc-
SAHH 
[Ado] varied for synthesis of AdoHcy 
 
kcat (s-1) 
 
12.5 ± 
0.2 
 
13.2 ± 0.4 
 
11.8 ± 0.2 
 
15.0 ± 0.5 
 
15.5 ± 
0.3 
 
Km (µM) 
 
1.5 ± 0.1 
 
1.4 ± 0.1 
 
1.1 ± 0.1 
 
2.0 ± 0.2 
 
1.2 ± 0.1 
[Hcy] varied for synthesis of AdoHcy 
 
kcat (s-1) 
 
16.2 ± 
0.9 
 
16.9 ± 1.1 
 
14.6 ±1.2 
 
15.6 ± 0.6 
 
16.7 ± 
1.1 
 
Km (µM) 
 
160 ± 28 
 
171 ± 24 
 
188 ± 27 
 
100 ± 12 
 
219 ± 26 
[AdoHcy] varied for hydrolysis of AdoHcy 
 
kcat (s-1) 
 
3.2 ± 0.1 
 
3.3 ± 0.1 
 
3.2 ± 0.1 
 
3.2 ± 0.2 
 
3.7 ± 0.1 
 
Km (µM) 
 
6.4 ± 0.4 
 
6.2 ± 0.4 
 
5.8 ± 0.4 
 
14.3 ± 0.3 
 
3.2 ± 0.3 
aStandard deviations were obtained from least-squares fitting with Origin software, 
version 7.5. The fit was carried out with mean values from three experiments. 
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Figure 3.2. The temperature dependence of the rate constant koff for dissociation of 
NAD+ from Hs-SAHH, Hs-18Pf-SAHH, Tc-18Hs-SAHH, and Tc-SAHH. The lines 
are intersecting Eyring plots with the parameters given in Table 3.3. 
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Here, the subscript ℓ denotes the quasi-thermodynamic parameters of 
activation for the low-temperature regime and the subscript h denotes those for the 
high-temperature regime. The values of the quasi-thermodynamic parameters of 
activation are given in Table 3.3. The conversion temperature To for passage from the 
low-temperature regime to the high-temperature regime was calculated from eq (3) 
[8] and values are also given in Table 3.3. 
To  =  [(∆H‡h ) – (∆H‡ℓ )] / [(∆S‡h ) – (∆S‡ℓ )]    (3) 
 
Fig. 3.2. shows that the mutants Hs-18Pf-SAHH and Tc-18Hs-SAHH produce 
behavior that is intermediate between those of the two wild-type enzymes from which 
they derive. Table 3.3. shows that, as with the wild-type enzymes, a low-enthalpy, 
small positive entropy dependence at low temperatures is replaced by a high-
enthalpy, large positive entropy change at high temperatures (the data are not 
persuasively biphasic for Tc-18Hs-SAHH, but a break is visually detectable).  
 
3.3.5. The slow-binding kinetics of the association of NAD+ with apo-Hs-
18Pf-SAHH and apo-Tc-18Hs-SAHH show the same biphasic 
temperature dependences observed with Hs-SAHH and Tc-SAHH. 
 
The wild-type enzymes were earlier found [8] to exhibit both a fast-binding 
phase (within the instrumental dead-time) and a slow-binding phase for the 
association of the apo-enzymes with NAD+. The fast-binding phase was negligible at  
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Table 3.3.  Quasi-thermodynamic parameters of activation for the low-temperature 
and high-temperature regimes, and conversion temperaturesa To between the regimes 
for NAD+ dissociation from  Tc-SAHH (21 °C to 37 °C), Tc-18Hs-SAHH (26 °C to 
46.5 °C), Hs-18Pf-SAHH (29 °C to 45.5 °C), and Hs-SAHH (31 °C to 45.5 °C) at pH 
7.4. 
 
Enzyme 
 
 
∆S‡ℓ 
(J/mol-K) 
 
∆H‡ℓ 
(kJ/mol) 
 
∆S‡h 
(J/mol-K) 
 
∆H‡h 
(kJ/mol) 
 
To, K 
 
Tc-SAHH 
 
 
170 ± 15 
 
154 ± 8 
 
610 ± 30 
 
287 ± 8 
 
 
302 ± 34 
(29 °C) 
 
Tc-18Hs-
SAHH 
 
274 ± 1 
 
181 ± 1 
 
438 ± 9 
 
232 ± 4 
 
309 ± 11 
(36 °C) 
 
Hs-18Pf-
SAHH 
 
64 ± 7 
 
119 ± 8 
 
533 ± 18 
 
265 ± 8 
 
311 ± 19 
(38 °C) 
 
Hs-SAHH 
 
50 ± 2 
 
 
116 ± 4 
 
600 ± 25 
 
297 ± 9 
 
314 ± 21 
(41 °C) 
aTemperature of intersection of the high-temperature and low-temperature limbs of 
the temperature dependence and thus the apparent temperature of conversion 
between the two regimes. 
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concentrations of NAD+ of 5 µM and lower. Here the mutant enzymes were studied at 
5 µM NAD+. The first order rate constants kapp for association of NAD+ with Hs-
18Pf-SAHH and Tc-18Hs-SAHH were measured at 5 µM NAD+ and used to 
calculate the second-order rate constants ko, as kapp/[NAD+] [8].  Fig. 3.3. presents the 
Eyring plots of the slow-binding rate constants ko measured over a range of 
temperatures. A few representative points (not shown) were measured for Hs-18Tc-
SAHH but were found to lie directly on the line for Hs-SAHH. We conclude that at 
least this property and perhaps others of Hs-SAHH are not altered by the 18Tc 
mutation. We therefore turned to Hs-18Pf-SAHH for further studies. The association 
kinetics and their temperature dependences for both Hs-18Pf-SAHH and Tc-18Hs-
SAHH are distinctly different from the two wild-type enzymes and from each other 
(Fig. 3.3.). 
 
A model developed previously [8] from similar data for the wild-type 
enzymes ascribes the decrease in association rate at higher temperatures to a (perhaps 
local) reversible unfolding phenomenon. The temperature dependence of the apparent 
association constant ko is then described by eq (4), where we take the standard-state 
concentration of NAD+, [NAD+]ss = 1 M: 
ℓn (ko/T) = (∆S‡on / R) – (∆H‡on / RT) – ℓn {1 + exp [(∆Soun / R) – (∆Houn / RT)]} 
                                - ℓn [NAD+]ss + ℓn (k/h)                                            (4) 
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Figure 3.3. The temperature dependence of the rate constant for the slow-binding 
phase of the association of NAD+ with the apo-forms of Hs-SAHH, Hs-18Pf-SAHH, 
Tc-18Hs-SAHH, and Tc-SAHH. The lines are plots of eq (4) with the parameters 
shown in Table 3.4.  
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Here the subscript “on” denotes the quasi-thermodynamic parameters of 
activation for cofactor binding and the subscript “un” denotes the thermodynamic 
parameters of the reversible unfolding process (thus ko = kon/[1 + Kun]). The values of 
the enthalpies and entropies are given in Table 3.4. The table also gives the ratio 
∆Houn/∆Soun, as a rough measure of the “melting temperature” for the presumed local 
structural transition.  
 
3.3.6. Thermal structural perturbation of wild-type enzymes and helix-18 
mutants analyzed by DSC and CD. 
 
Fig. 3.4. presents thermograms obtained from DSC studies of wild-type and 
mutant enzymes as apo-enzymes, holo-enzymes, and holo-enzyme in the presence of 
20 mM NAD+. All the proteins showed an irreversible thermal unfolding process. A 
sharp reduction in heat capacity indicated that aggregation ensued rapidly after 
unfolding. Therefore, thermodynamic analysis by fitting data to models for reversible 
phase-transition processes is not possible. Thus, we hereafter use the term “stability” 
in this connection in a casual, non-thermodynamic sense simply to reflect changes in 
response of the protein to temperature variation, as detected by DSC and the 
spectroscopic techniques described below. Light-scattering measurements (data not 
shown) confirmed that aggregation followed unfolding. 
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Table 3.4. Thermodynamic and quasi-thermodynamic parametersa for NAD+ 
association with Tc-SAHH, Tc-18Hs-SAHH, Hs-18Pf-SAHH, and Hs-SAHH at 
temperatures in the interval 11 - 45 °C, pH 7.4. 
 
Enzyme 
 
 
∆S‡on 
(J/K-mol) 
 
∆H‡on 
(kJ/mol) 
 
∆Soun 
(J/K-mol) 
 
∆Houn 
(kJ/mol) 
 
∆Houn/∆Soun 
(K) 
 
Tc-SAHH 
 
 
225 ± 13 
 
118 ± 4 
 
631 ± 8 
 
182 ± 2 
 
288 ± 5 
(15 °C) 
 
Tc-18Hs-
SAHH 
 
 
119 ± 19 
 
89 ± 6 
 
815 ± 5 
 
247 ± 1 
 
303 ± 2 
(30°C) 
 
Hs-18Pf-
SAHH 
 
 
- 42 ± 16 
 
42 ± 5 
 
765 ± 7 
 
234 ± 2 
 
306 ± 4 
(33 °C) 
 
Hs-SAHH 
 
- 56 ± 9 
 
38 ± 3 
 
788 ± 5 
 
243 ± 2 
 
308 ± 3 
(35 °C) 
aParameters were obtained by least-squares fitting to eq 4 (Origin version 7.5). The 
subscript “on” identfies the quasi-thermodynamic parameters of activation for the 
binding rate constant of the slow-binding phase of cofactor binding. The subscript 
“un” identfies the equilibrium thermodynamic parameters for local unfolding in or 
near the cofactor binding site. 
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Figure 3.4.   DSC thermograms from 30 to 70 °C of the apo- and holo-forms 
(purified from E. coli cells, fully bound with cofactors: approximately 95 % of NAD+ 
and 5 % of NADH) of Hs-SAHH, Hs-18Pf-SAHH, Tc-18Hs-SAHH, and Tc-SAHH.  
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Table 3.5. shows the apparent melting temperatures, which were taken to be 
the temperatures at which a maximum heat capacity was observed (Fig. 3.4A and 
3.4B).  In addition, data for CD observations are included in Table 3.5. and these 
agree with the DSC results in all cases. 
 
Table 3.5. shows apo-Hs-SAHH is somewhat less thermally stable than apo-
Tc-SAHH but that this difference is erased in the holo-enzymes and excess cofactor 
raises the melting temperatures of both enzymes further, either by assuring full 
cofactor-occupancy or by non-specific binding and stabilization. The observation that 
holo-Tc-SAHH melts at the same temperature as apo-Tc-SAHH is the result of an 
artifact: the DSC thermogram (Fig. 3.4.) shows that the cofactor dissociates at about 
42 °C, so that the melting event at 53 °C reflects, in fact, the melting of the apo-
enzyme (see also Fig. 3.5.).  
 
The mutant Tc-18Hs-SAHH does not produce evidence in the data of Fig. 3.5. 
for such an anomaly, but the single peak in the thermogram of Fig. 3.4. is very broad, 
consistent with dissociation of the cofactor simultaneously with the larger structural 
changes. Consistent with this explanation, addition of excess cofactor produces a 
sharp peak in the thermogram, presumably by maintaining a high population of bound 
cofactor during global unfolding. The mutant Hs-18Pf-SAHH melts at slightly lower 
temperatures than the parent Hs-SAHH but is otherwise unremarkable with respect to 
more extensive unfolding. 
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Table 3.5. Apparent melting temperatures (˚C)a from differential scanning 
calorimetry (DSC, Fig. 3.4.) for the apo-enzyme and holo-enzyme forms (the latter 
also in the presence of  20 mM NAD+) of Tc-SAHH, Tc-18Hs-SAHH, Hs-18Pf-
SAHH, and Hs-SAHH, and similar data for apo-enzymes and holo-enzymes from 
circular dichroism (CD), determined from the midpoints of thermal unfolding curves.  
 
 
Enzyme 
 
DSC 
 
CD 
 
Apo 
 
Holo 
 
Holo + 20 mM 
NAD+ 
 
Apo 
 
Holo 
 
Tc-SAHH 
 
53.0 ± 0.2 
 
53.2 ± 0.2 
 
62.1 ± 0.4 
 
54.0 ± 0.2 
 
54.0 ± 0.2 
 
Tc-18Hs-
SAHH 
 
53.0 ± 0.1 
 
63.4 ± 0.2 
 
65.2 ± 0.3 
 
54.1 ± 0.2 
 
62.0 ± 0.3 
 
Hs-18Pf-
SAHH 
 
41.3 ± 0.2 
 
51.4 ± 0.1 
 
62.8 ± 0.5 
 
41.2 ± 0.3 
 
52.4 ± 0.5 
 
Hs-
SAHH 
 
44.2 ± 0.1 
 
55.2 ± 0.3 
 
63.6 ± 0.4 
 
44.4 ± 0.2 
 
55.4 ± 0.3 
 
aErrors were obtained from the range of two independent measurements. 
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Figure 3.5.    Thermally induced fluorescence changes for Tc-SAHH and Tc-18Hs-
SAHH in the presence of the dye 8-anilino-1-naphthalene-sulfonate, which fluoresces 
when bound in a non-polar environment. At 42 °C, the cofactor dissociates from Tc-
SAHH and the dye occupies the cofactor site. No such dissociation is seen with Tc-
18Hs-SAHH. The large maxima result from global unfolding of apo-Tc-SAHH and of 
holo-Tc-18Hs-SAHH. 
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All holo-enzymes exhibit, in the presence of excess NAD+, very similar 
apparent melting temperatures of around 62 - 65 °C as expected for their high 
sequence similarity and consistent with the composition of helix-18 having little or no 
influence on global unfolding.   
 
The apo-enzymes apo-Hs-SAHH and apo-Hs-18Pf-SAHH show similar 
melting temperatures of 44 and 41 °C, respectively, while the apo-Tc-SAHH and apo-
Tc-18Hs-SAHH both melt at 53 °C, consistent with a somewhat greater global 
stability for Tc-SAHH than for Hs-SAHH, with the mutated helix-18 producing no 
change in the thermal behavior of the wild-type enzyme. The holo-enzymes 
uniformly melt about 10 - 11 °C higher than do the apo-enzymes, consistent with 
thermal stabilization by the cofactor, except for the anomalous holo-Tc-SAHH (see 
above). 
 
3.4. Discussion 
 
3.4.1. The total helix propensities of helix 18 and structures for human 
and parasitic SAHHs suggest lower stability and perhaps larger 
mobility for the parasitic helices.   
 
Helix 18 in the structure of SAHHs is relatively distant from the substrate-
binding region and the surrounding catalytic residues [10] of the active site but 
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relatively close to the cofactor binding site (Fig. 3.1.). Helix 18 therefore seemed an 
attractive possibility for a significant contribution to the distinct kinetics and 
thermodynamics of cofactor association and dissociation observed for Hs-SAHH and 
Tc-SAHH, while at the same time conserving the catalytic kinetic properties of the 
two enzymes. We explored this hypothesis initially by use of helix propensities, 
supported by X-ray structures. 
 
Table 3.1. shows the sequences in the helix-18 regions of Hs-SAHH, Tc-
SAHH, Ld-SAHH, and Pf-SAHH, together with the total helix propensity for helix-
18 in each of the enzymes. As predictors that a peptide segment will assume a helical 
conformation in a statistically averaged protein environment [9], helix propensities 
are limited by the omission of effects from nearby residues and their side chains in 
the primary sequence and the effect of environmental factors not accounted for in the 
statistical average. X-ray crystallographic structural data, now available [1, 2] for Hs-
SAHH, Pf-SAHH, and Tc-SAHH, however, indicate some mitigating factors. Helix 
18 in all of these SAHHs is located on the enzyme surface and makes few interactions 
with other parts of the protein (Fig. 3.6.).  
 
All of the interactions identified in Fig. 3.6. suggest a greater stability for Hs-
SAHH, and secondarily for Tc-SAHH, than for the other enzymes. Furthermore, the 
negatively charged E411, near the N-terminus of helix 18 in Hs-SAHH, should 
interact favorably with the helix dipole [11, 12] but is replaced by electrically neutral  
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               Hs                                            PF                                                   TC 
 
 
 
 
Figure 3.6. Hydrogen bonds formed between residues of helix 18 and nearby residues 
of the enzyme and among the residues within helix 18 for Hs-SAHH, Tc-SAHH, and 
Pf-SAHH. 
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residues in two of the three parasitic enzymes (Table 3.1.). The electrically neutral 
Q415 toward the C-terminus of the helix in Hs-SAHH is replaced by destabilizing 
[11, 13] negatively charged residues in two of the three parasitic enzymes.  
 
The helix-propensity prediction (Table 3.1.) of a stability order for helix 18 of 
Hs-SAHH > Tc-SAHH > Ld-SAHH > Pf-SAHH appeared sufficiently supported by 
structural data to encourage further investigation of the effects of helix-18 sequences 
on cofactor binding and other properties of the human and parasitic enzymes. In 
addition to serving as indicators of helix stability, the helix propensities seemed 
possible indicators of the subtler property of helix mobility or flexibility. If it is 
assumed that a more stable or immobile helix-18 would provide a more stable 
cofactor binding site, then the results are consistent with the observation that the 
human enzyme binds NAD+ more tightly than the parasitic enzymes [6-8]. 
 
3.4.2. Catalytic properties of wild-type and mutant enzymes.   
 
Investigations of the role of helix 18 in the distinct properties of human and 
parasitic enzymes were pursued through construction of three mutants for comparison 
with wild-type enzymes: (1) Hs-18Tc-SAHH, the human enzyme bearing the helix 18 
of Tc-SAHH in place of its own, (2) Tc-18Hs-SAHH, the trypanosomal enzyme 
containing the helix 18 of Hs-SAHH, and (3) Hs-18Pf-SAHH, the human enzyme 
with the helix 18 of Pf-SAHH. As will be described below, the properties of Hs-
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18Tc-SAHH were found at an early point in this work to be essentially 
indistinguishable from those of Hs-SAHH. Therefore Hs-18Pf-SAHH was prepared 
with the sequence of helix 18 corresponding to that of lowest helix propensity; indeed 
the properties of this mutant were different from those of Hs-SAHH and further 
studies made use of this mutant. As expected, mutations in helix 18, quite distant 
from the catalytic site, produced no major changes in the catalytic properties of the 
wild-type enzymes, which are very similar to each other in this regard (Table 3.2.). 
 
3.4.3. Helix 18 is stabilized by the binding of NAD+ and a thermally 
induced structural change in or near helix 18 accelerates the 
dissociation of NAD+.   
 
The dissociation of NAD+ from Hs-SAHH and Tc-SAHH was earlier found 
[8] to occur in a simple first-order fashion. For both enzymes, the rate constants 
increased with temperature biphasically, a transition occurring at 29 °C for Tc-SAHH 
and at 41 °C for Hs-SAHH. The transition altered a linear Eyring dependence with 
low enthalpy of activation and small positive entropy of activation (low temperatures) 
to a linear Eyring dependence with high enthalpy of activation and large positive 
entropy of activation (high temperatures). The sharpness of the transition from a low-
temperature to high-temperature regime suggests a structural transition as the origin 
of this relatively abrupt change. As elaborated below, changes in helix 18 seem a 
likely source of this behavior. 
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If the conversion between the two temperature regions is caused by a thermal 
perturbation of helix 18, then the activation parameters of Table 3.3. appear 
consistent with a view that the altered structure at higher temperatures binds the 
cofactor more tightly but generates substantially more entropy upon its release. A 
second point is that the apparent unfolding in the presence of the cofactor results in an 
accelerated dissociation of the cofactor. This involves a large positive entropy of 
activation that more than compensates for an increased enthalpy of activation. This 
finding would also be consistent with a greater mobility of the enzyme following the 
unfolding of helix 18 and dissociation of the cofactor. 
 
3.4.4. Helix 18 (and/or its neighborhood) is the site of local structural 
perturbation that attenuates the association of NAD+ with apo-
SAHHs at higher temperatures.       
 
As described above, NAD+ associates with Hs-SAHH and Tc-SAHH in a 
relatively complex manner that, in contrast to the catalytic properties, is quantitatively 
different for the two enzymes. Binding occurs in two phases, a fast-binding phase that 
occurs within the dead-time of the measurement method and a slow-binding phase 
that occurs over some minutes and exhibits saturation with respect to the cofactor [8], 
with the results in Fig. 3.3. and Table 3.4. referring to the slow-binding phase.   
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A striking difference in the wild-type enzymes is the local-unfolding 
temperature of about 35 °C for Hs-SAHH and about 15 °C for Tc-SAHH, as noted 
earlier [8]. It was also earlier realized [8] that the structural alteration cannot 
correspond to global unfolding of the enzyme since that occurs in the range of 62-65 
°C (Table 3.5.).  
 
The data for the two mutants, Hs-18Pf-SAHH and Tc-18Hs-SAHH, lend 
strong support to the hypothesis that the site of this local alteration is, in fact, helix 
18. Introduction of the plasmodial helix 18 into the human enzyme shifts the 
perturbation temperature from 35 to 33 °C (although this shift is within the 
considerable error of the curve fit to the model, the phenomenological shift in the 
rate-constant maxima is clearly visible in Fig. 3.3.). More dramatically, introduction 
of the human helix 18 into the trypanosomal enzyme shifts this transition temperature 
in the opposite direction, from 15 to 30 °C, clearly beyond the errors of curve fitting 
and also readily visible in the temperature-dependent kinetic data of Fig. 3.3. These 
results are consistent with the concept that helix 18 of Hs-SAHH is, as indicated by 
helix propensities and structural information, a more stable and perhaps rigid entity 
than is helix 18 of Tc-SAHH and Pf-SAHH. 
 
Furthermore, the data suggest that the general context of helix 18 is more 
dynamic in Tc-SAHH than in Hs-SAHH. Thus, introduction of the more rigid human 
helix-18 into the presumably flexible environment of Tc-SAHH results in a large rise 
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in the transition temperature, while introduction of the presumably most flexible 
plasmodial helix 18 into the rigid Hs-SAHH environment results in only a small 
downward shift of the transition temperature. The same idea can also explain the 
observation that the introduction of the trypanosomal helix 18 into the rigid Hs-
SAHH matrix produces little or no effect. 
 
 It should be noted that the approximate order of the transition temperatures of 
helix 18 in the apo-enzymes, as here estimated from the cofactor association kinetics 
(Table 3.4.), namely, Hs-SAHH (35 °C) > Hs-18Pf-SAHH (33 °C) > Tc-18Hs-SAHH 
(30 °C) > Tc-SAHH (15 °C) is the same as the order of the estimated conversion 
temperatures from the low-temperature to the high-temperature regime of the 
cofactor-dissociation kinetics (Table 3.3.) discussed above, namely: Hs-SAHH (41 
°C) > Hs-18Pf-SAHH (38 °C) > Tc-18Hs-SAHH (36 °C) > Tc-SAHH (29 °C).  
Admittedly, in some cases such comparisons fall well within the computed errors, but 
visual analysis of the figures lends support to their validity.  
 
Most simply, the conversion temperatures for dissociation of cofactor are 
larger (29 °C to 41 °C) than the transition temperatures for its association (15 °C to 
35 °C). This result would indicate that the helix has significantly greater thermal 
stability in the presence of the cofactor. Scheme 3.1. summarizes the situation. At left, 
the apo-enzyme consists of an equilibrium mixture of two forms: a high-temperature 
form incapable of binding the cofactor C and a low-temperature form capable of  
 115
 
 
 
Scheme 3.1.  Temperature effects on the cofactor on-rates and off-rates. 
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binding C, so that the on-reaction (rate constant kon) proceeds from the fraction of 
apo-enzyme in the low-temperature form. The conversion temperature between the 
two forms is 15-35 °C and we suspect the conversion is a local structural change in or 
near helix 18. The holo-enzyme at right likewise consists of an equilibrium mixture of 
low-temperature and high-temperature forms. Each releases the cofactor C but the 
high-temperature form does so more rapidly, with a steeper temperature dependence. 
The conversion temperatures here are larger, around 29-41 °C. Again we suppose the 
conversion to be caused by local structural changes in or near helix 18. Conceivably 
the structural changes involved in the on-reaction and off-reaction are the same or 
similar but the conversion temperatures tend to be higher for the off-reaction because 
the cofactor stabilizes helix 18 and its neighborhood. 
 
3.4.5. Helix 18 has only a minor role in the global stability of SAHHs.  
 
The global unfolding temperatures given in Table 3.5. show that, for all forms 
of the wild-type and mutant enzymes, global unfolding occurs for apo-enzymes in the 
range 41-65 °C and for holo-enzymes in the range 51-65 °C.  This is beyond the 
temperature range of 15-41 °C for which structural alterations of helix 18 are 
proposed as the cause of the biphasic transitions observed in the kinetics of 
association and dissociation of the cofactor from SAHHs. This strongly suggests that 
the phenomenon involved in the cofactor association-dissociation kinetics is not due 
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to the onset of global unfolding, but rather results from the proposed conformational 
changes in helix 18. 
 
3.5. Conclusion 
 
Previous studies [8] showed that the human enzyme Hs-SAHH and the 
parasitic enzyme Tc-SAHH have similar catalytic properties but differ distinctly in 
the on- and off-rates of the tightly bound NAD+ cofactor
.
 Structural information and 
calculations of helix propensities suggest that differences in the stability and possible 
mobility of helix 18, near the C-terminus and embedded into the cofactor binding site 
of the partner subunit, might account for these observations. Mutants were therefore 
constructed of the wild-type enzymes Hs-SAHH and Tc-SAHH in which the human 
helix 18 (predicted to be more stable and perhaps more rigid than the parasitic 
helices) has been replaced by a plasmodial helix 18 (predicted to be less stable), Hs-
18Pf-SAHH, and in which the trypanosomal helix 18 (predicted to be of lower 
stability) has been replaced by the human helix 18 (Tc-18Hs-SAHH). These wild-
type and mutant enzymes (1) exhibited essentially the same catalytic kinetic 
constants; (2) showed biphasic temperature dependences of the dissociation rate 
constants for NAD+, with a thermal inflection reflecting structural changes in or near 
the cofactor binding sites, and the transition temperatures sytematically varying from 
29 °C (Tc-SAHH) to 41 °C (Hs-SAHH), the two mutants falling between these limits; 
(3) showed biphasic temperature dependences of the association rate constants for 
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NAD+, with a thermal maximum reflecting local changes in or near the cofactor 
binding sites, and the transition temperatures sytematically varying from 15 °C (Tc-
SAHH) to 35 °C (Hs-SAHH), the two mutants again falling between these limits; (4) 
underwent more global unfolding at temperatures in the range 62 °C to 65 °C, 
indicating that helix 18 has little direct role in global thermal stability, and that the 
thermal transitions at considerably lower temperatures involved in the on-off rate 
alterations for NAD+, indeed reflect local, reversible structural changes, probably 
within helix 18 itself. 
 
Helix 18 and other nearby structures may therefore identify critical sites at 
which inhibitory ligands that have the capacity to distinguish between human and 
parasitic enzymes could be designed to bind. Such compounds have the potential to 
function as specific antiparasitic drugs. Figure 3.6. shows some of the details of the 
structures of helix 18 in Hs-SAHH, Tc-SAHH, and Pf-SAHH. 
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Chapter 4  
 
The Role of the Conserved Hydrophobic Residues in β-Sheet 
A of the Rossmann Motif in Comparative Kinetics of Cofactor 
Association and Dissociation for Hs-SAHH and Tc-SAHH. 
 
4.1. Introduction 
 
This chapter has focused on the NAD+ binding motif (Rossmann motif) and 
its contribution to the kinetics and thermodynamics of NAD+ dissociation and 
association for SAHH. It emerges as useful, as will be apparent, to include the 
properties of the wild-type enzyme from Plasmodium falciparum. 
 
 The Rossmann motif (Fig. 4.1.), a βαβαβ unit, is found in most NAD(P)+ 
binding proteins [1, 2]. The motif that binds NAD(P)+ usually has a second repeated 
βαβαβ unit that is structurally related to the first one by approximately a two fold 
rotation, with the more N-terminal β-sheets adjacent to each other. Among the 30-35 
amino acids of the fingerprint sequences of the Rossmann motif, there are six small, 
generally conserved, hydrophobic residues, distributed with two each on the first β-
sheet (βA in SAHH), the first α-helix (αB in SAHH), and the second β-sheet (βB in 
SAHH). These six residues form the hydrophobic core of the motif, and are  
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Figure 4.1. The monomeric-subunit structure of Hs-SAHH (pdb file 1LI4). The N-
terminus is at bottom left and the large N-terminal domain is the substrate-binding or 
catalytic domain (substrate in green ball-and-stick representation), while the large 
upper domain is the cofactor-binding domain (cofactor in purple ball-and-stick 
representation). The Rossmann motif [2] consists of β-sheet A (residues 215-219 in 
blue ball-and-stick representation), followed by α-helix B (223-234),  β-sheet B (238-
242), α-helix C (246-254), and β-sheet C (258-260), all of which along with 
intervening loops are shown in gold ribbon representation [3]. The C-terminal 
extension is at right; it protrudes into the partner subunit where helix 18 (red) forms 
part of the cofactor-binding site of that subunit. A similar extension from the partner 
subunit also contributes its helix 18 to the binding site shown here. Helix 18 (red) was 
the locus of mutational studies reported in the preceding publication [4] and β-sheet A 
(blue) is the locus of mutational studies reported in the present paper. A second repeat 
of the Rossmann motif (residues 271-322) is shown in pink ribbon representation: no 
alterations in this region were made in the present work. 
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commonly considered necessary for proper steric relationships in the packing of the 
β-sheets against the α-helices [1]. 
 
SAHH exhibits two classical Rossmann motifs in each monomeric subunit: 
one is in the substrate-binding domain (recall that the substrate is a nucleoside) and 
the other in the cofactor-binding domain. In this study, only the Rossmann motif in 
the NAD+ binding domain (which consists of residues 215 through 260 in Hs-SAHH; 
Fig. 4.1.) was subjected to systematic alteration. A second repeated Rossmann motif, 
shown in pink in Fig. 4.1. (residues 271-322), was not altered.  
 
 Alignment of the 30-35 amino acids of the fingerprint sequences of the 
Rossmann motif in the NAD+-binding domain of human and parasitic (Trypansoma 
cruzi, Plasmodium falciparum, and Leishmania donovani) SAHHs reveals that the 
two small, generally conserved, hydrophobic residues on β-sheet A are conserved as 
hydrophobic residues in Hs-SAHH and Pf-SAHH, but are replaced by two 
hydrophilic residues in Tc-SAHH and Ld-SAHH (Table 4.1.). The replacement of the 
hydrophobic residues by two hydrophilic residues would seem likely to weaken the 
stabilizing hydrophobic interactions and thus increase the flexibility of the 
hydrophobic core region formed by the six hydrophobic residues and other residues. 
Such an increased flexibility could influence the kinetics and thermodynamics of 
NAD+ association and dissociation. To examine this hypothesis, a Tc-SAHH mutant 
(Tc-βAHs-SAHH [Tc-(T214V, C216V)-SAHH], a partially “humanized” parasite 
enzyme) was constructed with the two hydrophilic residues of β-sheet A replaced by 
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Table 4.1. The sequences and β-sheet-propensity values for β-sheet A (Fig. 4.1.) of 
the Rossmann motif in the NAD+ binding domain of Hs-SAHH, Hs-βATc-SAHH, 
Tc-βAHs-SAHH, Tc-SAHH, Pf-SAHH and Ld-SAHH. Individual sequence ranges 
for β-sheet A are shown beneath the species identifier at left and the β-sheet 
propensities [5] of the individual residues are shown as subscripts. 
 
      SAHH                      Sequences
 (propensity value) Total β-sheet-propensity 
 
Hs-         V(1.89)A(0.78)V(1.89)V(1.89)A(0.78)                7.23 
       (215-219) 
 
Hs-βATc-        T(1.21)A(0.78)C(1.26)V(1.89)A(0.78)               5.92 
       (215-219) 
 
Tc-βAHs-       V(1.89)A(0.78)V(1.89)V(1.89)C(1.26)               7.71 
       (214-218) 
 
Tc-         T(1.21)A(0.78)C(1.26)V(1.89)C(1.26)                6.40 
       (214-218) 
 
Pf-          I(1.65)V(1.89)V(1.89)I(1.65)C(1.26)                   8.34 
(259-263) 
 
Ld-   T(1.21)C(1.26)C(1.26)V(1.89)C(1.26)                    6.88 
       (214-218) 
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the two hydrophobic residues present at the corresponding positions in Hs-SAHH. A 
Hs-SAHH mutant (Hs-βATc-SAHH [Hs-(V215T, V217C)-SAHH], a partially 
“parasitized” human enzyme) was created with the two hydrophobic residues of β-
sheet A replaced by the two hydrophilic residues present in β-sheet A of Tc-SAHH. 
The kinetics and thermodynamics of NAD+ association and dissociation were 
investigated and the results compared with those for the wild type enzymes, Hs-
SAHH, Tc-SAHH, and Pf-SAHH. 
 
4.2. Methods 
  
4.2.1. Site-directed mutagenesis.   
 
 All mutants were created by site-directed mutagenesis using PCR. Each 
amplification reaction contained the following in a volume of 50 µL: 25 pmol of each 
primer, 20 nmol of each deoxynucleoside triphosphate, 20 ng of template DNA, 6 µL 
of 10x Pfu DNA ploymerase buffer and 3U Pfu DNA polymerase (Stratagene).  The 
sequences of the primers used for site-directed mutagenesis were 
 5’-GGCAAGACAGCGTGTGTAGCAG-3’ and 
 5’-CTGCTACACACGCTGTCTTGCC-3’ for Hs-SAHH, and 
 5’-GCTGGAAAGGTTGCCGTTGTTTGTGG-3’ and 
 5’-CCACAAACAACGGCAACCTTTCCAGC-3’for Tc-SAHH.  After 4 min of a 
heat-start step at 92˚C, 25 cycles of the following program were initiated: 20 sec at 
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92˚C, 30 sec at 55˚C and 20 min at 68˚C. PCR products were purified with a PCR 
purification kit (Qiagen).  After treatment with Dpn I (Biolab), the PCR products 
were transformed into BL21(DE3) E. coli (Stratagene). The sequences of mutant 
genes were confirmed by DNA sequencing. 
 
4.2.2. Determination of rate constants for association of NAD+ with apo-
enzymes (apparent first-order rate constant kapp and apparent 
second-order rate constant ko).   
 
This process was executed as described previously [6].  Typically, except for 
Pf-SAHH and Tc-βAHs-SAHH, a 50 µL solution (50 mM phosphate buffer, pH 7.4, 1 
mM EDTA) containing 2 µM apo-enzyme was added to a pre-incubated 50 µL 
aliquot of NAD+ solution with a concentration in the range from 2 to 600 µM.  
Samples were taken for activity assay at measured times during incubation at the 
desired temperature. The measured activities A were either converted to the amount 
of enzyme:NAD+ complex or used directly in eq. 1. 
 A = Af  + (Ao – Af)[exp(-kappt)]      (1) 
 
 Here, A is the activity measured at time t, Ao is the activity at the apparent 
time zero (reflecting reaction during the dead-time of the experiment), Af is the 
activity at the end of the experiment, and kapp is a first-order rate constant for 
association that generally will be a function of [NAD+]. At [NAD+] = 5 µM, Ao is 
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quite small and kapp is approximately proportional to [NAD+]; an apparent second-
order rate constant for the association reaction ko was therefore calculated from data 
at this concentration as ko = kapp/[NAD+]. 
 
       For Pf-SAHH and Tc-βAHs-SAHH, the method is the same as described above 
except that apo enzyme concentration was 10 µM, NAD+ concentration was in the 
range from 0.1 to 20 mM and the ko was calculated from data at 2 mM NAD+ 
concentration as ko = kapp/[NAD+]. 
 
4.2.3. Determination of the rate constants (koff) for dissociation of NAD+ 
from Hs-βATc-SAHH, Pf-SAHH, and Tc-βAHs-SAHH.  
 
Briefly, NAD+ was allowed to dissociate from fully reconstituted enzyme in 
the presence of excess NADH which irreversibly traps each vacated binding site. The 
decrease in enzyme activity occurred in a first-order fashion with a rate constant kobs 
= koff + kina, where kina is the first-order rate constant for thermal inactivation, 
determined in control experiments. The dissociation rate constants koff were 
calculated as koff = kobs - kina. The measurements for Pf-SAHH reconstituted in vitro 
and Tc-βAHs-SAHH reconstituted in vitro were carried out on a much shorter time 
scale and thus, in contrast to the above, NADH, alcohol dehydrogenase, and 2-
propanol were not added; no measurement of kina was made; and the dissociation 
process was carried out at 4 oC, instead of at 37 oC. 
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4.2.4. Notation for cofactor-association rate constants and calculation 
of the cofactor dissociation constant (Kd).   
 
Binding of NAD+ occurs on both a fast time-scale, for which rate constants 
are not obtained, and a slow time-scale with an apparent first-order rate constant kapp. 
The rate constant kapp exhibits saturation kinetics with [NAD+] according to eq. (2c) 
below, yielding a second-order rate constant for slow binding ka/Ka. At sufficiently 
low [NAD+], the ratio kapp/[NAD+] yields a good approximation to ka/Ka, which we 
denote ko. As the temperature is increased, a local, reversible unfolding phenomenon 
inhibits association of NAD+, such that the temperature dependence of ko is described 
by ko = kon/(1 + Kun), where Kun is the equilibrium constant for the local, reversible 
unfolding process. Here kon is the approximate second-order rate constant for 
association of [NAD+] with fully folded enzyme. The value of the equilibrium 
dissociation constant of NAD+ can be calculated as the ratio of off-rate constant koff to 
the on-rate constant ka/Ka or approximated as koff/kon or, at temperatures where 
unfolding is negligible, koff/ko. 
 
4.3. Results 
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4.3.1. The mutant enzymes Tc-βAHs-SAHH and Hs-βATc-SAHH have 
secondary and quaternary structure unaltered from the wild-type 
enzymes.   
 
The sequences of β-sheet A of the Rossmann motifs in Hs-SAHH, Pf-SAHH 
and Tc-SAHH are listed in Table 4.1. To generate Tc-βAHs-SAHH, the hydrophilic 
residues T214 and C216 of Tc-SAHH were replaced by the valines present at the 
corresponding positions (V215, V217) of Hs-SAHH (thus mutations T214V/C216V 
of Tc-SAHH).  To generate Hs-βATc-SAHH, mutations V215T and V217C were 
introduced in Hs-SAHH. Studies of the CD spectra and size-exclusion 
chromatography showed that the mutations had no significant effects on secondary or 
quaternary structure (data not shown; the methods and results were very similar to 
those exemplified in reference [7]).   
 
4.3.2. Catalytic properties of mutant enzymes differ from those of the 
wild-type enzymes only by small factors.   
 
Table 4.2. shows the steady-state kinetic parameters obtained from a partial 
kinetic characterization of Pf-SAHH, Hs-βTc-SAHH, and Tc-βHs-SAHH. The 
parameters consist, for the hydrolysis of AdoHcy, of the values of kcat, Km, and their 
ratio (the full kinetics) and, for the synthesis of AdoHcy, the values of kcat and Km 
from variation of [Hcy] at a single concentration of Ado (ca. 250KmAdo) and from  
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Table 4.2. Kinetic parametersa for Hs-SAHH, Hs-βATc-SAHH, Pf-SAHH, Tc-βAHs-
SAHH and Tc-SAHH measured in 50 mM phosphate buffer, pH 7.4, 1 mM EDTA at 
37°C. 
kinetic 
parameter 
Hs-SAHHb Hs-βATc-
SAHH 
Pf-SAHH Tc-βAHs-
SAHH 
Tc-SAHHb 
[Ado] varied for synthesis of AdoHcy at [Hcy] = 1mM = ca. 5KmHcy 
 
kcat (s-1) 
 
 
12.5 ± 0.2 
 
6.5 ± 0.2 
 
2.1 ± 0.2 
 
1.4 ± 0.1 
 
15.5 ± 0.3 
 
Km (µM) 
 
 
1.5 ± 0.1 
 
3.5 ± 0.1 
 
2.0 ± 0.3 
 
0.7 ± 0.1 
 
1.2 ± 0.1 
 
106kcat/Km  
(M-1s-1) 
 
8.3 ± 0.6 
 
1.9  ± 0.08 
 
1.1 ± 0.2 
 
2.0 ± 0.3 
 
12.9  ± 1.1 
[Hcy] varied for synthesis of AdoHcy at [Ado] =  1 mM = ca. 250KmAdo 
 
kcat (s-1) 
 
 
16.2 ± 0.9 
 
6.2 ± 0.3 
 
2.0 ±0.1 
 
1.4 ± 0.1 
 
16.7 ± 1.1 
 
Km (µM) 
 
 
160 ± 28 
 
135 ± 18 
 
68 ± 5 
 
40 ± 6 
 
219 ± 26 
 
106kcat/Km  
(M-1s-1) 
 
0.10 ± 0.02 
 
0.05 ± 0.01 
 
0.03 ± 0.003 
 
0.04 ± 0.01 
 
0.08 ± 0.01 
[AdoHcy] varied for hydrolysis of AdoHcy 
 
kcat (s-1) 
 
 
3.2 ± 0.1  
 
3.1 ± 0.1 
 
0.5 ± 0.1 
 
0.8 ± 0.1 
 
3.7 ± 0.1 
 
Km (µM) 
 
 
6.4 ± 0.4 
 
10.8 ± 0.4 
 
2.1 ± 0.1 
 
6.2 ± 0.4  
 
3.2 ± 0.3 
 
106kcat/Km  
(M-1s-1) 
 
0.50 ± 0.03 
 
0.29 ± 0.01 
 
0.24 ± 0.05  
 
0.13 ± 0.02 
 
1.2 ± 0.5 
aStandard deviations were obtained from least-squares fitting of specific velocities to the Michaelis-
Menten equation by Origin version 7.5. The fit was carried out with the mean of values from three 
experiments. bData for Tc-SAHH and Hs-SAHH from reference [6]. 
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variation of [Ado] at a single concentration of  Hcy (ca. 5KmHcy). Corresponding 
values for Hs-SAHH and Tc-SAHH from a previous study are also included in Table 
4.2.  Although the kinetic information on the synthetic reaction is incomplete (a 
complete characterization with simultaneous variation of [Ado] and [Hcy] would 
have yielded precise values of KmAdo, KmHcy, and KiAdo [8]), the results are adequate to 
demonstrate that these mutations in β-sheet A produce no large effects on the 
catalytic properties of either parent enzyme. All properties of Hs-βATc-SAHH are 
within 4-fold of the corresponding properties of Hs-SAHH. All properties of Tc-
βAHs-SAHH are within about 12-fold of the corresponding properties of Tc-SAHH.  
  
4.3.3. The dissociation of NAD+ from Hs-βATc-SAHH is slightly faster 
than from Hs-SAHH and the dissociation of NAD+ from Tc-βAHs-
SAHH is 13 times slower than from Tc-SAHH.  
 
 As previously observed with Hs-SAHH, Tc-SAHH and their mutants in the 
helix-18 region [6, 9], the dissociation of cofactor from the holoenzymes leads to a 
simple mono-exponential decay of the enzyme activity from its initial value to zero. 
The same is true with the β-sheet A mutants and Pf-SAHH examined here (Fig. 4.2.).  
Hs-βATc-SAHH, with the two hydrophobic residues in β-sheet A replaced by two 
hydrophilic residues (see Table 4.1.), showed a slightly faster NAD+ dissociation rate 
than the wild type Hs-SAHH enzyme. Tc-βAHs-SAHH, having the two hydrophilic 
residues in β-sheet A replaced by two hydrophobic residues, showed a NAD+  
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Figure 4.2.  The rate of dissociation NAD+ from Hs-SAHH, Hs-βATc-SAHH, Tc-
βAHs-SAHH, Pf-SAHH, and Tc-SAHH at 37 °C in 50 mM phosphate buffer, pH 7.4.  
Data were calculated from three independent measurements. The rate constants 
(105koff, s-1) with standard deviations in parentheses are shown next to each curve. 
The curves correspond to an exponential decay of relative activity from unity to zero 
activity.  
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dissociation rate constant 13 times smaller than that for Tc-SAHH, similar in 
magnitude to the rate constant for NAD+ dissociation from Pf-SAHH.  
 
 
4.3.4. The association of NAD+ with apo-Hs-βATc-SAHH is qualitatively 
and semi-quantitatively similar to the cofactor-association 
processes of Hs-SAHH and Tc-SAHH.  
 
The process of NAD+ association with apo-Hs-βATc-SAHH is qualitatively similar to 
that of the two wild-type enzymes, apo-Hs-SAHH and apo-Tc-SAHH. The 
association of NAD+ with the three apo-enzymes leads to a time-dependent rise in 
activity that can be described by three constants: Ao, the initial enzyme activity at 
time zero; kapp, an exponential relaxation constant; and Af, the final enzyme activity 
[6]. Ao is a measure of the amount of fast binding of the cofactor, occurring within the 
dead time of the experiment. The parameter kapp is the rate constant for slow binding 
of the cofactor, with Af measuring the amount of total binding (fast plus slow) and Af 
− Ao measuring the amount of slow binding. The constants Ao, Af, and kapp (and thus 
the fraction of fast binding, the fraction of slow binding, and the rate constant of slow 
binding) are all dependent on [NAD+]. Figure 4.3.A shows the dependence of the 
fractions of fast and slow binding as a function of [NAD+] for Hs-βATc-SAHH, and 
Fig. 4.3.B shows the dependence of kapp on [NAD+]. 
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Figure 4.3.   A: The dependence on [NAD+] of the fractions of enzyme activity 
generated with Hs-βATc-SAHH in the fast-binding phase, the slow-binding phase, 
and the total activity. B: The dependence on the concentration of NAD+ of the rate 
constant for the slow-binding phase of the association of NAD+ with the apo-forms of 
Hs-βATc-SAHH at 23 °C and pH 7.4. The curves show the best fit of the data to eqs 
2 with the parameters given in Table 4.3. (also shown on Fig. 4.3.B). 
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Table 4.3. Values of rate and equilibrium constants in the kinetics of the fast and 
slow binding phases of the association reaction of NAD+ with Hs-SAHH, Hs-βATc-
SAHH, Tc-βAHs-SAHH, Pf-SAHH at 23 °C and pH 7.4, from reference [6] and from 
fits of the data in Figs. 3-5 to eqs. 2. 
a The data for total binding to Tc-βAHs-SAHH and Pf-SAHH in Fig. 4.5.AB show anomalies: a poor 
fit for total binding to a saturation function and, for Tc-βAHs-SAHH, a decrease in binding at higher 
[NAD+], so that estimates of the constant Kf (either from total binding or slow binding) are likely to be 
erroneous. The data for fast binding to either enzyme, even at levels approaching 10 mM [NAD+], are 
insufficient to contain any information on the saturation constant Ko. Thus we omit estimates of Kf and 
Ko. 
 
Enzyme 
 
Ko, µM 
binding to fully 
functional sites 
of apo-SAHH 
Ka, µM 
binding to 
non- 
functional 
sites of 
apo-SAHH 
Kf, µM 
binding to fully 
functional sites 
of holo-SAHH 
ka, s-1 
 
transformation 
of non-functional 
apo-sites to 
functional holo-sites 
ka/Ka, M-1s-1 
binding and 
transformation of 
apo-sites to holo-
sites 
 
Hs-SAHH 
 
 
33 ± 4 
n = 3.3 ± 1.4 
 
19 ± 8 
 
1.4 ± 0.3 
 
5.5 ± 0.8 x 10-2 
 
2.9 ± 1.2 x 103 
 
Hs-βATc-
SAHH 
 
30 ± 2 
n = 4.5 ± 0.8 
 
17 ± 7 
 
2.0 ± 0.2 
 
3.9 ± 0.6 x 10-2 
 
2.3 ± 0.9 x 103 
 
Tc-SAHH 
 
 
38 ± 9 
n = 1.6 ± 0.4 
 
3.8 ± 
0.6 
 
1.8 ± 0.4 
 
6.0 ± 0.2 x 10-3 
 
1.6 ± 0.3 x 103 
 Ko Ka, mM Kf ka, s-1 ka/Ka, M-1s-1 
Tc-βAHs-
SAHH 
a 5.8 ± 
0.5 
a 2.1 ± 0.1 x 10-3 0.36 ± 0.04  
Pf-SAHH a 7.9 ± 
1.7 
a 1.6 ± 0.2 x 10-3 0.20 ± 0.05  
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 A model that accounts for such results [4, 6] envisions an apo-enzyme with 
two classes of active sites, equal in number: one which generates full activity when 
occupied by cofactor, but which binds cofactor relatively weakly; another which 
generates no activity when occupied by cofactor, but which binds cofactor relatively 
strongly. The binding occurs rapidly on the time scale of the experiment. The activity 
at time zero Ao is given by eq 2a, allowing for the activity-generating half of the sites 
to become saturated with NAD+ with dissociation constant Ko and Hill coefficient n. 
Here, At represents the total enzyme activity at a saturating [NAD+] after completion 
of slow binding. Occupancy of the second class of sites produces no activity, but their 
binding of the cofactor (dissociation constant Ka) stimulates the slow conversion of 
these sites (rate constant ka to sites of full activity and simultaneous conversion of all 
sites to ones of higher affinity for cofactor (dissociation constant Kf) than either class 
of binding sites in the apo-enzyme. The dependence of Af and kapp on [NAD+] are 
thus given by eqs 2b and 2c, where the treatment is simplified by the omission of 
possible cooperativity (n = 1). 
Ao = (At/2){[NAD+]n/(Kno + [NAD+]n)}     (2a) 
Af  = (At){[NAD+]/(Kf + [NAD+])}      (2b) 
kapp  =  ka{[NAD+]/(Ka + [NAD+])}       (2c) 
 
The curves shown in Fig. 4.3.A are plots of Ao/At (fast binding), [Af - Ao]/At 
(slow binding), and Af/At (total binding) with the parameters Ko, n, and Kf shown in 
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Table 4.3. The curve shown in Fig. 4.3.B is a plot of eq 2c with the parameters ka and 
Ka shown in Table 4.3. 
 
4.3.5. The association of NAD+ with apo-Tc-βAHs-SAHH is quantitatively 
similar to the cofactor-association process of apo-Pf-SAHH and 
very different from those of either apo-Hs-SAHH or apo-Tc-SAHH.  
 
In contrast to Hs-SAHH, Hs-βATc-SAHH, and Tc-SAHH, all of which 
undergo fast and slow binding of cofactor with initial and final cofactor-dissociation 
constants Ko, Ka, and Kf in the micromolar range, the levels of cofactor required for 
association with apo-Tc-βAHs-SAHH are in the millimolar range (Fig. 4.4.A). This 
behavior emerges as very similar to that of Pf-SAHH (Fig. 4.4.B). 
 
 Application of the model leading to eqs. 2 then produces the results shown in 
Fig. 4.5.A for the cofactor-concentration dependence of the fractions of fast binding 
and slow binding, and in Fig. 4.5.B for the cofactor-concentration dependence of the 
rate constant for slow binding. The curves plotted in Fig. 4.5. correspond to the 
parameters shown for Tc-βAHs-SAHH and Pf-SAHH in the lower part of Table 4.3.. 
As expected, the initial and final equilibrium cofactor-dissociation constants for these 
two species are larger than those for Hs-SAHH, Hs-βATc-SAHH, and Tc-SAHH by 
3-4 orders of magnitude. The rate constant for slow binding, however, remains in the 
same range for all enzymes. 
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Figure 4.4. Time dependence of NAD+ binding to Tc-βAHs-SAHH (A) and to Pf-
SAHH (B) as measured by the development of catalytic activity. As the concentration 
of cofactor increases, the intercept at zero time increases (fast binding, within the 
dead-time of the experiment), the final activity increases, and the rate of approach to 
the final level (slow binding) increases. Note that in both cases, the cofactor levels 
required to reach final binding that approaches complete saturation within the two-
hour period are of millimolar magnitudes.  
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Figure 4.5. The dependence on [NAD+] of the fractions of enzyme activity generated 
with Tc-βAHs-SAHH (A) and Pf-SAHH (B) in the fast-binding phase, the slow-
binding phase, and the total activity. C: The dependence on the concentration of 
NAD+ of the rate constants for the slow-binding phase of the association of NAD+ 
with the apo-forms of Tc-βAHs-SAHH and Pf-SAHH at 23 °C and pH 7.4. The 
curves show the best fit of the data to eqs 2 with the parameters given in the lower 
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part of Table 4.3. (also shown on Fig. 4.5.C). increasing with temperature at low 
temperatures and decreasing with temperature at high temperatures. This behavior 
was noted [6] to correspond to a model in which the normal rise in rate constant as 
temperature rises is opposed by a local, reversible unfolding phenomenon such that 
the cofactor binding site becomes increasing disabled as temperature rises. Thus ko = 
kon(1/[1 + Kun]), where Kun is the equilibrium constant for local unfolding and the 
factor in parentheses gives the fraction of still folded enzyme.  
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4.3.6. The Temperature dependence of the association reaction of NAD+ 
with apo-Hs-βATc-SAHH is little changed from that of apo-Hs-
SAHH while cofactor association with apo-Tc-βAHs-SAHH is far 
slower than cofactor association with apo-Tc-SAHH.  
 
For association of NAD+ with Hs-SAHH and Tc-SAHH, it was previously 
established that at [NAD+] = 5 µM, the fraction of fast-binding was negligible and the 
dependence of the slow-binding rate constant kapp on [NAD+] was linear. Thus a 
phenomenological second-order rate constant for slow binding, which we denote ko, 
can be obtained as kapp/[NAD+]. The measurements were possible over a range of 
temperatures [6]. Figure 4.6.A presents the effect of temperature on k0 in the form of 
Eyring plots for Hs-SAHH, Hs-βATc-SAHH, and Tc-SAHH. The curves in all cases 
are biphasic, with ko.  
 
The temperature dependence of the apparent association constant ko is then 
described by eq (3), where we take the standard-state concentration of NAD+, 
[NAD+]ss = 1 M: 
 
ℓn (ko/T) = (∆S‡on / R) – (∆H‡on / RT) – ℓn {1 + exp [(∆Soun / R) – (∆Houn / RT)]} 
                                - ℓn [NAD+]ss + ℓn (k/h)                                            (3) 
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Figure 4.6. Temperature dependence of the rate constant for the slowing-binding 
phase of the association of NAD+ with apo forms of Hs-SAHH, Hs-βATc-SAHH, Tc-
SAHH (A), Pf-SAHH and Tc-βAHs-SAHH (B). The curves are plots of eq (3) with 
the parameters listed in Table 4.4.      
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Table 4.4. Thermodynamic and quasi-thermodynamic parametersa for NAD+ 
association with Tc-SAHH, Pf-SAHH, Tc-βAHs-SAHH, Hs-βATc-SAHH, and Hs-
SAHH at temperatures in the interval 10 - 45 °C, pH 7.4. 
 
Enzyme 
 
 
∆S‡on 
(J/K-mol) 
 
∆H‡on 
(kJ/mol) 
 
∆Soun 
(J/K-mol) 
 
∆Houn 
(kJ/mol) 
 
∆Houn/∆Soun 
(K) 
 
Hs-SAHH 
 
- 56 ± 9 
 
38 ± 3 
 
788 ± 5 
 
243 ± 2 
 
308 ± 3 
(35 °C) 
 
Hs-βATc-SAHH  
 
-8 ± 12 
 
 
52 ± 4 
 
752 ± 6 
 
 
233 ± 2 
 
 
310 ± 4 
(37 °C) 
 
Tc-SAHH 
 
 
225 ± 13 
 
118 ± 4 
 
631 ± 8 
 
182 ± 2 
 
288 ± 5 
(15 °C) 
 
Tc-βAHs-SAHH  
 
83 ± 33 
 
98 ± 9 
 
 
599 ± 8 
 
 
178 ± 2 
 
 
297 ± 5 
(24 °C) 
 
Pf-SAHH 
 
 
83 ± 318 
 
100 ± 91 
 
 
1205 ± 34 
 
 
354 ± 10 
 
294 ± 12 
(21°C) 
aParameters were obtained by least-squares fitting to eq 3 (Origin version 7.5). The 
subscript “on” identfies the quasi-thermodynamic parameters of activation for the 
binding rate constant of the slow-binding phase of cofactor binding. The subscript 
“un” identfies the equilibrium thermodynamic parameters for local unfolding in or 
near the cofactor binding site. 
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In eq (3), the subscript “on” denotes the quasi-thermodynamic parameters of 
activation for cofactor binding and the subscript “un” denotes the thermodynamic 
parameters of the reversible unfolding process. The values of the enthalpies and 
entropies are given in Table 4.4. The table also gives the ratio ∆Houn/∆Soun, as a rough 
measure of the “melting temperature” for the presumed local structural transition.  
 
4.3.7. The temperature dependence of the dissociation reaction of the 
mutant enzymes is qualitatively similar to the biphasic 
dependence for the wild-type enzymes.  
 
Figure 4.7. presents Eyring plots of the first-order rate constants koff for 
dissociation of the cofactor NAD+ from the mutant enzymes, Hs-βATc-SAHH (29 °C 
to 45.5 °C) and Tc-βAHs-SAHH (23 °C to 43.5 °C). Previously measured 
dependences [6] are shown for the wild-tpe enzymes, Hs-SAHH and Tc-SAHH. The 
Eyring plots for all enzymes are nonlinear, consisting of a linear low-temperature 
regime and a linear high-temperature regime. As before [6], two Eyring equations (4a 
and 4b) were used for fitting of the data. 
 
koff / (kT/h)  =  {exp [ (∆S‡l / R) – (∆H‡l / RT)]}  (4a)  
 
koff / (kT/h)  =  {exp [ (∆S‡h / R) – (∆H‡h / RT)]}  (4b)  
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Figure 4.7. Temperature dependence of the rate constant koff for dissociation of 
NAD+ from Hs-SAHH, Hs-βATc-SAHH, Tc-βAHs-SAHH, and Tc-SAHH. The lines 
are intersecting Eyring plots with the parameters given in Table 4.5. 
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Table 4.5.  Quasi-thermodynamic parameters of activation for the low-temperature 
and high-temperature regimes, and conversion temperaturesa To between the regimes 
for NAD+ dissociation from Tc-SAHH (21 °C to 37 °C), Tc-βAHs-SAHH (23 °C to 
43.5 °C), Hs-βATc-SAHH (29 °C to 45.5 °C), and Hs-SAHH (31 °C to 45.5 °C) at 
pH 7.4. 
 
Enzyme 
 
 
∆S‡ℓ 
(J/mol-K) 
 
∆H‡ℓ 
(kJ/mol) 
 
∆S‡h 
(J/mol-K) 
 
∆H‡h 
(kJ/mol) 
 
To, K 
 
Tc-SAHH 
 
 
170 ± 15 
 
154 ± 8 
 
610 ± 30 
 
287 ± 8 
 
 
302 ± 34 
(29 °C) 
 
Tc-βAHs-SAHH 
 
183 ± 13 
 
154 ± 8 
 
 
453 ± 22 
 
 
237 ± 10 
 
307 ± 56 
(34 °C) 
 
Hs-βATc-SAHH 
 
111 ± 6 
 
 
135 ± 5 
 
 
644 ± 24 
 
 
302 ± 10 
 
313 ± 25 
(40 °C) 
 
Hs-SAHH 
 
50 ± 2 
 
 
116 ± 4 
 
600 ± 25 
 
297 ± 9 
 
314 ± 21 
(41 °C) 
aTemperature of intersection of the high-temperature and low-temperature limbs of 
the temperature dependence and thus the apparent temperature of conversion 
between the two regimes. 
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 In above equations, the subscript ℓ denotes the quasi-thermodynamic 
parameters of activation for the low-temperature regime and the subscript h denotes 
those for the high-temperature regime. Table 4.5. summarizes the values of the quasi-
thermodynamic parameters of activation. The conversion temperature To for passage 
from the low-temperature regime to the high-temperature regime was calculated from 
eq (5) and values are also listed in Table 4.5. 
 
 To =  [(∆H‡h ) – (∆H‡ℓ )] / [(∆S‡h ) – (∆S‡ℓ )]   (5) 
  
The Eyring plots for the mutants Hs-βATc-SAHH and Tc-βAHs-SAHH are 
similar in character to the ones for Hs-SAHH and Tc-SAHH and lie between the 
latter. The values listed in Table 4.5. show that a low-enthalpy, small positive entropy 
dependence at low temperatures is replaced by a high-enthalpy, large positive entropy 
change at high temperatures for both wild-type enzymes and mutant enzymes.  
 
4.4. Discussion 
 
4.4.1. Mutants at sites in β-sheet A of the Rossmann motif of Hs-SAHH 
and Tc-SAHH, the “parasitized” human enzyme Hs-βATc-SAHH 
and the “humanized” parasitic enzyme Tc-βAHs-SAHH, exhibit 
intact secondary and quaternary structure and catalytic 
properties little changed from those of Hs-SAHH and Tc-SAHH.  
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The loci and character of the mutations V215C/V217C in Hs-SAHH and 
T214V/C216V in Tc-SAHH are not expected to cause changes in secondary or 
quaternary structure, given the strong similarity of these structures in the two wild-
type enzymes, Hs-SAHH (11-15) and Tc-SAHH (16), and indeed the circular 
dichroism spectra are near-identical and size-exclusion chromatography shows both 
mutant enzymes to be homotetrameric. Little effect is also expected on the catalytic 
properties as the mutational loci are quite distant from the site of chemical changes in 
catalysis (Fig. 4.1.) and the catalytic properties of Hs-SAHH and Tc-SAHH are 
themselves not very different. Indeed all four enzymes are very similar in their 
catalytic properties (Table 4.2.). 
 
4.4.2. The complete dissociation of the cofactor NAD+ from all four 
subunits of the mutant enzymes Hs-βATc-SAHH and Tc-βAHs-
SAHH is a simple first-order reaction with rate constant 
intermediate in magnitude between those of Hs-SAHH and Tc-
SAHH.  
 
It was established in previous work that dissociation of the four bound 
cofactor molecules from the tetrameric Hs-SAHH and Tc-SAHH enzymes [6] and 
enzymes mutated at sites in helix-18 [4] was in each case a simple single-exponential 
relaxation process. In contrast to the very similar catalytic properties of Hs-SAHH 
and Tc-SAHH, Hs-SAHH underwent cofactor dissociation at 37 °C nearly 100-fold 
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more slowly than Tc-SAHH (these data are also shown in Fig. 4.2.). The dissociation 
rates for the mutant enzymes Hs-βATc-SAHH and Tc-βAHs-SAHH fall between the 
rates for Hs-SAHH and Tc-SAHH, in a pattern that was also true for the helix-18 
mutants [4]. Cofactor dissociates from the “parasitized” human enzyme, Hs-βATc-
SAHH, more rapidly than from Hs-SAHH, but only by less than a factor of two (Fig. 
4.3.). Cofactor dissociates from the “humanized” parasitic enzyme, Tc-βAHs-SAHH, 
more slowly than from Tc-SAHH but here by a more substantial factor of 13 (Fig. 
4.2.).  
 
 This pattern was previously seen [4] with mutations in helix-18 of Hs-SAHH 
and Tc-SAHH: “parasitizing” mutations of Hs-SAHH tended to produce small shifts 
of enzyme properties in the direction of the properties of Tc-SAHH, while 
“humanizing” mutations of Tc-SAHH produced larger shifts of enzyme properties in 
the direction of the properties of Hs-SAHH. It was noted that Hs-SAHH had a larger 
total helix propensity for helix-18 than was the case for Tc-SAHH, and that Hs-
SAHH might therefore have a more robust or rigid and less easily perturbed helix-18 
than Tc-SAHH. The mutational effects for Tc-SAHH would then be larger than those 
for Hs-SAHH, as observed. A similar case could also be made here: the total β-sheet 
propensity of β-sheet A of the Rossmann motif is about 7.2 for Hs-SAHH and 6.4 for 
Tc-SAHH. Thus β-sheet A may be more robust and less easily perturbed in Hs-
SAHH, giving rise to smaller mutational effects, then in Tc-SAHH, where larger 
mutational effects are observed. 
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4.4.3. Association of NAD+ with the “parasitized” human enzyme apo-
Hs-βATc-SAHH resembles association of NAD+ with apo-Hs-SAHH 
and apo-Tc-SAHH, both qualitatively and quantitatively.  
 
Cofactor association with the apo-enzymes of Hs-SAHH, Tc-SAHH, and their 
mutants at helix-18 sites exhibits a kinetic pattern similar to that for association with 
apo-Hs-βATc-SAHH (Fig. 4.3.). This pattern is consistent with a model having the 
following properties [4, 6]: 
 
(a) The tetrameric apo-enzyme has four cofactor-binding sites that fall into 
two classes, equal in number.  
 
(b) Half of the sites exhibit a relatively larger cofactor-dissociation constant 
Ko (ca. 33 µM for Hs-SAHH) and occupation of these sites by cofactor produces a 
full complement of catalytic activity. These sites are rapidly occupied (within the 
dead-time of the experiment), and give rise to an initial fast-binding activity Ao which 
increases with cofactor concentration according to eq 2a above. For Hs-SAHH and 
Tc-SAHH, fast binding is cooperative with Hill coefficients n around 2-3. 
 
(c) Half of the sites exhibit a relatively smaller cofactor-dissociation constant 
Ka (ca. 19 µM for Hs-SAHH), are also rapidly occupied but generate no immediate 
catalytic activity. Instead, occupancy of these sites stimulates a time-dependent 
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conversion of all sites in the enzyme (rate constant kapp) to sites of full activity Af 
with a still smaller cofactor-dissociation constant Kf.  The cofactor-concentration 
dependences of Af and kapp are given by eqs 2b and 2c, respectively. The slow-
binding activity is Af - Ao. 
 
(d) Plots of the dependence on cofactor concentration of the fractions of fast-
binding activity (Ao/At), of slow-binding activity ([Af – Ao]/At), and of total binding 
activity (Af/At), where At is the final activity after slow binding is complete of the 
fully saturated enzyme, give the appearance of Fig. 4.3.A. Briefly, the fast-binding 
curve tends to be sigmoidal, not hyperbolic, so that relatively little fast binding occurs 
at low cofactor concentrations. This gives rise to the steep increase of the slow-
binding curve at low cofactor levels, with slow binding accounting for 80% or more 
of the total. As the fast binding mode begins to account for more binding, the slow-
binding curve drops and both then level off at half of the total binding in accord with 
the equal populations of the two kinds of sites. 
 
(e) Plots of kapp against cofactor concentration have in previous work, tended 
to present an appearance similar to Fig. 4.3.B. 
 
Apparently, as Fig. 4.3. suggests, the same model can describe the association 
of NAD+ with the “parasitized” human enzyme Hs-βATc-SAHH. Indeed, essentially 
all of the quantities determined in the analysis are nearly the same for Hs-SAHH and 
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Hs-βATc-SAHH and only slightly different for Tc-SAHH (upper part of Table 4.4.). 
This may indicate that the structural and dynamic phenomena underlying features (a), 
(b), and (c) of the association model described above are insensitive to structure in β-
sheet A of the Rossmann motif. 
 
4.4.4. Association of NAD+ with the “humanized” parasitic enzyme apo-
Tc-βAHs-SAHH differs radically from association of NAD+ with 
apo-Hs-SAHH or apo-Tc-SAHH, but resembles association of 
NAD+ with apo-Pf-SAHH.  
 
Fig. 4.4. shows the time courses of the binding of NAD+ to apo-Tc-βAHs-
SAHH (Fig. 4.4.A) and to apo-Pf-SAHH (Fig. 4.4.B). These time courses resemble 
qualitatively the corresponding data for binding to apo-Hs-SAHH and apo-Tc-SAHH: 
the initial activity Ao, the final activity Af, and the relaxation constant kapp all rise 
with increasing [NAD+]. However, the range of [NAD+] required to span a 
corresponding range of the parameters for apo-Hs-SAHH and apo-Tc-SAHH was 1 - 
100 µM whereas in Fig. 4.4., the range for apo-Tc-βAHs-SAHH is 40 µM to 6 mM 
and the range for apo-Pf-SAHH is 300 µM to 7 mM.  
 
Obviously the chemical potential of NAD+ required to drive cofactor binding 
to these two enzymes is greater than the requirement for Hs-SAHH, Hs-βATc-SAHH, 
and Tc-SAHH by around 2 orders of magnitude. Indeed the complete kinetic profile 
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of association could not be explored except by use of cofactor levels approaching 20 
mM, at which point anomalies (perhaps arising from self-association [10, 11] or 
inhibition of enzyme activity) are already appearing. Because the accessible data (Fig. 
4.5., Table 4.3.) are limited and partly anomalous, it cannot be definitely shown that 
the model described for the other enzymes also holds for cofactor association with 
apo-Tc-βAHs-SAHH and apo-Pf-SAHH.  
  
However, if it is assumed that the model holds, then the derived parameters 
(lower part of Table 4.3.) suggest that initial cofactor binding to the apo-enzyme 
occurs with dissociation constants Ka in the millimolar rather than the supra-
micromolar range. The rate constant ka for slow binding is not so different from that 
seen with Tc-SAHH, but the greatly increased dissociation constant makes the value 
of ka/Ka smaller by nearly four orders of magnitude. 
The structural basis for this phenomenon is currently unknown. It is being 
investigated by computational methods. 
 
4.4.5. The temperature dependences of the slow-binding rate constants 
for association of NAD+ are similar for apo-Hs-SAHH and apo-Hs-
βATc-SAHH and four orders of magnitude faster than for apo-Pf-
SAHH and apo-Tc-βAHs-SAHH.   
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It has already been noted and discussed [4, 6] that the local structural 
transition that impedes cofactor association occurs in apo-Tc-SAHH at a substantially 
lower temperature (15 °C) than is the case for apo-Hs-SAHH (35 °C). Mutations in 
helix-18 of the cofactor binding site that interchanged human/parasitic structures, 
analogous to the β-sheet A mutations reported here, gave rise to species with 
intermediate transition temperatures. Hs-α18Pf-SAHH showed a small shift (perhaps 
none) from 35 °C to 33 °C, while Tc-α18Hs-SAHH showed a dramatic shift from 15 
°C to 30 °C. This and other evidence led to the tentative conclusion that the “site of 
this local alteration is, in fact, helix 18.” 
 
 The results reported here require a more complex picture (Fig. 4.6., Table 
4.4.). The mutant enzyme Hs-βATc-SAHH gives a temperature dependence 
(transition temperature 37 °C) scarcely distinguishable from that of Hs-SAHH, in 
agreement either with the locus of the transition being elsewhere (perhaps helix 18) or 
instead with the robustness of β-sheet A in the human enzyme, in common with the 
robustness of helix 18 in the human enzyme. The mutant enzyme Tc-βAHs-SAHH 
shows a transition temperature of 24 °C, dramatically shifted from the Tc-SAHH 
value of 15 °C in the direction of the human enzyme. This result would suggest a role 
for β-sheet A in controlling the transition or at least an interaction between structure 
at β-sheet A and at helix 18 during the transition. 
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 Far more striking is the fact that the values of kon are smaller by a factor 
around 40,000, a property that is shared by the wild-type plasmodial enzyme Pf-
SAHH. These two enzymes, Pf-SAHH and Tc-βAHs-SAHH, also share the property 
of possessing a β-sheet A consisting of  four hydrophobic residues followed by a 
cysteine (Table 4.1.) and they possess the two highest total β-sheet propensities (8.34 
and 7.71, respectively) in Table 4.1. We hope that theoretical work may elucidate the 
molecular origins of this phenomenology. 
 
4.4.6. The temperature dependences of the rate constants for 
dissociation of NAD+ from Hs-βATc-SAHH and Tc-βAHs-SAHH are 
similar in character to and quantitatively intermediate between 
those for Hs-SAHH and Tc-SAHH.  
 
The temperature dependences of the cofactor-dissociation rate constants (Fig. 
4.7., Table 4.5.) can be seen from a far simpler perspective. The biphasic dependence 
with a shift to higher enthalpies of activation at temperatures from 29 °C (Tc-SAHH, 
with the fastest dissociation) to 41 °C (Hs-SAHH, roughly 10-30-fold slower 
dissociation) is reproduced by the mutants, with the properties of Hs-βATc-SAHH 
scarcely changed from those of Hs-SAHH, while Tc-βAHs-SAHH shows a large shift 
from Tc-SAHH in the direction of Hs-SAHH. Thus the indication of a robustness of 
the Hs-SAHH properties, contrasting with the malleability of Tc-SAHH, is 
maintained. 
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4.5. Summary and Conclusions.  
 
The following generalizations may be advanced: 
 
1. As with the helix-18 mutants [4] in chapter 3, the mutants here discussed in 
β-sheet A of human and trypanosomal SAHHs have negligible effects on the catalytic 
properties of the enzymes, as is expected, in one sense, for mutational sites so distant 
from the locus of the catalytic chemistry (see Fig. 4.1.). Although much evidence on 
hydride-transfer processes of exactly the kind that participate in the redox partial 
reaction of SAHHs [12] indicates the vibrational involvement of remote residues in 
catalysis, the present study has produced no such indications.  
 
2. For the kinetics of dissociation of cofactor from the enzyme and their 
temperature dependence (Fig. 4.2., Fig. 4.7., Table 4.5.), the introduction of mutations 
in Hs-SAHH  such that β-sheet A of the Rossmann motif more closely resembles the 
same structure in Tc-SAHH (“parasitizing” mutations, Hs-βATc-SAHH), the rate 
constants and their Eyring plot are moved away from the data for wild-type Hs-
SAHH in the direction of the data for wild-type Tc-SAHH. Correspondingly, the 
introduction of “humanizing” mutations in β-sheet A of the Rossmann motif of Tc-
SAHH (Tc-βAHs-SAHH) results in changes of the rate constants and their Eyring 
plots in the direction of the data for wild-type Hs-SAHH. Here as in other cases, the 
mutationally induced changes are larger in magnitude for Tc-SAHH than for Hs-
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SAHH, in agreement with ascription of greater structural robustness or resilience to 
Hs-SAHH in contrast to Tc-SAHH. In a development (Fig. 4.2.) that presages other, 
more dramatic findings described below, the rate constant for cofactor dissociation at 
37 °C, pH 7.4, for Tc-βAHs-SAHH (36 x 10-5 s-1 vs. 461 x 10-5 s-1 for Tc-SAHH) is 
very close to that for the wild-type plasmodial enzyme Pf-SAHH (45 x 10-5 s-1). 
 
3. The kinetics of NAD+ association for the “parasitized” human enzyme Hs-
βATc-SAHH are similar to and intermediate between the data for the wild-type 
human enzyme Hs-SAHH and the wild-type trypanosomal enzyme Tc-SAHH (Fig. 
4.3., Table 4.3.; Fig. 4.6., Table 4.4.). In stark contrast, the “humanized” 
trypanosomal enzyme Tc-βAHs-SAHH exhibits an equilibrium dissociation constant 
for cofactor after slow binding that is 2-3 orders of magnitude weaker, roughly 
millimolar rather than micromolar, than for Hs-SAHH, Tc-SAHH, and Hs-βATc-
SAHH (Figs. 4.4 and 4.5., Table 4.3.). The slow binding rate constants, however, are 
similar for all four enzymes. The data for Tc-βAHs-SAHH are extremely similar to 
those, where available, for Pf.-SAHH (Figs. 4.4 and 4.5, Table 4.3., Fig. 4.6., Table 
4.4.). 
 
4. The results reported here for mutations in β-sheet A of the Rossmann motif, 
like those reported earlier [4] for mutations in helix 18 of the cofactor binding site, 
support the proposal [4, 6] that design of inhibitory ligands for binding to the cofactor 
site, rather than in the catalytic site, is a promising approach to anti-parasitic therapy.  
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Chapter 5 
 
The Role of Lysyl and Tyrosyl Residues of the C-terminal 
Extension in Comparative Kinetics of Cofactor Association 
and Dissociation for Hs-SAHH and Tc-SAHH. 
 
5.1. Introduction  
 
Several X-ray crystallographic structures of Hs-SAHH [1] and Tc-SAHH 
(unpublished data of Drs. Q.-S. Li and W. Huang) are available. Both SAHHs are 
homotetramers and each subunit contains a substrate-binding domain, a cofactor 
(NAD+/NADH)-binding domain and a C-terminal tail which covers the cofactor-
binding site of the neighboring subunit (Fig. 5.1.). A lysine and a tyrosine located on 
the C-terminal chain are very close to the NAD(H) cofactor in the x-ray structures 
and may make important contributions to the cofactor binding of the SAHHs. The 
studies of the kinetics and thermodynamics of the association and dissociation 
reactions of the nicotinamide cofactors study on cofactor binding of Hs-SAHH and 
Tc-SAHH, revealing significant differences in binding properties between these two 
enzymes. However, the atomic-level mechanism of the differential nicotinamide 
cofactor binding properties between Hs-SAHH and Tc-SAHH is not yet clear [4]. 
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Figure 5.1. The “dimer” structure of SAHHs [1]. The contributing monomers are 
shown in red and green, with cofactor ligands in blue ball-and-stick representation 
and a substrate-analog ligand in a gold ball-and-stick representation. The C-terminal 
extension of each monomer, containing helix 18, can be seen penetrating into the 
partner monomer to form part of the cofactor binding site (top left, in green; bottom 
right, in red). K426 (yellow) and Y430 (purple) are located in the final coil between 
helix 18 and the C-terminus.  
C-loop 
 162
To analyze microscopic differences in NAD binding to Hs-SAHH and Tc-
SAHH, we have performed calculations of cofactor binding free energies and 
computational alanine scanning (CAS) based on the Molecular Mechanics-
Generalized Born Surface Area (MM-GBSA) approach. The free energy calculations 
allow the identification of residues which contribute the most to cofactor binding. 
CAS is a different approach, using computational mutagenesis to provide predictions 
of key residues in protein structure and/or function [5]. According to the increased 
binding free energy caused by alanine mutation, residues may be divided into hot 
spots (> 4.0 kcal/mol), warm spots (2.0 – 4.0 kcal/mol) and null spots (< 2.0 
kcal/mol) [6]. The identified hot spots may then be used to guide further research on 
protein structure and function [5]. In present study, experimental mutagenesis was 
performed to test the computational calculations for two pairs of conserved residues: 
a lysine and a tryptophan in the C-terminal tail in both enzymes. 
 
5.2. Methods: 
 
5.2.1. Computational procedures:  
 
The starting crystallographic structures of Hs-SAHH and Tc-SAHH were 
downloaded from the Protein Data Bank (PDB), entries 1A7A and 1XBE, 
respectively. Calculations for another crystal structure of Hs-SAHH (PDB code: 
1IL4) yielded very similar results. Thus, only the data for the 1A7A structure are 
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shown in this study. The 1A7A structure was solved by incorporating selenium atoms 
(SE) in place of the sulfurs in Met residues. Assuming that this does not influence the 
structure, Se atoms were replaced by S atom and the residue names were changed 
from MSE to MET. After this modification, the 1A7A structure was ready for 
calculation. The simulation system was set up using the Xleap module of Amber 7 
software. According to the SAHH’s homotetramer structure, subunits A and B form a 
dimer, with the second dimmer formed by subunits C and D. To calculate the binding 
free energy of NADH to subunit A, our analysis includes the residues of subunit A as 
well as the C-terminal tail of neighboring subunit B, which forms close contacts with 
the NADH bound to A. In brief, the protein (AB dimer with two NADH bound) was 
solvated using a periodic truncated octahedral box of 29,419 water molecules, 
described by a TIP3P model [7], extended to a distance of 10 Å from any solute atom. 
The system was then neutralized by 16 sodium cations initially placed around the 
protein using a Coulombic potential on a grid.  Then all minimization and MD were 
performed in the Amber 7 suite of programs.  The ff99 force field (parm99) was used 
for proteins and NADH cofactor throughout the energy minimization and MD. The 
starting geometry of ligands was taken from the protein PDB files. The input files of 
ligands for MD simulation were prepared with the antechAmber program in Amber 7 
which uses the General Amber Force Field (GAFF).  Partial charges of the ligand 
atoms were calculated with the AM1-BCC method available in antechAmber [8].    
 
5.2.1.1. Energy Minimization.  
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The energy minimization was performed using the sander module in the 
Amber 7 suite of programs with the particle - mesh Ewald method for inclusion of 
long-range electrostatic interactions [9]. There were two stages of energy 
minimization.  In the first stage, only water molecules were minimized while the 
protein was fixed.  The second stage minimized the entire system.  Each stage was 
conducted with 500 cycles of steepest descent followed by 4500 conjugate steps of 
gradient minimization.  The non-bonded cutoff was set to 12.0 Å.    
 
5.2.1.2. Molecular Dynamics Simulations.  
 
The equilibration process was carried out in two stages following the protocol 
suggested in the Amber manual.  In the first stage, the system was heated gradually 
from a low temperature of 100 K to 300 K over 10 picoseconds (ps) simulation time 
with a time step of 2 femtoseconds (fs). A cutoff distance of 12 Å was used for the 
non-bonded interaction. The SHAKE algorithm was used to constrain the bonds 
involving hydrogen atoms and the force evaluations for these bonds were omitted.  A 
periodic boundary with a constant volume and without pressure control was used. 
Then a second 10 ps equilibration was continued under a constant pressure and a 
constant temperature with isotropic position scaling to adjust the density of water to 
experimental values. After that, the whole system was equilibrated for 100 ps under a 
constant temperature of 300 K and a constant pressure of 1 bar. The SHAKE 
algorithm and 2 fs time steps were employed through all MD stages. 
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A 500 ps production run was performed with the same protocol as in the final 
stage of equilibration.  After the simulation was completed, the ptraj module in 
Amber 7 was used to re-image the whole trajectory (including all equilibration and 
production runs), and to remove the waters and Na+ from the trajectory file, and to 
calculate the root-mean-square deviations (rmsd) of backbone atoms from the starting 
structure over the whole course. Fifty snapshots were taken at 2-ps intervals from the 
section of the MD trajectory where the rmsd reached a plateau were used for further 
analysis. These sections corresponded to a rmsd of about 1.7 Å for Hs-SAHH and a 
rmsd of about 1.3 Å for Tc-SAHH.  
 
5.2.1.3. Calculation of binding free energy by MM-GBSA.  
 
MM-GBSA was used in evaluating binding free energies of the cofactor 
NADH to SAHH. In this method, the thermodynamic cycle shown in Scheme 5.1. 
was used to calculate the binding free energy:  
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Scheme 5.1.: 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
Ligandsol  +   Receptorsol  Complexsol 
∆Gbinding 
-
∆Gsol 
(Ligand) 
Ligandgas  +  Receptorgas 
∆Ggas 
Complexgas 
-∆Gsol 
(Receptor) 
+ ∆Gsol 
(Complex) 
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The free energy of a molecule (ligand or receptor or complex), which is a sum 
of the internal energy, the electrostatic interaction energy, the van der Waals 
interactions, the free energy of polar solvation, the free energy of nonpolar solvation 
and the entropic contribution to the molecular free energy, is calculated as: 
 
Gmolecule = <Einternal> + <Eelectrostatic> + <EvdW> + <Gpolar-solvation> + <Gnonpolar-solvation> 
                                                                                                        - T∆S                  (1)  
 
Here, the symbol < > denotes an average over a set of snapshots along an MD 
trajectory. Einternal includes the bond, angle and torsional angle energies. Gpolar--solvation 
was calculated with the GB model of Sander. It describes the difference in 
electrostatic free energy between charging up the solute in vacuum and the solvent 
modeled as a dielectric continuum. The polar solvation process is equivalent to the 
transfer of a protein from one medium whose dielectric constant is equal to that of the 
interior of the protein to another medium whose dielectric constant is equal to that of 
the exterior of the protein. Gnonpolar-solvation includes cavity creation in water and van 
der Waals interactions between the modeled nonpolar protein and water molecules. 
∆Gnonpolar-solvation = γ A + b, where A is the solvent-accessible surface area calculated 
by Paul Beroza’s molsurf  program  with the values of the constant γ = 0.00542 
kcal/mol ⋅ Å and the constant b = 0.92 kcal/mol [10].  
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 The free energy of ligand (Cofactor) binding to receptor (Apoenzyme) to form 
the complex (Enzyme-cofactor) was calculated using the following equation:  
 ∆Gbinding = Gcomplex   - (Gcofactor + Gapoenzyme)   (2) 
 
 The above ∆Ggas is the interaction energy between ligand and receptor in the 
gas phase and ∆Gsol(ligand), ∆Gsol(receptor), ∆Gsol(complex) are the solvation free 
energies of ligand, receptor, and complex, which are estimated using a continuum 
approach.  
 
Normal-mode analysis was used to estimate conformational entropy -T∆S. 
Because this analysis requires extensive computer time, only six snapshots were taken 
in this study to estimate the order of magnitude of the conformational entropy.  Also 
the total number of atoms of the SAHH dimer (~16000) made calculations on the 
whole system impossible, so only one subunit was considered.       
 
5.2.1.4. Calculation of energy decomposition by MM-GBSA.  
 
 
MM-GBSA calculations were performed using the mm_pbsa.pl script in the 
Amber package. A single-trajectory approximation was used to estimate the free 
energy of NADH binding from trajectories of the SAHH:NADH complexes only and 
what approximations this entails, which was assumed to provide reliable information 
on the residues responsible for differential cofactor binding in human and parasitic 
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SAHHs and in the calculation of the binding free energy of NADH to subunit A. The 
SAHHs used in analysis includes subunit A and its neighboring residues, the C-
terminal tail of subunit B, which forms close contacts with the NADH bound to 
subunit A. The simulated complexes include inhibitor-bound enzyme [closed-form 
Hs-SAHH with DHCeA (pdb code: 1A7A) and closed-form Tc-SAHH with NepA 
(pdb code: 1XBE)] as well as cofactor NADH. Our assumption is that enzyme has the 
same conformation before and after cofactor binding, which may not be true. This 
assumption simplifies the calculation and focuses on the role of the residues in the 
experimentally determined complex structure on the binding free energy of cofactor 
to enzyme. Based on this assumption, the snapshots for enzyme and cofactor were 
extracted from the MD trajectory projections.  
 
5.2.1.5. Computational alanine scanning by MM-GBSA.  
 
 
For alanine scanning, alanine was used to replace selected protein residues 
one at each time. This alanine mutation was assumed not to cause a significant 
conformation change from wild type enzyme, so snapshot of the wild type trajectory 
were used in these calculations. The 38 residues within 5 Å of the NAD(H) binding 
site in SAHHs were used in the binding free energy calculation. The binding free 
energy differences between the mutant and wild type complexes are defined as:  
∆∆Gbinding = ∆Gbinding-mutant - ∆Gbinding-wild type    (3) 
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5.2.2. Experimental procedures: 
 
 
5.2.2.1. Construction of the mutants of Hs-SAHH and Tc-
SAHH.  
 
The wild type genes of Hs-SAHH and Tc-SAHH were inserted in the pPROK-
1 vector (Clonetech, CA), respectively.  Three alanine mutants (HsY430A, TcK431A, 
TcY435A) were prepared by the site-directed mutagenesis PCR.  The primer 
sequences are listed below: 
 
HsY430A:          5’-- CAAGCCGGATCACGCCCGCTACTGAGA -- 3’ 
                        
      5’ -- TCTCAGTAGCGGGCGTGATCCGGCTTG -- 3’ 
TcK431A:          5’ – ACGGCCCATTCGCGCCGGACCACTACC – 3’ 
                           5’ – GGTAGTGGTCCGGCGCGAATGGGCCGT – 3’ 
TcY435A:          5’ – AAGCCGGACCACGCCCGCTACTAATCG – 3’ 
                        
           5’ – CGATTAGTAGCGGGCGTGGTCCGGCTT – 3’  
 
The amplification reactions of HsY430A, TcK431A and TcY435A were 
performed in a volume of 50 µL containing 20 ng template, 25 pmol of 5’ and 3’ 
primers, 12.5 nmol of each deoxynucleoside triphosphate, 3 U native Pfu DNA 
polymerase (Stratagene), 6 µL 10x Pfu buffer and 2.5 µL DMSO.  The steps of the 
PCR program were set up as follows: 1) 92 °C for 4 mins; 2) 25 cycles of 92 °C for 
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30 sec, 52 °C for 30 sec and 68 °C for 20 mins; 3) 68 °C for 10 mins; 4) hold at 4 °C. 
The PCR products of HY430A and TcK431A were purified with a Qiagen PCR 
purification kit, while the PCR product of TcY435A contains two fragments of 
different sizes. The correct-size band (large size) was cut and collected from a 1 % 
DNA gel (low melting point) and then the PCR product was recycled by a Qiagen gel 
extraction kit. These three purified PCR products were digested by DpnI (Biolab) and 
transformed into E. coli competent cell stain JM109 (Sigma). The purified mutant 
genes were confirmed by DNA sequencing.   
 
5.2.2.2. Determination of contents of NADH in isolated Hs-
SAHH and Tc-SAHH mutants.  
 
The mutant proteins (395 µg in 90 µL of 50 mM phosphate buffer, pH 7.2, 1 
mM EDTA) were mixed with 10 µL of 1 M Na2CO3/NaHCO3, pH 10.7. Then a 
volume of 700 µL of 95 % ethanol was added to denature the proteins and release 
NADH into solution. After centrifugation for 10 mins at 18,760 xg to remove 
precipitated proteins, the fluorescence intensity of NADH was measured by a photon 
technologies QM-3 scanning luminescence spectrophotometer. The excitation 
wavelength was 340 nm and the emission wavelength was 450 nm. NADH standards 
were prepared ranging from 0.1–10 µM. The NADH content of SAHH inactivated by 
NepA was used as a control (100 % NAD+ reduced to NADH).  
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5.2.2.3. Determination of contents of NAD+ in Hs -SAHH and 
Tc-SAHH mutants.   
 
The mutant proteins (395 µg in 80 µL of 50 mM KPB, pH 7.2, 1 mM EDTA) 
were denatured by addition of 2 µL of 5 M HClO4.  Samples were centrifuged at 
18760 xg for 10 mins at 4 °C to remove precipitated proteins. Supernatant was 
injected into a reversed-phase C18 column (Vydac 218TP54, 300 , 5 µm, 4.5x250 
mm) to measure the concentration of NAD+ at 258 nm. The NAD+ standard curve 
was made for a range of 1-200 µM. NAD+ was eluted from the HPLC column at ~ 5.9 
min by a gradient of 2-10 % mobile phase B over 20 min with a flow rate of 1 
mL/min. Mobile phase A contained 10 mM 1-heptanesulfatic acid, 50 mM sodium 
phosphate, pH 3.2 and mobile phase B 80 % acetonitrile and 20 % 2-propanol.  
 
5.3. Results: 
 
5.3.1. Computational Results 
 
5.3.1.1. MM-GBSA calculation of the free energy of NADH 
binding indicates stronger binding to Hs-SAHH than 
to Tc-SAHH.  
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The calculated results are listed in Table 5.1. The free energy of binding of 
NADH to wild type Hs-SAHH is much more negative (-42.43 kcal/mol) than the free 
energy of binding of NADH to wild type Tc-SAHH (-26.75 kcal/mol). 
 
5.3.1.2. Single-residue contributions to free energy of NADH 
binding to Hs-SAHH and Tc-SAHH.   
 
Hs-SAHH and Tc-SAHH share about 70 % identity of their amino-acid 
sequences. In superimposed structures of Hs-SAHH and Tc-SAHH, with the 
superposition centered on the center of gravity of the cofactor ligand NADH, there 
are 38 protein residues within a spherical volume of 5-Å radius about the center of the 
cofactor. To identify protein residues with the largest contributions to differential 
cofactor binding of Hs-SAHH and Tc-SAHH, contributions to NADH binding free 
energy from every residue within 5Å of the cofactor binding site were calculated and 
the results are listed in Table 5.2. Thirty-four of these 38 residues (89 %) are identical 
in Hs-SAHH and Tc-SAHH. Four pairs of these identical residues (Hs#AaaTc#: 
191ASN193; 243GLU242; 426LYS431; 430TYR435), which are shown in red, make 
significantly different free-energy contributions to the binding of NADH to Hs-
SAHH and Tc-SAHH.  
 
5.3.1.3. Hot spots of Hs-SAHH and Tc-SAHH identified by 
computational alanine scanning.  
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Table 5.1.  Free energy calculation of NADH binding to the apo form of Hs-SAHH 
(pdb code: 1A7A) and Tc-SAHH (pdb code: 1XBE) using the Generalized Born (GB) 
method. The components are shown with the standard deviations of fit in parentheses.  
                                                  ∆G 
Cofactor + Apoenzyme                   Enzyme-cofactor complex 
 
∆G = G(complex)-[G(receptor) +G(ligand)] 
T∆S* was estimated for one chain bound with one substrate and one cofactor using 
normal mode because of the limitation of the software.  All other numbers were 
estimated for dimer with two substrates and cofactors bound.     
 
 [Refer Amber Manual 7: GAS – ∆Eelectrostatic + ∆EvdW + ∆Einternal; GBSUR – 
hydrophobic contribution to slovation free energy for GB calculations; GB – reaction 
field energy calculation by GB; GBSOL – GBSUR + GB; GBELE – GB + Eelectrostatic; 
GBTOT – GBSOL + GAS; ∆Gbinding = ∆GBTOT -T∆S.] 
 
 
Contribution Apo-Tc-SAHH + NADH 
(kcal/mol) 
Apo-Hs-SAHH + NADH 
(kcal/mol) 
∆Eelectrostatic 122.95 (12.03) 174.88 (17.38) 
∆EvdW -87.00  (4.29) -84.73 (5.46) 
∆Einternal 0.01 (0.02) 0.02 (0.02) 
∆GAS  35.96  (11.50) 90.17 (15.54) 
∆GBSUR -10.49 (0.16) -10.37 (0.18) 
∆GB -86.56 (10.15) -155.46 (13.43) 
∆GBSOL -97.05 (10.13) -165.83 (13.45) 
∆GBELE      36.39 (5.42) 19.42 (7.64) 
∆GBTOT -61.09 (4.46) -75.67 (6.81) 
T∆S* -34.34 -33.24 
∆Gbinding -26.75 -42.43 
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Table 5.2. Free energy contribution of the 38 residues within 5 Å of the NAD(H) 
binding site in Hs-SAHH and Tc-SAHH. The unit of free energy is kcal/mol. Four 
pairs of non-identical residues are shown in bold, while four pairs of residues are 
colored in red due to their significant difference in free energy contribution.  
Hs-SAHH 
Residues 
157 
THR 
158 
THR 
159 
THR 
181 
ASN 
186 
LYS 
190 
ASP 
191 
ASN 
195 
CYS 
219 
ALA 
220 
GLY 
Free energy 
Contribution 
-2.16 -6.26 -1.48 0.04 -0.72 0.10 -6.29 -0.60 -0.90 -1.55 
Tc-SAHH 
residues 
156 
THR 
157 
THR 
158 
THR 
180 
ASN 
185 
LYS 
189 
ASP 
190 
ASN 
194 
CYS 
218 
CYS 
219 
GLY 
Free energy 
Contribution 
-3.00 -6.88 -1.54 -0.29 -1.36 0.45 -1.55 -0.16 -0.86 -1.30 
 
Hs-SAHH 
Residues 
221 
TYR 
222 
GLY 
223 
ASP 
224 
VAL 
225 
GLY 
242 
THR 
243 
GLU 
244 
ILE 
245 
ASP 
248 
ASN 
Free energy 
Contribution 
-1.44 -5.23 -0.36 -5.19 -0.51 -0.15 -3.30 -3.06 0.27 -1.19 
Tc-SAHH 
residues 
220 
TYR 
221 
GLY 
222 
ASP 
223 
VAL 
224 
GLY 
241 
THR 
242 
GLU 
243 
VAL 
244 
ASP 
247 
ASN 
Free energy 
Contribution 
-0.79 -3.61 0 -4.71 -0.12 -0.23 -9.68 -2.42 0.16 -0.11 
 
Hs-SAHH 
Residues 
275 
THR 
276 
THR 
277 
GLY 
278 
CYS 
281 
ILE 
299 
ILE 
300 
GLY 
301 
HIS 
305 
GLU 
344 
LEU 
Free energy 
Contribution 
-0.26 -3.18 -0.27 -0.34 -1.23 -1.63 -1.41 -0.13 0.34 -0.60 
Tc-SAHH 
residues 
274 
THR 
275 
THR 
276 
GLY 
277 
ASN 
280 
ILE 
298 
ILE 
299 
GLY 
300 
HIS 
304 
GLU 
343 
LEU 
Free energy 
Contribution 
-0.13 -3.56 -0.96 -0.67 -0.98 -1.85 -1.09 -1.96 0.50 -0.52 
 
Hs-SAHH 
Residues 
346 
ASN 
353 
HIS 
407* 
THR 
409* 
LEU 
413* 
GLN 
417* 
LEU 
426* 
LYS 
430* 
TYR 
  
Free energy 
Contribution 
-2.84 -0.46 -0.99 -0.63 0.02 -0.17 -10.01 -3.87 
  
Tc-SAHH 
residues 
344 
ASN 
352 
HIS 
412* 
THR 
414* 
LEU 
418* 
GLN 
422* 
ILE 
431 * 
LYS 
435* 
TYR 
  
Free energy 
Contribution 
-2.08 0.06 -0.58 -0.19 0.12 -1.06 -2.65 -0.49 
  
*: These residues are from the tail of the second chain.   
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Based on the free energy contributions of the 38 pairs of residues, selected 
residues were replaced by alanine, computationally, one at a time. Comparing the 
difference from ∆Gbinging-mutant-∆Gbinding-wildtype (∆∆G) of Hs-SAHH and Tc-SAHH, 
residues contributing most to differential binding were identified. Table 5.3. lists four 
pairs of identical residues showing significant ∆∆G values (> 5.5 kcal/mol) and they 
are the same pairs of residues making significantly different free energy contributions 
of NADH to SAHH, which are highlighted in red in Table 5.2.  However, only the 
two pairs of residues located on the tail of the second chain were focused on in the 
following experimental research.  
 
5.3.2. Experimental Results 
 
5.3.2.1. Y430 in the C-terminal extension of Hs-SAHH may 
slightly influence binding of NAD+ and NADH to apo-
Hs-SAHH.  
 
The mutant HsY430A was purified and found to be of the correct molecular 
mass (190 kDa). It also possessed intact tetrameric structure (size exclusion 
chromatography). The enzyme is isolated from the expression system with 30 ± 5 % 
active-site occupancy by NAD+ (HPLC) and 86 ± 5 % active-site occupancy by 
NADH (fluorescence). Denaturation of the isolated enzyme yielded 3.1 ± 0.1 % 
adenosine and 81 ± 1 % adenine. Reconstitution of apo-HsY430A with NAD+ yielded  
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Table 5.3. Computational alanine scanning for the effect on cofactor binding affinity 
of four pairs of residues identical in Hs-SAHH and Tc-SAHH. The parameters are 
shown in the figures with the standard deviations of fit in parentheses. For the wild-
type enzymes, ∆Gbinding-wildtype = -75.67 ± 6.81 kcal/mol (Hs-SAHH); -61.09 ± 4.46 
kcal/mol (Tc-SAHH). ∆Gbinding is calculated from the 38 residues within 5 Å of the 
NAD(H) binding site in both enzymes. 
 
Hs-SAHH 
  
 
N191A 
 
E243A 
 
K426A 
 
Y430A 
 
∆Gbinding-mutant 
(∆Gbinding for the 
   Ala mutant)  
   kcal/mol 
 
 
-67.92 ± 
6.24 
 
-64.38 ± 
6.53 
 
-53.72 ± 
7.12 
 
-69.29 ± 
7.02 
 
  mutational effect  
  on ∆Gbinding, 
  ∆∆G, 
  kcal/mol 
 
 
 
7.8 ± 9.2 
 
 
 
 
11.3 ± 9.4 
 
 
 
22.0 ± 9.9 
 
 
 
6.4 ± 9.8 
 
     
 
Tc-SAHH 
 
 
N190A 
 
E242A 
 
K431A 
 
Y435A 
   
 ∆Gbinding-mutant 
   (∆Gbinding for the 
   Ala mutant)  
   kcal/mol 
 
 
-58.84 ± 
4.29 
 
-36.23 ± 
3.85 
 
-54.36 ± 
4.58 
 
-61.55 ± 
4.39 
 
  mutational effect  
  on ∆Gbinding, 
  ∆∆G, 
  kcal/mol 
 
 
 
2.3 ± 6.2 
 
 
 
 
24.9 ± 5.9 
 
 
 
6.7 ± 6.4 
 
 
 
- 0.5 ± 6.3 
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Protein with 79 ± 1 % occupancy (HPLC) and 70 ± 1% catalytic activity. 
Reconstitution of apo-HsY430A with NADH yielded protein with 94 ± 1% 
occupancy (fluorescence). 
 
5.3.2.2. K431 in the C-terminal extension of Tc-SAHH is 
required for the binding of NAD+ and NADH to apo-
Tc-SAHH.  
 
The mutant TcK431A was purified and found to be of the correct molecular 
mass (194 kDa) and possessed an intact tetrameric structure (size exclusion 
chromatography). The enzyme was isolated from the expression system with no 
NAD+ occupancy (detection limit 0.1 % active-site occupancy) and little NADH 
occupancy (1.30 ± 0.03 % active-site occupancy by fluorescence). Attempts at 
reconstitution with cofactor of apo-TcK431A yielded no detectable occupancy by 
either NAD+ or NADH. 
 
5.3.2.3. Y435 in the C-terminal extension of Tc-SAHH is 
required for tight binding of NAD+ and NADH to apo-
Tc-SAHH.  
 
The mutant TcY435A was purified and found to be of the correct molecular 
mass (194 kDa) and possessed an intact tetrameric structure (size exclusion 
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chromatography). The enzyme is isolated from the expression system with 18 ± 1 % 
active-site occupancy by NAD+ (HPLC) and 90 ± 1 % active-site occupancy by 
NADH (fluorescence). Denaturation of the isolated enzyme yielded 24 ± 1% 
adenosine and 65 ± 1 % adenine. Attempted reconstitution of apo-TcY435A with 
NAD+ or NADH yielded protein with no detectable cofactor occupancy. 
 
5.3.2.4. Rate constants for dissociation of NAD+ from mutant 
SAHHs HsY430A and TcY435A are 20-fold and 255-
fold larger, respectively, than those for the 
corresponding wild-type enzymes.  
 
Cofactor dissociated from the mutant enzymes is a simple first-order 
relaxation process as previously observed in other cases ([2, 4, 11] and unpublished 
data of Dr. Qing-Shan Li) in which the enzymatic activity proceeded from full 
activity to zero. Mutant HsY430A released cofactor at 30 °C, pH 7.4, with koff = 4.2 ± 
0.1 x 10-4 s-1 while the wild-type enzyme Hs-SAHH released cofactor with koff = 1.9 ± 
0.3 x 10-5 s-1. The mutation therefore increases the dissociation rate constant by a 
factor of about 20. Mutant TcY435A released cofactor at 24 °C, pH 7.4, with koff = 
2.8 ± 0.2 x 10-2 s-1 while the wild-type enzyme Tc-SAHH released cofactor with koff = 
1.1 ± 0.2 x 10-4 s-1. The mutation therefore increases the dissociation rate constant by 
a factor of about 255. The values of these rate constants are included with other data 
in Table 5.4.    
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5.3.2.5. Association kinetics of NAD+ with mutant SAHHs 
HsY430A and TcY435A.  
 
These mutant enzymes exhibited (Supporting information) association time 
courses like those seen with other SAHHs [[2, 4, 11] and unpublished data of Dr. Li]: 
fast binding occurred within the dead-time of the experiment giving rise to an initial 
enzyme activity Ao; slow binding ensued with an apparent first-order rate constant 
kapp and combined with Ao to give a final activity Af. Each of these three parameters 
is a function of [NAD+]. The expected dependences on the basis of a model to be 
described in the Discussion Section are given by eqs 1. 
 
Ao = (At/2){[NAD+]n/(Kno + [NAD+]n)}     (1a) 
Af  = (At){[NAD+]/(Kf + [NAD+])}      (1b) 
kapp  =  ka{[NAD+]/(Ka + [NAD+])}       (1c) 
 
Here At is the total enzyme activity at saturating [NAD+] after completion of 
both phases of binding. Figure 5.2. shows (a) the dependences on [NAD+] of the 
fraction of fast binding Ao/At, the fraction of slow binding (Af - Ao)/At, and the 
fraction of total binding Af/At; (b) the dependence of kapp on [NAD+] for the mutants 
HsY430A and TcY435A. The curves in Fig. 5.2. represent least-squares best fits of 
eqs 1 to the data, with parameters Ko, n, Kf, ka, and Ka as given in Table 5.4. 
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Figure 5.2. Above: The fractions of fast binding, slow binding, and total binding of 
NAD+ to the mutant enzyme HsY430A (left) and the value of the slow-binding rate 
constant kapp (right), both as a function of [NAD+]. Below: The fractions of fast 
binding, slow binding, and total binding of NAD+ to the mutant enzyme TcY435A 
(left) and the value of the slow-binding rate constant kapp (right), both as a function of 
[NAD+]. The curves are drawn from eqs 1 with the least-squares best-fit parameters 
given in Table 5.4. Note that the concentration scales for HsY430A are below 300 
µM while those for TcY435A go up to 5 mM.  
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5.4. Discussion 
 
5.4.1. MM-GBSA calculation of the free energy of cofactor NADH 
binding to SAHHs indicates stronger binding to Hs-SAHH than to 
Tc-SAHH.  
 
Previous experimental data shows that cofactor NAD(H) binds to Hs-SAHH 
more tightly than to parasite SAHH [4, 11]. Detailed studies on the kinetic properties 
of cofactor NAD(H) association and dissociation for both Hs-SAHH and Tc-SAHH 
have recently been reported and determined in chapter 4  [4]. In this work, we attempt 
to explain the differential cofactor binding properties between the two enzymes, 
focusing on the contributions of individual residues to cofactor binding affinity. The 
calculated binding free energies ∆Gbinding for NADH-Tc-SAHH (-26.75 kcal/mol) and 
for NADH-Hs-SAHH (-42.43 kcal/mol) (Table 5.1) indicate that cofactor NADH 
binds more favorably to the latter enzyme in qualitative agreement with the 
experimental results. Thus, reliable results on differential cofactor binding may be 
obtained from the single-trajectory approximation.  
 
5.4.2. Computed free-energy contributions of individual residues to the 
cofactor affinities of Hs-SAHH and Tc-SAHH identify four 
conserved residues as the locus of differential cofactor affinities.  
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The 38 residues within 5 Å of the NAD(H) binding site, which may form 
strong interactions with cofactor NAD(H), were chosen for this study. The structures 
of Hs-SAHH and Tc-SAHH were overlaid and 34 out of the 38 residue pairs were 
found to be identical. The four pairs of non-identical residues were, HsA219, 
TcC218; HsI244, TcV243; HsC278, TcN277; HsL417, TcI422, shown in boldface 
font in Table 5.2.. However, none of these four non-identical residues makes a 
significant free-energy contribution to the differential in the free energy of cofactor 
binding between Hs-SAHH and Tc-SAHH (Table 5.2.). In fact, it is four pairs of 
identical residues (shown in red in Table 5.2: Hs/Tc N191/190; E243/242; K426/431; 
Y430/435) that show the most significant differential free-energy contributions (from 
about 3.4 to 7.4 kcal/mol) to the cofactor binding of Hs-SAHH and Tc-SAHH.  
 
5.4.3. Computational alanine scanning allows selection of K426/435 and 
Y430/435 for experimental study of differential cofactor binding to 
Hs-SAHH and Tc-SAHH.  
 
Computational alanine scanning replaces individual residues with alanines, 
assuming the conformation of the rest of the protein remains unchanged [12]. 
Computed from the equation ∆∆Gbinding = ∆Gmutant - ∆Gwild type, the calculated binding 
free-energy changes can be seen in Table 5.3. for the mutant enzymes HsN191A, 
TcN190A; HsE243A, TcE242A; HsK426A, TcK431A; HsY430A, TcY435A. Table 
5.3. also shows the mutational effect on the binding free-energy change, which 
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exceeds the probable error only for HsE243A, HsK426A, TcE242A, and TcK431A 
(slightly). In these cases, the mean values are all positive indicating that the mutation 
decreases affinity for the cofactor. Even where the probable error exceeds the 
prediction, the mean values are all positive except for TcY435A. 
 
These findings confirm the computational results of residue free energy 
contribution (Table 5.2), which indicated these residues to play important roles in 
cofactor binding. In deciding which cases to address experimentally, we took note of 
the facts that Turner et al. [13] had identified HsK426 and HsY430 of special interest 
because they are “involved in interactions with the NAD bound predominantly to the 
other monomer,” an unusual feature of cofactor binding in SAHHs, and that Ault-
Riché et al [14] had prepared the mutant HsK426A and found it to be devoid of 
cofactor affinity and catalytic activity. We therefore decided to concentrate on 
HsK426, HsY430, and the corresponding residues of Tc-SAHH, TcK431 and 
TcY435. 
 
5.4.4. Y430 in the C-terminal extension of Hs-SAHH only slightly 
influences binding of NAD+ and NADH to apo-Hs-SAHH.  
 
The mutant HsY430A continues to bind NAD+ and NADH sufficiently 
strongly that the enzyme passes through the purification procedure from the 
expression system with essentially full occupancy of the cofactor sites (116 ± 7%). A 
 186
preponderance of the cofactor sites were occupied by NADH (86 ± 5%). Denaturation 
resulted in release of a small amount of adenine (ca. 3%) and a larger amount (81 ± 
1%) of adenosine. One possible explanation of these observations is that at least part 
of the NADH arose by oxidation of adenosine in the active site to 3’-ketoadenosine, 
which can decompose to adenine, the fragments then remaining in the active site in 
the “closed” conformation [1, 3] of the enzyme. The isolated enzyme could be 
converted to the apo-enzyme and reconstituted to around 79 % occupancy by NAD+, 
with the reconstituted enzyme exhibiting around 70 % of the activity of wild-type 
enzyme, which has full occupancy of NAD+. The HsY430A mutation thus has no 
major effect on the effective affinity of the enzyme for NAD+ or NADH, and little or 
no effect on the enzyme activity. 
 
5.4.5. K431 in the C-terminal extension of Tc-SAHH is required for the 
binding of NAD+ and NADH to apo-Tc-SAHH.  
 
The mutant TcK431A is the equivalent of the mutant HsK426A, prepared in 
previous work [11] and shown to have lost both cofactor affinity and tetrameric 
structure. TcK431A maintains its tetrameric structure but is isolated from the 
expression system without cofactor and cannot be reconstituted under normal 
conditions with either NAD+ or NADH. Thus, as with Hs-SAHH, this lysine residue 
is critical for cofactor affinity (it is thought to form hydrogen bonds to the 2’- or 3’-
OH group of the nicotinamide-bearing ribose ring [1]). It is striking that the mutation 
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causes loss of tetrameric structure in Hs-SAHH but not in Tc-SAHH. Previous 
comparisons ([4, 11] and unpublished data of Dr. Qing-Shan Li) of Hs-SAHH, Tc-
SAHH, and their mutants have suggested that Hs-SAHH possesses a structure more 
robust with respect to mutation, typically showing smaller changes in its properties 
upon mutation than does Tc-SAHH. The quaternary structure would seem to be an 
exception to the rule. 
 
5.4.6. Y435 in the C-terminal extension of Tc-SAHH is required for tight 
binding of NAD+ and NADH to apo-Tc-SAHH.  
 
The mutant TcY435A is the equivalent of HsY430A described above. Like 
HsY430A, the Tc-mutant is isolated with high occupancy of cofactor (mostly NADH) 
and releases a mixture of adenosine and adenine upon denaturation. Unlike 
HsY430A, the apo-form of the Tc-mutant no longer exhibits sufficient effective 
affinity for cofactor to permit reconstitution. The kinetic experiments reported here 
were conducted with enzyme as isolated from the expression system. 
 
5.4.7. Rate constants for dissociation of NAD+ from mutant SAHHs 
HsY430A and TcY435A are 20-fold and 255-fold larger, 
respectively, than those for the corresponding wild-type enzymes.  
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The alanine-scanning calculations predicted a reduced affinity for NADH of 
HsY430A of around 6 kcal/mol (about a factor of 104) and an increased affinity for 
NADH of TcY435A of around 0.5 kcal/mole (about a factor of 2-3), although the 
estimated errors in both values were larger than the values themselves. The 
experimental results, related to NAD+ rather than NADH, show that loss of the 
tyrosine in both enzymes increases the cofactor dissociation rate constant, but by a 
factor that is an order of magnitude larger than for the Tc-enzyme. This is consistent 
with the systematic observation cited above ([2, 4, 11] and unpublished data of Dr. 
Qing-Shan Li) that the human enzyme is less susceptible to mutational induced 
changes in its properties than the trypanosomal enzyme.   
 
5.4.8. Association kinetics of NAD+ with mutant SAHHs HsY430A and 
TcY435A.  
 
Cofactor combination with these mutant enzymes follows a model previously 
observed with Hs-SAHH, Tc-SAHH and various mutants of both ([2, 4, 11] and 
unpublished data of Dr. Qing-Shan Li). The elements of this model are the following: 
(1) The apo-enzyme possesses two equally numbered classes of active sites.  
(2) Half of the sites are capable of binding cofactor rapidly (during the dead time of 
the experiment), with a relatively low affinity, and generating the full activity of these 
sites. This phenomenon accounts for the fast-binding activity Ao observed at time 
zero from sites with cofactor-dissociation constant Ko and Hill coefficient n. 
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(3) Half of the apo-enzyme sites (slow-binding sites) are capable of binding cofactor 
rapidly, with a relatively high affinity (dissociation constant Ka), but generating 
initially no enzymic activity. These events initiate a time-dependent reorganization 
with rate constant ka in which the slow-binding sites acquire full enzymatic activity 
and all sites acquire a common cofactor-dissociation constant Kf, the final activity 
being Af. 
 
This model generates eqs 1 above, which were fit to the data as shown in Fig. 
5.2, producing the values of Ko, Ka, Kf, ka, and n given in Table 5.4. Table 5.4. also 
gives these values for Hs-SAHH and Tc-SAHH as determined previously [4]. Finally 
Table 5.4. gives values of the “on” rate constant for NAD+, estimated as described in 
the Materials and Methods section by two different methods, and the “off” rate 
constant for NAD+, obtained as described above. Together these allow the calculation 
of the equilibrium constant Kd for NAD+. 
 
Comparison of the association kinetics for the wild-type enzymes Hs-SAHH 
and Tc-SAHH show no dramatic differences. The value of koff is about 5-fold larger 
for Tc-SAHH and values for kon smaller by 2 or 3-fold; the result is a dissociation 
constant 10 or 20-fold larger.  
 
The mutant HsY430A has lower affinity for the fast-binding sites and a 
smaller reorganization rate constant ka than wild type Hs-SAHH, perhaps suggesting 
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that some of the binding and reorganization events involve Y430 or its neighbors. The 
mutant off-rate is over 20-fold larger and the on-rate 4-fold slower than for Hs-
SAHH, resulting in a dissociation constant larger by about 100-fold. 
 
The mutant TcY435A exhibits far more dramatic effects: the constants Ko, Ka, 
and Kf have all risen from the wild type Tc-SAHH values at approximately 
micromolar values to around millimolar values, indicating that these affinities are 
significantly damaged by the removal of the tyrosine residue. The rate constant for 
reorganization is unaffected but the off-rate of cofactor is increased by nearly 1000-
fold, while the on-rates are smaller by about 100-fold. The result is cofactor binding 
with a millimolar dissociation constant in the mutant, as compared to a sub-
micromolar dissociation constant for the wild-type Tc-SAHH. 
 
This relationship is similar to that for the HsY430A mutation and for the Tc-
SAHH/Hs-SAHH comparison: a somewhat smaller decrease in on-rate combines with 
a larger increase in off-rate to generate a weaker cofactor binding in the mutant 
enzyme compared to the wild-type enzyme or in Tc-SAHH compared to Hs-SAHH. 
 
5.5. Conclusion.  
 
Computational approaches and crystallographic structures of SAHHs suggest 
that a lysine residue and a tyrosine residue on a C-terminal extension of each subunit 
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that forms part of the NAD+/NADH binding site in a partner subunit might be critical 
for full cofactor affinity. Earlier work [14] showed that the mutation HsK426A of the 
human enzyme Hs-SAHH destroyed both cofactor affinity and the terameric structure 
of the enzyme. Here we show that the corresponding mutation TcK431A of the 
trypanosomal enzyme Tc-SAHH reduces cofactor affinity strongly but leaves the 
tetrameric structure intact, a rare example in which the trypanosomal enzyme appears 
more robust to mutational change than the human enzyme. The residue HsY430 
modulates the association-dissociation kinetics noticeably in the case of Hs-SAHH, 
generating by its mutation to Ala a decreased cofactor affinity of just under 100-fold. 
The corresponding mutation TcY435A decreased cofactor affinity by around 
100,000-fold. Both effects arise from a larger increase in the cofactor off-rate, 
combined with a smaller decrease in on-rate.   
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Figure 5.S1.  The dependence on the concentrations of NAD+ of the rate constants 
for the slow-binding phase of the association of NAD+ with the apo-forms of mutant 
HY430A and wild type Hs-SAHHa at 23 °C and pH 7.4. Some obvious signs of 
cooperativity for Hs-SAHH have been neglected and the data in both cases have been 
fitted to the simple hyperbolic saturation function of equation kapp = (ka)([NAD+]/{Ka 
+ [NAD+]}). The parameters are shown in the figures with the standard deviations of 
fit in parentheses.     a The figure of wild type Hs-SAHH is cited from reference [4]. 
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Figure 5.S2.  The dependence on the concentrations of NAD+ of the rate constants 
for the slow-binding phase of the association of NAD+ with the apo-forms of mutant 
TcY435A and wild type Tc-SAHH (the figure of wild type Tc-SAHH is cited from 
our paper submitted to Biochemistry [4, 11]) at 23 °C and pH 7.4. The data in both 
cases have been fitted to the simple hyperbolic saturation function of equation kapp = 
(ka)([NAD+]/{Ka + [NAD+]}). The parameters are shown in the figures with the 
standard deviations of fit in parentheses. 
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 Table 5.SI: Full tables of residue free energy contribution and alanine scanning.  
∆G WT-Hs = -75.67 (6.81) kcal/mol; ∆G WT-Tc = -61.09 (4.46) kcal/mol. 
Human (1a7a) 
 
 
157T 158T 191N 217A 224V 243E 244I 
Mutant (∆G) 
(kcal/mol) 
-73.80 
(6.62) 
-69.64 
(6.37) 
-67.92 
(6.24) 
-75.67 
(6.81) 
-73.21 
(6.57) 
-64.38 
(6.53) 
-72.29 
(6.74) 
∆∆G 
(kcal/mol) 
1.87 6.03 7.75 0 2.46 11.29 3.38 
   
 
  
 
 
T. Cruzi  159T 160T 193N 219C 226V 245E 246V 
Mutant (∆G) 
(kcal/mol) 
-56.92 
(4.42) 
-55.39 
(3.97) 
-58.84 
(4.29) 
-61.08 
(4.45) 
-58.05 
(4.44) 
-36.23 
(3.85) 
-59.52 
(4.35) 
∆∆G 
(kcal/mol) 
4.17 5.70 2.25 0.01 3.04 24.86 1.57 
 
Human(1a7a) 
 
 
276T 278C 279I 417L* 426K* 430Y* 
Mutant (∆G) 
(kcal/mol) 
-73.59 
(6.73) 
-75.18 
(6.83) 
-75.60 
(6.81)  
-75.43 
(6.80) 
-53.72 
(7.12) 
-69.29 
(7.02) 
∆∆G 
(kcal/mol) 
2.08 0.49 0.07 0.24 21.95 6.38 
     
  
T. Cruzi  278T 280N 281D 425I* 434K* 438Y* 
Mutant (∆G) 
(kcal/mol) 
-58.14 
(4.59) 
-60.63 
(4.43) 
-60.25 
(4.45) 
-59.83 
(4.52)  
-54.36 
(4.58) 
-61.55 
(4.39) 
∆∆G 
(kcal/mol) 
2.95 0.46 0.84 1.26 6.73 -0.46 
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Chapter 6 
 
Studies on Selective Anti-parasitic Inhibitors Based on 
Substrate Structure  
 
6.1. Introduction 
 
Modification of substrate structure is a common strategy in designing 
inhibitors. In our case, the nicotinamide cofactors are involved in a redox step of the 
catalytic mechanism of SAHHs [1], so that the different binding properties suggest a 
possible role in achieving differential inhibition of Tc-SAHH over Hs-SAHH for 
substrate analogs that undergo the redox reaction. However, the situation appears 
more complex. A screen of 122 substrate analogs kindly provided by Drs. Morris 
Robins and Stanley Wnuk (unpublished work) resulted in some selective inhibition of 
Tc-SAHH by only 12 (only one similar in activity to ribavirin, considered below) 
while the remainder showed no inhibition of either enzyme (89), roughly equivalent 
inhibition of both enzymes (10) or stronger inhibition of Hs-SAHH (11).  
 
Ribavirin (Fig. 6.1.), an antiviral drug [2], which is an analog of adenosine, 
has been reported to exhibit inhibition of Hs-SAHH [3]. In this study we report the 
selective inactivation by ribavirin of Tc-SAHH over Hs-SAHH and some of its 
kinetic features.  
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Figure 6.1. Top: Structures of ribavirin and adenosine. Bottom: Catalytic cycle of 
SAHHs in the synthetic direction, showing 3’-oxidation of substrate by the tightly-
bound NAD+ in the reactions leading to the intermediate, followed by 3’-reduction in 
the reactions leading from the intermediate to the final product. 
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6.2. Methods  
 
6.2.1. Measurement of NADH content vs. fraction of inactivation of 
enzyme activity.  
 
A set of ten samples of 120 µL 100 µM SAHH was incubated with 400 µM 
ribavirin (Sigma, R9644) in 50 mM phosphate buffer, pH 7.2, 1 mM EDTA, 100 µM 
NAD+ at 37 °C for 4-9 hours. SAHH activity was measured at times roughly 
corresponding to 25, 50, 75 and 100 % inactivation. Once the hydrolytic activity was 
reduced to a chosen level, the solution was immediately frozen with dry ice/ethanol. 
Just before analysis, the frozen solution was thawed and 90 µL of solution was 
transferred into a new tube and 10 µL of 1 M Na2CO3/NaHCO3 at pH 10.75 was 
added immediately. A volume of 700 µL of 95 % ethanol was added to denature the 
protein and release the NADH into solution. The precipitated proteins were removed 
by centrifugation and the supernatant was subjected to a fluorescence assay to 
determine the concentration of NADH released. The NADH released from SAHH 
that had been inactivated by NepA was measured as a control (100% NAD+ reduced 
to NADH by NepA).  
 
6.2.2. LC ESI+/MS analysis of SAHHs fully inactivated by ribavirin.  
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A volume of 60 µL 100 µM SAHH was incubated with 400 µM ribavirin in 
50 mM phosphate buffer, pH 7.2, 1 mM EDTA, 100 µM NAD+ at 37 °C for 4-9 
hours which roughly 100 % inactivated the activity of SAHH. ESI spectra were 
acquired on a Q-Tof-2 (Micromass Ltd, Manchester UK) hybrid mass spectrometer 
operated in MS mode and acquiring data with the time-of-flight analyzer. The 
instrument was operated for maximum sensitivity with all lenses optimized while 
infusing a sample of lysozyme. The cone voltage was 60 eV and Ar was admitted to 
the collision cell. Spectra were acquired at 11364 Hz pusher frequency covering the 
mass range 800 to 3000 amu and accumulating data for 5 seconds per cycle. Time-to-
mass calibration was made with CsI cluster ions acquired under the same 
conditions. Samples were desalted on a short column (3 cm x 1 mm ID) of reverse 
phase C18 resin (Zorbax, 5 µM, 300 Å).  Proteins (2.5 µg) were loaded onto the 
reverse phase column from H2O, washed in same and eluted with H2O directly into 
the ESI source. The resulting suite of charge states in the ESI spectrum were subject 
to charge state deconvolution to present a “zero” charge mass spectrum using the 
MaxEnt1 routine in MassLynxs software. Samples were also analyzed using a 
different (acidic) buffer system: loading buffer and washing buffer were 1% formic 
acid solution and elution buffer was 90% methanol and 0.5% formic acid.  
 
6.2.3. Kinetic model for enzyme inactivation by ribavirin.  
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The kinetic model used for the reaction between ribavirin and the NAD+ form 
of SAHH is shown in Scheme 6.1.a [4]. 
 
 
a E(NAD) represents the NAD+ form of SAHH; E-I(NAD) represents the complex of 
ribavirin bound to the NAD+ form of SAHH; E’I’(NADH) represents the complex of the 
oxidized ribavirin bound to the NADH form of SAHH; KI represents the equilibrium 
dissociation constant { KI = [E(NAD)][I]/[E-I(NAD)]}. 
 
The velocity v of inactivation is given by eq 1, where [E]0 represents the total 
concentration of enzyme in all forms. 
v = ki [E]0 [I]/(KI+[I])    (1) 
 
6.2.4. Equilibrium affinity of NADH forms of SAHHs for ribavirin.  
 
The equilibrium binding of ribavirin (R) to the enzymes reconstituted with 
NADH (E(NADH)) generates a complex E-R(NADH) shown in Scheme 6.2.  
 
 
The equilibrium dissociation constant KR (= [E(NADH)][R]/[E-R(NADH)]) could serve to 
some degree to estimate the relative affinity of Hs-SAHH and Tc-SAHH for the 
unoxidized drug.    
E(NAD) + 
I 
E-I (NAD) E’I’(NADH) 
ki 
KI 
E(NADH) + R  E-R (NADH) 
KR 
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The fluorescence intensity F0 of E(NADH) is greater than F, the fluorescence 
intensity in the presence of ribavirin. Assuming the fluorescence intensity is reduced 
by quenching in the complex E-R(NADH), F at a concentration [R] of ribavirin will be 
given by FE [E(NADH)] + FER [E-R(NADH)] where FE and FER are the intrinsic 
fluorescence intensities of the two forms of the enzyme and brackets denote 
concentrations. The normalized decrease in fluorescence intensity ∆F/[E]0 is then 
given by eq 2, where [E]0 is as above,  the total concentration of enzyme in all forms: 
∆F/[E]0 = F0/[E]0-F/[E]0 = FE - FE{KR/([R] + KR)} - FER {[R]/([R] + KR)} (2a) 
∆F/[E]0 = (FE – FER) {[R]/([R] + KR)}     (2b) 
∆F = (FE – FER) [E]0 {[R]/([R] + KR)}     (2c) 
Measurement of ∆F as a function of [R] will therefore yield FE, FER and KR. 
 
6.3. Results  
 
6.3.1. Inhibition by ribavirin of Tc-SAHH and Hs-SAHH is time-
dependent.  
 
Figure 6.2. shows that ribavirin inactivates both enzymes in a first-order 
reaction (ribavirin in 100-fold excess over enzyme). The first-order rate constant at 
this concentration of ribavirin is about six-fold larger for Tc-SAHH than for Hs-
SAHH (caption of Fig. 6.2.).  
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Figure 6.2. Time-dependent loss of activity of Tc-SAHH and Hs-SAHH during 
incubation with ribavirin. Tc-SAHH and Hs-SAHH, both 1 µM, fully reconstituted 
with NAD+, were incubated with 50 µM NAD+ and 100 µM ribavirin in phosphate 
buffer (pH 7.2) at 37 ºC. The activity of the enzymes was measured in the hydrolytic 
direction. The exponential curves shown yield first-order rate constants of (3.48 ± 
0.08) x 10-4 s-1 for Tc-SAHH and (0.57 ± 0.005) x 10-4 s-1 for Hs-SAHH. 
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6.3.2. Inactivation by ribavirin of Hs-SAHH and Tc-SAHH is 
accompanied by an increase in fluorescence.  
 
Figure 6.3. presents the time course of fluorescence emission at 450 nm 
(excitation 340 nm) as Hs-SAHH and Tc-SAHH are incubated with ribavirin. Fits of 
the data to eq 3 yield first-order rate constants of 4.05 ± 0.002 x10-4 s-1 for Tc-SAHH 
and 7.54 ± 0.006 x10-5 s-1 for Hs-SAHH, corresponding to the solid lines in Fig. 6.3. 
F = Fmax + (F0 - Fmax) exp (-kt)    (3) 
 
The values of Fmax/E0 are 2.27 ± 0.08 x 1010 M-1 for Tc-SAHH and 1.82 ± 
0.06 x 1010 M-1 for Hs-SAHH. Taking the value of the molar fluorescence of the 
enzymes reconstituted with NADH (3.13 ± 0.14 x 1010 M-1 for Tc-SAHH and 2.20 ± 
0.044 x 1010 M-1 for Hs-SAHH; see below in connection with Fig. 6.6.) as a standard 
of 100 %, the values of Fmax/E0 represent 72.5 ± 4.1 % (Tc-SAHH) and 82.7 ± 3.2 % 
(Hs-SAHH) of the fluorescence of ENADH. As a control experiment, Tc-SAHH and 
Hs-SAHH were incubated with NepA and the final fluorescence values determined. 
These were, compared to ENADH, 5.4 ± 0.3 % for Tc-SAHH and 2.4 ± 0.05 % for Hs-
SAHH.  
 
6.3.3 The fractional conversion of NAD+ to NADH in Tc-SAHH and Hs-
SAHH equals the fractional degree of inactivation by ribavirin.  
 
 205
0 5000 10000 15000
0
50000
100000
150000
200000
250000
Hs-SAHH, F
max
=182369 + 5663
Tc-SAHH, F
max
=226933 + 8429
Fl
u
o
re
sc
en
ce
 
In
te
n
sit
y
Time (sec)
 
 
 
Figure 6.3. Time course of the development of fluorescence during incubation of Tc-
SAHH and Hs-SAHH with ribavirin. Reconstituted NAD+ forms of Tc-SAHH and 
Hs-SAHH (10 µM) were incubated with 200 µM ribavirin and 100 µM NAD+ in 50 
mM phosphate buffer (pH 7.2), 1 mM EDTA at 37 °C. The wavelengths of excitation 
(340 nm) and emission (450 nm) are consistent with the conversion of NAD+ to 
NADH. The solid line represent fits of the data to a first-order relationship (eq 3), 
which yields F0 = -549 ± 49 (Tc-SAHH), 2196 ± 11 (Hs-SAHH); k = (4.05 ± 0.002) x 
10-4 s-1 (Tc-SAHH), (7.54 ± 0.006) x 10-5 s-1 (Hs-SAHH); and the values of Fmax are 
shown in the figure.  
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In order to ascertain whether the increase in fluorescence that accompanies 
ribavirin inactivation arises from the conversion of NAD+ to NADH in the course of 
inactivation, samples were quenched at specific levels of inactivation and the amount 
of NADH present was determined. Figure 6.4. shows a plot of the fractional 
conversion to NADH vs. the fractional level of inhibition for both Hs-SAHH and Tc-
SAHH. A linear fit to the total data set yields an intercept of 0.09 ± 0.04 and slope of 
0.89 ± 0.07, a linear fit to the data for Hs-SAHH yields an intercept of 0.15 ± 0.06 
and slope of 0.76 ± 0.08 and a linear fit to the data for Tc-SAHH yields an intercept 
of 0.01 ± 0.07 and slope of 0.99 ± 0.09. Thus the fractional conversion of NAD+ to 
NADH is equal to the fractional degree of inactivation for Tc-SAHH and probably for 
Hs-SAHH (predicted intercept 0.0 and slope 1.0). 
 
6.3.4. Time-dependent inactivation by ribavirin of Hs-SAHH and Tc-
SAHH conforms to a model of reversible binding followed by a 
slow inhibitory reaction.  
 
Figure 6.5. shows plots of the first-order rate constants at various ribavirin 
concentrations for the time-dependent inactivation by ribavirin of Hs-SAHH and Tc-
SAHH. The curves of v/[E]0 vs. concentration of ribavirin [I] are described by the 
hyperbolic function of eq 4. This expression corresponds to a reversible-binding step 
(equilibrium constant KI) followed by a slow development of inhibition with rate  
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Figure 6.4. Comparison with the fractional loss of enzyme activity with the fractional 
conversion of enzyme-bound NAD+ to NADH in the course of ribavirin-induced 
inactivation of Tc-SAHH and Hs-SAHH. Tc-SAHH and Hs-SAHH (100 µM, 
reconstituted with NAD+) were incubated with 400 µM ribavirin and 100 µM NAD+ 
in 50 mM phosphate buffer (pH 7.2), 1 mM EDTA at 37 °C. Samples frozen at 
various fractions of inhibition were later thawed and both activity in the hydrolytic 
direction and NADH content determined, the latter by liberation and fluorescence 
determination. The data for Tc-SAHH, for Hs-SAHH, and for both enzymes together 
are in reasonable agreement with the expectation for an equivalence of NADH 
formation and inhibition (see text for calculated slopes and intercepts). The straight 
line shown is for intercept =0 and slope = 1. 
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Figure 6.5. Dependence of the rate constant for slow inhibition of Tc-SAHH and Hs-
SAHH on the concentration of ribavirin. Tc-SAHH and Hs-SAHH (9.07 µM, 
reconstituted with NAD+) were incubated with various concentrations of ribavirin (0-
1.8 mM) and 50 µM NAD+ in 50 mM phosphate buffer (pH 7.2), 1 mM EDTA at 37 
°C. The initial velocity of the development of NADH was measured by use of 
fluorescence (excitation at 340 nm and emission at 450 nm). Data were fit to the 
hyperbolic saturation model (eq 4) and results are shown in Table 6.1. 
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constant ki and also corresponds to various more complex models [4]. The parameters 
obtained from the fit of the data to eq 4 are shown in Table 6.1. 
v/[E]0 = ki
 
[I]/(KI+[I])     (4) 
 
6.3.5. Ribavirin shows almost no discrimination in equilibrium binding 
to the NADH forms of Hs-SAHH and Tc-SAHH.  
 
Figure 6.6. shows that incubation of Hs-SAHH and Tc-SAHH, both 
reconstituted with NADH, with ribavirin leads to quenching of the NADH 
fluorescence. No NADH was released from the enzyme, so the quenching is 
presumably caused by binding of ribavirin adjacent to the NADH molecule in the 
active site. The data were fitted to the hyperbolic-saturation model of eq 2c. The 
dissociation constant KR of ribavirin from the ENADH:ribavirin complex was 407 ± 6 
µM for Hs-SAHH and 586 ± 12 µM for Tc-SAHH (see Supporting Information, 
Table S1). The initial molar fluorescence of ENADH were 3.13 ± 0.14 x 1010 M-1 for 
Tc-SAHH and 2.20 ± 0.044 x 1010 M-1 for Hs-SAHH; the final values for the 
complexes with unoxidized ribavirin were 1.69 ± 0.05 x 109 M-1 (5.4 ± 0.27 % of the 
value for ENADH) for Tc-SAHH and 1.90 ± 0.08 x 109 M-1 (8.6 ± 0.4 % of the value 
for ENADH) for Hs-SAHH.  
 
6.3.6. LC ESI+/MS analysis shows no evidence of covalent bond 
between ribavirin and SAHHs.  
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Table 6.1.a: Parameters describing the rate of slow inhibition at pH 7.2 and 37°C of 
Tc-SAHH and Hs-SAHH by ribavirin as a function of the concentration of ribavirin 
(eq 4). Experimental data and fitted curves are shown in Figure 6.5.  
 
aTc-SAHH and Hs-SAHH fully reconstituted with NAD+ (both enzymes at 9.07 
µM) were incubated with ribavirin (0-1.8 mM) and 50 µM NAD+ in 50 mM 
phosphate buffer (pH 7.2), 1 mM EDTA at 37°C. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Parameters of eq 4 Tc-SAHH Hs-SAHH 
KI (µM) 194 ± 12 266 ± 8 
ki (s-1)  7.6 ± 0.16 x 10-4 1.5 ± 0.02 x 10-4 
ki/KI (M-1s-1) 3.92 ± 0.26 0.56 ± 0.017 
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Figure 6.6. Dependence of the loss of NADH fluorescence of Tc-SAHH and Hs-
SAHH, both reconstituted with NADH, on the concentration of ribavirin. The 
enzymes (10 µM) were incubated with various concentrations of ribavirin (0-6 mM) 
in 50 mM phosphate buffer (pH 7.2), 1 mM EDTA at 37 °C. Data were fit to the 
hyperbolic saturation model (eq 2c) and results are shown in Table S1 of the 
supporting information.   
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The deconvoluted mass spectra show that the molecular weight of SAHHs fully 
inactivated by ribavirin is exactly the same as that of native SAHHs (see Supporting 
Information, Figure S1).   
 
6.4. Discussion 
 
6.4.1 Ribavirin exhibits time-dependent inhibition of both Hs-SAHH and 
Tc-SAHH with Tc-SAHH reacting about six-fold faster.  
 
Figure 6.2. shows that both enzymes react in a first-order fashion with 
ribavirin (in 100-fold excess), resulting in a completely inhibited enzyme after several 
hours for Tc-SAHH and considerably longer for Hs-SAHH (37 °C, pH 7.2). The ratio 
of first-order rate constants is around six, with Tc-SAHH reacting faster. 
 
6.4.2. Inactivation of Hs-SAHH and Tc-SAHH by ribavirin is 
accompanied by reduction of NAD+ to NADH.  
 
Figure 6.3. shows that the fluorescence of the solution at a wavelength 
characteristic of NADH increases in the presence of ribavirin with rate constants that 
are similar to those seen for the development of inhibition (the differences are very 
likely related to the somewhat different reaction conditions required for the 
fluorescence experiment). NADH is not released into the solution, so that the reduced 
cofactor remains bound to the enzyme. When the inhibition experiment was 
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interrupted and the enzyme denatured to release NADH, the data shown in Fig. 6.4. 
are obtained. The figure shows that for both enzymes, the fractional degree of 
reduction of cofactor is essentially equal to the fractional degree of inhibition of the 
enzyme: thus cofactor reduction and enzyme inhibition are parallel events. This 
suggests that ribavirin is a Type I inhibitor according to the classification of 
Borchardt and Wolfe (Scheme 6.3.) [5], reacting as a substrate through the initial 
redox reaction. The same behavior is observed in the presence or absence of Hcy (see 
Supporting Information, Table III), giving some indication that, on this time scale (12 
min), ribavirin undergoes 3’-oxidation but not the 4’,5’-elimination reaction which 
would have allowed Hcy to carry it through the catalytic cycle and restore the enzyme 
activity. This is characteristic of other Type I inhibitors such as DHCeA and NepA, 
which are tightly bound in the oxidized form. 
 
Scheme 6.3. Typical type I inactivation mechanism shown by inhibitor NepA. 
 
 
 
 
 
 
6.4.3. The kinetics of ribavirin inactivation of Hs-SAHH and Tc-SAHH 
correspond to the common model of time-dependent inhibition.  
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Figure 6.5. shows that the rate constants for time-dependent inhibition obey 
the general hyperbolic model for time-dependent inactivation (Scheme 6.1.) which in 
this case corresponds to a rapid, reversible binding step (equilibrium constant KI) 
followed by the essentially irreversible oxidation step with rate constant ki. The 
values of these parameters are given in Table 6.1. The initial binding is weak in both 
enzymes, with KI approaching millimolar values and the affinity slightly greater for 
Tc-SAHH. The oxidation step is about five-fold faster for Tc-SAHH and the second-
order rate constant reflecting both affinity and oxidation rates is about seven-fold 
greater for Tc-SAHH. 
 
6.4.4. Fluorescence differences upon binding and oxidation distinguish 
ribavirin from DHCeA and NepA.  
 
Both DHCeA and NepA in their oxidized forms quench the fluorescence of 
the NADH cofactor in the active site to about 2-5% of its fluorescence in ENADH with 
no other ligand. This behavior is seen with both Hs-SAHH and Tc-SAHH. Roughly 
the same is true if ribavirin itself (in the reduced form) is bound to the NADH form of 
either enzyme. In contrast the enzyme-inhibitor complexes of ribavirin continue to 
exhibit around 70-80% of the fluorescence of ENADH. This origin of this effect is 
unknown but one possibility is that the oxidized ribavirin is unstable in the active site 
and decomposes to generate compounds that do not quench the NADH fluorescence. 
The matter is under investigation.  
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6.4.5. LC ESI+/MS analysis excludes the possibility of irreversible 
covalent bond between ribavirin and SAHHs.  
 
The LC/MS analyses were performed both in H2O and in an acidic (1 % 
formic acid) environment. Water was chosen to avoid the possible acid-catalyzed 
degradation of the exposed ribavirin that may be covalently bound to SAHHs. 
Compared to native SAHHs, there is no increase of protein molecular weight in the 
deconvoluted mass spectrum of SAHHs fully inactivated by ribavirin. This 
observation shows there is no ribavirin (oxidized or reduced) or any fragment thereof 
covalently attached to the SAHHs. The information we have to date indicates that the 
conversion of NAD+ to NADH in the SAHH active site by 3’-oxidation of ribavirin 
is not accompanied by or succeeded by irreversible covalent bond formation to the 
enzyme. Among the possible circumstances are: (a) the oxidized ribavirin, intact or as 
its decomposition products, either remains in the active site or departs, with the main 
cause of inhibition being irreversible conversion of the enzyme to the non-
physiological form with NADH as the cofactor, a species which is normally restored 
to the NAD+ form in the second part of the catalytic cycle (Fig. 6.1.); (b) reversible 
covalent binding (e.g., 3’-Schiff’s base formation with lysine) is partially responsible 
for inhibition, the main reason still being “stalling” of the enzyme with cofactor in the 
wrong oxidation state.  
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6.5. Summary 
 
Ribavirin shows weak inhibitory selectivity for Tc-SAHH over Hs-SAHH in 
its time-dependent action. It also appears to inhibit the SAHH of P. falciparum 
selectively (see Supporting Information, Table S2) and may therefore be useful as a 
starting point in proceeding toward more selective inhibitors. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 217
6.6. References & Supporting Information 
1. Palmer, J.L. and R.H. Abeles, The mechanism of action of S-
adenosylhomocysteinase. J Biol Chem. , 1979. 254(4): p. 1217-26. 
2. Bougie, I. and M. Bisaillon, The broad spectrum antiviral nucleoside ribavirin 
as a substrate for a viral RNA capping enzyme. The Journal of Biological 
Chemistry, 2004. 279(21): p. 22124-30. 
3. Fabianowska-Majewska, K., J.A. Duley, and H.A. Simmonds, Effects of novel 
anti-viral adenosine analogues on the activity of S-adenosylhomocysteine 
hydrolase from human liver. Biochem Pharmacol, 1994. 48(5): p. 897-903. 
4. Cook, P.F. and W.W. Cleland, Enzyme Kinetics and Mechanism. Garland 
Sciences Publishing, New York and London, 2007: p. 196-204. 
5. Wolfe, M.S. and R.T. Borchardt, S-adenosyl-L-homocysteine hydrolase as a 
target for antiviral chemotherapy. J Med Chem. , 1991. 34(5): p. 1521-30. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 218
Supporting information: Table 6. Ia. Parameters describing the loss of NADH 
fluorescence from the NADH forms of Tc-sAHH and Hs-SAHH as a function of the 
concentration of ribavirin (eq 2c). Experimental data and fitted curves are shown in 
Figure 6.6.   
 
aTc-SAHH and Hs-SAHH fully reconstituted with NADH (both enzymes at 10 µM) 
were incubated with ribavirin (0-6 mM) in 50 mM phosphate buffer (pH 7.2), 1 mM 
EDTA at 37 °C. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Parameters of eq 2c Tc-SAHH Hs-SAHH 
FE (µM-1)-FER (µM-1) 29638.4 =31326.7-1688.3 20994.4 =21994.3-1899.8 
FE : FER 18.56: 1 11.6: 1 
KR (µM) 586 ± 12 407 ± 5.5 
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Supporting information: Table 6.IIa: Inactivation of Hs-SAHH, Tc-SAHH and Pf-
SAHH by ribavirin. Activity assay of SAHHs was performed in the synthetic 
direction by use of HPLC. 
 
aTc-SAHH and Hs-SAHH fully reconstituted with NAD+ (both enzymes at 0.816 µM) 
were incubated with 198 µM ribavirin in 50 mM phosphate buffer (pH 7.2), 1 mM 
EDTA at 22 °C for 30 min or 4hours. 
Inhibition (%) Hs-SAHH Tc-SAHH Pf-SAHH Time 
Ribavirin -7.7 15.6 9.9 30 min 
Ribavirin 13.0 52.5 41.7 4 hours 
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Supporting information: Table 6. III: Data of Figure 6.4. 
 
 Activity Inhibition (%) NADH Content (%) 
Tc-SAHH  39.04 ± 2.58 % 41.47 ± 0.45 % 
Tc-SAHH 56.30 ± 5.42 % 57.62 ± 0.56 % 
Tc-SAHH 73.24 ± 2.10 % 69.20 ± 0.76 % 
Tc-SAHH 95.42 ± 13.3 % 98.42 ± 1.11 % 
Tc-Positive Control 
(NepA) 
97.31 ± 10.85 % 100 ± 0.97 % 
 
 Activity Inhibition (%) NADH Content (%) 
Hs-SAHH 30.07 ± 1.37 % 41.17 ± 0.40 % 
Hs-SAHH 56.17 ± 0.96 % 53.98 ± 0.56 % 
Hs-SAHH 72.63 ± 1.69 % 69.81 ± 0.70 % 
Hs-SAHH 96.01 ± 4.29 % 90.94 ± 1.08 % 
Hs-Positive Control 
(NepA) 
98.43 ± 9.94 %  100 ± 1.07 % 
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Supporting information: Figure 6.S1: The deconvoluted mass spectra of native Hs-
SAHH (a) and inactivated Hs-SAHH by ribavirin (b). 
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Chapter 7 
 
Conclusion and Future Work 
 
7.1. Summary and conclusion 
 
In both mammals and parasites, SAHH plays a unique and important role in 
regulating methylation of macromolecules and small molecules. The goals of my 
project are to conduct comparative investigations of the properties of human and 
parasite SAHHs, which can be lead to design selective inhibitors against parasite 
SAHH over Hs-SAHH. This dissertation presents systematic studies on different 
kinetic and thermodynamic properties of cofactor NAD(H) association and 
dissociation between Hs-SAHH and Tc-SAHH using biochemical, biophysical and 
computational methods, as well as research on selective inhibitors against the 
parasitic enzyme Tc-SAHH.  
 
Chapter 1 summarizes the structure and mechanism of Hs-SAHH and Tc-
SAHH, which share more than 70 % identity in sequence. Both SAHHs are 
homotertramers and each subunit includes one substrate-binding domain, one 
cofactor-binding domain and an extended C-terminal tail. The kinetics and inhibitor 
binding are comparable in Hs-SAHH and Tc-SAHH. There is no significant 
difference in structure detected by comparing their available crystal structures. 
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Furthermore, it was reported that some properties of parasite enzymes are different 
from those of the human enzyme, such as parasite enzyme Tc-SAHH binding with 
cofactor more loosely than Hs-SAHH. Chapter 2 describes the basic features of 
cofactor association and dissociation to Hs-SAHH and Tc-SAHH. The equilibrium 
and kinetic properties of the association and dissociation of the cofactor NAD+ from 
Hs-SAHH and Tc-SAHH are qualitatively similar but quantitatively distinct. Both 
enzymes bind NAD+ in a complex scheme. The four active sites of the 
homotetrameric apo-enzyme appear to divide into two numerically equal classes of 
active sites. One class of sites binds cofactor weakly and generates full activity very 
rapidly (in less than a minute). The other class binds cofactor more strongly but 
generates activity only slowly (over 30 min). In the case of Tc-SAHH, the final 
affinity for NAD+ is roughly micromolar and this affinity persists as the equilibrium 
affinity. In the case of Hs-SAHH, the slow-binding phase terminates in micromolar 
affinity also, but over a period of hours, the dissociation rate constant decreases until 
the final equilibrium affinity is in the nanomolar range. The slow binding of NAD+ by 
both enzymes exhibits saturation kinetics with respect to the cofactor concentration 
but binding to Hs-SAHH has a maximum rate constant around 0.06 s-1, while the rate 
constant for binding to Tc-SAHH levels out at 0.006 s-1. In contrast to the complex 
kinetics of association, both enzymes undergo dissociation of NAD+ from all four 
sites in a single first-order reaction. The equilibrium affinities of both Hs-SAHH and 
Tc-SAHH for NADH are in the nanomolar range. The dissociation rate constants and 
the slow-binding association rate constants for NAD+ show a complex temperature 
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dependence with both enzymes, but the cofactor always dissociates more rapidly from 
Tc-SAHH than from Hs-SAHH, the ratio being around 80-fold at 37 °C and the 
cofactor binds more rapidly to Hs-SAHH than to Tc-SAHH above about 16 °C. These 
features present an opening for selective inhibition of Tc-SAHH over Hs-SAHH, 
demonstrated with the thioamide analogs of NAD+ and NADH. Both analogs bind to 
Hs-SAHH with about 40 nanomolar affinities but much more weakly to Tc-SAHH 
(0.6 to 15 micromolar). Nevertheless, both analogs inactivated Tc-SAHH to the 
extent of 60% (NAD+ analog) or 100% (NADH analog) within 30 min, while 
inhibition of Hs-SAHH approached 30% only after 12 h. The rate of loss of activity is 
equal to the dissociation rate of the cofactor and thus 80-fold faster at 37 °C for Tc-
SAHH. 
 
To provide explanations on the differential cofactor binding properties 
between Hs-SAHH and Tc-SAHH, Chapter 3 identified a local structure factor, helix 
18, as a target. The binding of NAD+ and NADH to SAHH appears structurally to be 
mediated by helix 18, formed by seven residues near the C-terminus of the adjacent 
subunit. Helix-propensity estimates indicate decreasing stability of helix 18 in the 
order Hs-SAHH > Tc-SAHH > Ld-SAHH > Pf-SAHH, which would be consistent 
with previous observations. We report the properties of Hs-18Pf-SAHH, the human 
enzyme with plasmodial helix 18, and Tc-18Hs-SAHH, the trypanosomal enzyme 
with human helix 18. Hs-18Tc-SAHH, the human enzyme with trypanosomal helix 
18, was also prepared but differed insignificantly from Hs-SAHH. Association of 
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NAD+ with Hs-SAHH, Hs-18Pf-SAHH, Tc-18Hs-SAHH, and Tc-SAHH exhibited 
biphasic kinetics for all enzymes. A thermal maximum in rate, attributed to the onset 
of local structural alterations in or near the binding site, occurred at 35, 33, 30, and 15 
°C, respectively. This order is consistent with some reversible changes within helix 
18 but does require the influence of other properties of the “host enzyme.” 
Dissociation of NAD+ from the same series of enzymes also exhibited biphasic 
kinetics with a transition to faster rates (that is the larger enthalpy of activation more 
than compensated by larger entropy of activation) at temperatures of 41, 38, 36, and 
29 °C, respectively. This order is also consistent with changes in helix 18 but again 
requiring the influence of other properties of the “host enzyme.” Global unfolding of 
all fully reconstituted holo-enzymes occurred at around 63 °C, confirming that the 
kinetic transition temperatures did not arise from a major disruption of protein 
structure. 
 
Chapter 4 identified another structure element responsible for the difference 
between cofactor binding properties of Hs-SAHH and Tc-SAHH, β-sheet A in the 
Rossmann motif. Mutagenesis, which was used in Chapter 3, was also performed in 
this study. Mutations V215T and V217C in β-sheet A of the Rossmann motif of Hs-
SAHH result in a “parasitized” enzyme Hs-βATc-SAHH, with β-sheet A similar to 
that of Tc-SAHH. Mutations T214V and C216V of Tc-SAHH result in a “humanized” 
enzyme Tc-βAHs-SAHH with β-sheet A similar to that of the Hs-SAHH. Both Hs-
βATc-SAHH and Tc-βAHs-SAHH possess intact homotetrameric structures and 
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secondary structure nearly identical to those of the parent enzymes. The catalytic 
kinetics are also unaffected by these mutations. However, the kinetics of association 
and dissociation of the NAD+ cofactor show significant effects. The first-order 
dissociation rate constants of the mutant enzymes fall below the large dissociation 
rate constant of Tc-SAHH and above the small dissociation rate constant of Hs-
SAHH. Cofactor dissociation for Hs-βATc-SAHH is only slightly faster than for Hs-
SAHH and dissociation for Tc-βAHs-SAHH is substantially slower than for Tc-
SAHH, as expected if the structure of β-sheet A is more robust to mutational effects in 
Hs-SAHH than in Tc-SAHH. The temperature dependence of the rate constant for 
cofactor dissociation is biphasic for both mutant and wild-type enzymes, with the 
Eyring curves for the mutants lying between those for the wild-type enzymes; again 
the mutational effect is larger for Tc-SAHH than for Hs-SAHH. The association 
process of the cofactor with apo-Hs-βATc-SAHH follows the same fast-binding/slow-
binding scheme observed with the wild-type enzymes and with very similar kinetics 
(in particular, initial binding at micromolar levels of cofactor). In contrast, Tc-βAHs-
SAHH underwent cofactor binding only at millimolar levels, such that it was not 
possible to establish clearly that the overall kinetic scheme was the same as Hs-
SAHH, Hs-βATc-SAHH, and Tc-SAHH. The kinetics of cofactor association with Tc-
βAHs-SAHH was, however, qualitatively and quantitatively similar to that of the 
wild-type Pf-SAHH. These results support the view that drug-design targeted to the 
cofactor binding site is a promising avenue for anti-parasitic therapy. 
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Based on the available X-ray structures of the SAHHs, the Molecular 
Mechanics-Generalized Born Surface Area (MM-GBSA) method was applied with 
computational alanine scanning to predict residues which are important for the 
differential cofactor binding properties of Hs-SAHH and Tc-SAHH, within 5 Å of the 
cofactor NAD(H) binding site. Chapter 5 describes the computational predictions 
and experimental evidence. The only non-identical residues in this range make no 
contribution to differential cofactor binding between Hs-SAHH and Tc-SAHH. On 
the other hand, four pairs of identical residues are shown by computational alanine 
scanning to differentiate cofactor binding to Hs-SAHH and Tc-SAHH. Experimental 
mutagenesis was performed to test these predictions for a lysine and tyrosine residue 
of the C-terminal extension that penetrates a partner subunit to form part of the 
cofactor binding site. The K431A mutant of Tc-SAHH (TcK431A) loses its cofactor 
binding affinity but retains the wild type tetrameric structure, while the corresponding 
mutant of Hs-SAHH (HsK426A) loses cofactor affinity and also tetrameric structure 
[Ault-Riche et al. (1994) J Biol Chem. 269(50):31472-8.] The tyrosine mutants 
HsY430A and TcY435A change the NAD+ association and dissociation kinetics, with 
HsY430A increasing the cofactor equilibrium dissociation constant from around 10 
nM (Hs-SAHH) to about 800 nM and TcY435A increasing the cofactor equilibrium 
dissociation constant from around 100 nM (Tc-SAHH) to about 1 mM. Both changes 
result from larger increases in off-rate combined with smaller decreases in on-rate. 
Overall, the lysine and tryptophan predicted by computational alanine scanning play 
important roles in differential cofactor binding of SAHHs.  
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Further attempts to design and search for selective inhibitors against Tc-
SAHH were performed. Besides the cofactor-binding site identified as a plausible 
target site based on above obtained data (Chapter 2-5), the substrate-binding domain 
as a traditional design site for inhibitor was selected. Ribavirin (1, 2, 4-triazole-3-
carboxamide riboside) is a well-known antiviral drug. Ribavirin has also been 
reported to inhibit Hs-SAHH. Chapter 6 describes how ribavirin, which is 
structurally similar to adenosine, produces time-dependent inactivation of Hs-SAHH 
and Tc-SAHH. Ribavirin binds to the adenosine-binding site of both SAHHs and 
reduces the NAD+ cofactor to NADH. The reversible binding step of ribavirin to Hs-
SAHH and Tc-SAHH has similar KI
 
values (266 and 194 µM), but the slow 
inactivation step is five fold faster with Tc-SAHH. Ribavirin may provide a structural 
lead for design of more selective inhibitors of Tc-SAHH as potential anti-parasitic 
drugs.   
 
Overall, studies on differential cofactor association and dissociation properties 
between Hs-SAHH and Tc-SAHH should help us to better understand these two 
enzymes and lead to the design of more selective inhibitors for the treatment of 
Chagas disease.  
 
7.2. Potential future work 
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Besides the extended C-terminal tail and the first β-sheet of the Rossman 
motif, it is possible that additional structural elements may cause differences in the 
properties between the human and parasite enzymes. Improved computational 
methods can be very helpful in providing more accurate and useful information in this 
regard.  
 
As mentioned in Chapter 2, the cofactor binding process consists of two 
phases: a fast-binding phase (the dead time of binding) and a slow-binding phase. 
Stopped-flow rapid mixing is a technique which can detect ligand-binding reactions 
occurring on time scales as short as a few milliseconds. So the kinetics of cofactor 
binding to apo-SAHHs in the fast-binding phase can be measured by this method. 
Analysis of this cofactor fast-binding phase should improve our cofactor association 
model which was created based on data primarily from the slow-binding phase. 
Moreover, the binding process of cofactor to the apo-form of SAHHs can be 
simulated using available crystal structures and these data could improve our 
understanding of cofactor binding.   
 
In Chapter 5, computational alanine scanning predicted that four pairs of 
identical residues of Hs-SAHH and Tc-SAHH could cause differential cofactor 
binding properties. Due to limited time and computer resources, only two pairs of 
residues (LYS and TYR located on C-terminal tail) were chosen for this mutagenesis 
study. The other two pairs of identical residues (ASN located in the hinge region and 
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GLU located in cofactor-binding domain) could also be mutated to alanine for further 
studies. If the cofactor binding properties of these mutations matches the 
computational predictions, this will confirm that residue ASN191 of Hs-SAHH and 
residue GLU245 of Tc-SAHH could be evaluated for their roles in cofactor association 
and dissociation.     
 
Finally, Tc-SAHH is one of the parasite SAHHs of significant interest. 
Similar studies could be performed on other parasite enzymes, such as Pf-SAHH and 
Ld-SAHH, to help design either broad-spectrum or more specific anti-parasitic drugs.  
 
 
 
 
 
 
 
